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Abstract 
 
There is an increasing demand by regulators, pharmaceutical manufacturers and industry for 
reliable and ethically acceptable model systems to assess and predict the toxicity of 
pharmaceutical products, chemicals, and waste.  In particular, developmental toxicity of 
compounds has largely been ignored in the past raising massive concerns. While cell lines have 
great merits as test systems, they do not reflect the complexity of a developing embryo. Zebrafish 
and their embryos have been used in toxicity assays in the past and have a great potential for 
studying reproductive toxicity and the molecular basis of developmental toxicity. 
 
Toxicogenomics is a powerful tool for compound classification based on mechanistic studies, 
which could eventually lead to the prediction of the toxicity of novel compounds.  I have carried 
out here a systematic toxicogenomic study of zebrafish embryos with the aim to develop this 
system further as a model for molecular developmental toxicity studies. Questions such as stage- 
and compound specificity were addressed. The toxicogenomic responses to a series of 6 test 
compounds were highly stage-dependent. Moreover, exposure of late embryonic stages between 
96 and 120 hours post-fertilisation induced transcriptional profiles that are characteristic for 
specific compounds. This leads to the identification of 199 genes that are induced by at least one 
of the 11 compounds including a number of signature genes that appear specific for individual 
compounds or compound groups within the set of chemicals investigated. Moreover, I have tested 
whether one can observe toxicogenomic responses in the absence of apparent morphological 
effects. In several instances robust gene responses were measured at concentrations that did not 
have obvious morphological effects. This raises hopes that toxicogenomic studies in the zebrafish 
embryo could be used to predict chronic effects of low level exposure. In situ hybridisation of a 
number of selected genes showed that the responses can be highly tissue restricted indicating that 
the whole mount protocol developed here is highly sensitive.    
 
In conclusion, this toxicogenomic analysis, demonstrated that zebrafish embryos may be suitable 
to study the transcriptional responses to toxicants with high specificity and more sensitivity. The 
zebrafish may thus be developed into a system that will not only help to elucidate the molecular 
mechanisms of toxicity but may be also useful to predict the developmental toxicity of novel 
chemicals by comparison of toxicogenomic profiles.  
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Zusammenfassung 
 
Der Bedarf seitens Regulatoren, pharmazeutischer Hersteller und der Industrie an 
verlässlichen und ethisch vertretbaren Modellsystemen zur Bewertung und Vorhersage 
der Toxizität pharmazeutischer Produkte, Chemikalien und von Abfall steigt beständig. 
Insbesondere die Entwicklungstoxizität von Verbindungen wurde in der Vergangenheit 
weitestgehend ignoriert, wodurch massive Bedenken aufkamen. Zelllinien besitzen eine 
hohen Stellenwert als Test Systeme, reflektieren aber nicht die Komplexität eines 
Embryos. Zebrafische und deren Embryonen wurden bereits für Toxizitäts-Assays 
eingesetzt und besitzen großes Potential, um Reproduktionstoxizität und die molekulare 
Grundlage der Entwicklungstoxizität zu untersuchen. 
 
Die Toxikogenomik liefert ein leistungsfähiges Instrument zur Verbindungs-
Klassifizierung basierend auf mechanistischen Studien, wodurch letztlich eine Toxizitäts-
Prognose neuer Verbindungen möglich wird. Ich habe in der vorliegend Arbeit eine 
systematische toxikogenomische Studie an Zebrafischembryonen mit dem Ziel 
durchgeführt, dieses Testsystem zu einem Modell für Studien molekularer 
Entwicklungstoxizität weiterzuentwickeln. Fragen der Spezifität bezüglich Stadium und 
Verbindung wurden behandelt. Die toxikogenomische Antwort auf eine Serie von 6 
Verbindungen erwies sich als hochgradig abhängig vom Stadium. Darüber hinaus wurden 
nach Exposition später embryonaler Stadien zwischen 96 und 120 Stunden nach der 
Befruchtung Transkriptions-Profile induziert, welche charakteristisch für spezifische 
Verbindungen waren. Dies führte zur Identifizierung von 199 Genen, die zumindest 
durch eine von 11 Verbindungen induziert wurden, inklusive einer Reihe von Genen, 
welche sich als spezifisch für individuelle Verbindungen oder Verbindungs-Klassen 
erwiesen. Weiterhin habe ich untersucht, ob die Beobachtung einer toxikogenomischen 
Antwort ohne sichtbaren morphologischen Effekt möglich ist. In einigen Beispielen 
konnten stabile Gen-Antworten in Konzentrationsbereichen gemessen werden, bei denen 
keine offensichtlichen morphologischen Effekte auftraten. Dies lässt hoffen, dass 
toxikogenomische Studien an Zebrafischen-Embryonen zur Prognose chronischer 
Toxizität nach Exposition mit geringen Konzentrationen eingesetzt werden können. In 
situ-Hybridisierungen von einer Reihe ausgewählter Gene haben gezeigt, dass die 
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Antworten hohe Gewebespezifität zeigen, was ein hohes Mass an Sensitivität des hier 
entwickelten „whole-mount“ Protokolls indiziert. 
 
Schließlich zeigen die toxikogenomischen Analysen, dass sich Zebrafisch-Embryonen 
zur Untersuchung transkriptioneller Antworten auf Toxine mit hoher Spezifität und 
Sensitivität eignen. Der Zebrafisch kann daher möglicherweise zu einem System 
entwickelt werden, dass nicht nur bei der Aufklärung der molekularen Toxizitäts-
Mechanismen hilft, sondern auch in der Prognose der Entwicklungstoxizität neuer 
Chemikalien durch Vergleich von toxikogenomischen Profilen nützlich sein kann. 
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1. Introduction 
 
We are confronted with a steadily increasing number of compounds including 
pharmaceuticals, industrial products or waste with numerous potential sources of 
exposures. The impact of anthropogenic compounds on ecosystems and human health is 
an urgent and international issue since there is an ever-increasing number of examples of 
environmental disturbance, likely to affect biota and human health. Synergies and 
longterm low-dose effects, between this plethora of distinct chemicals increase the 
complexity or the potential toxic effects on the environment and human health.  
 
Classically, conventional toxicology methods assess potential adverse health outcomes 
resulting from chemical exposure by using gross endpoints such as morphological or 
body and organ weight changes and histopathological observations. However, the 
analysis of histopathological or biochemical markers provide less information about a 
toxicant’s mechanism of action. In addition, gross pathological changes are insensitive 
for detecting toxicity at low doses or early time point leading to incorrect assessment of 
potential toxicity or safety. In order to better evaluate the hazard associated with exposure 
to chemicals, we need to understand the specific mechanism of action of a toxicant. We 
are, however, far from a comprehensive understanding and assessment of chemical 
toxicity. 
 
The number of molecular studies aimed at understanding the mechanism of toxicity is 
relatively small. ``Much of the so-called mechanistic research to date has been 
descriptive, whether at the level of the whole animal, the cell or at the molecular level. 
But in fact, it is still largely describing the parts and phenomena`` (Moore MN., 2002). 
These are not really addressing the core problem of how complex molecules interact with 
and are affected by contaminant chemicals. Changes in regulatory laws have created the 
need to assess the toxic effect of thousands of chemicals. Effective methods to elucidate 
the molecular mechanism of toxicity and eventually make predictions of the toxic 
potential of novel compounds have to be developed. 
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1.1 Toxicogemomics 
The term toxicogenomics has been described as ‘an emerging discipline that combines 
expertise in toxicology, genetics, molecular biology, and environmental health to 
elucidate the response of living organisms to stressful environments (Ramos., 2003).  The 
‘-omics’ part of toxicogenomics also encompasses several other types of profiling 
technologies including protein profiling and metabolite profiling in a cell or tissue. The 
applications for toxicogenomics are diverse and include either mechanistic or predictive 
goals. Microarray-based approaches have the well-touted potential to be used for 
predictive toxicology with the ever expanding availability of large data sets of 
toxicogenomic data (Hamadeh et al., 2002; Pennie et al., 2001).   
 
A novel toxicant may be identified by comparing the expression pattern it elicits with the 
expression patterns of known chemically induced expression ‘signatures’. There is no 
doubt that toxicogenomic applications will lead to more effective and safer drug 
development, and will play an ever-increasing role in regulatory decisions leading to 
improved human health. There are challenges in using toxicogenomic approaches for 
mechanistic-based studies. As one pores over reams of toxicogenomic data, it is 
extremely difficult to glean mechanistic explanations linking the chemical exposure to 
the observed alterations in proximal and distal gene expression changes. Data enrichment 
through novel bioinformatics techniques has great potential, however, there are currently 
insufficient data sets to explain ever the simple chemically induced transcriptional 
responses. It is considerable more difficult to rationally explain the complex biological 
response by the genes found altered by a given chemical or drug. But the identification of 
chemically mediated gene expression changes that are associated with observed toxicities 
at multiple life stages within and across species, will likely get us closer to important 
players in the toxic response. The identification of these genes will open up opportunities 
for molecular and genetic based studies. 
 
The measurement of gene expression levels upon exposure to a chemical can both 
provide information about the mechanism of action and form a sort of genetic signature 
from the pattern of gene expression changes. Furthermore the development of such gene 
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expression signatures would allow fast screening of unknown or suspected toxicants on 
the basis of their similarity to known toxicants (Lettieri., 2006).  
 
1.2 DNA-microarray 
 
The field of DNA microarray has evolved from EM Southern’s key insight (Southern 
1975) showing that labeled nucleic acid molecules could be used to interrogate nucleic 
acid nucleotides attached to a solid support. The Southern blot is considered to be the first 
DNA array (Southern 2000). Essentially the availability of the complete human and 
several other organisms (Drosophila, mice, and fish) genome sequences made the high 
throughput DNA array to become a practical method. Additionally, several new and 
highly sensitive techniques have been developed to promote the DNA microarray 
application. The first was the use of nonporous solid support, such as glass, which has 
facilitated the miniaturization of the array and the development of fluorescence-
hybridization detection (Lochhart et al., 1996; Schena et al., 1995,1996). The second 
critical innovation was the development of methods for high-density spatial synthesis of 
oligonucleotides, which allows the analysis of thousands of genes at the same time. Third 
some specific mathematic analysis methods and software have been developed, which are 
used for microarray data analysis.  
 
Nucleic acid microarrays use short oligonucleotides (15-25 nt), long oligonucleotides 
(50-120 nt) and cDNA (100-3,000 nt) as array elements. The short oligonucleotides are 
used primarily for the detection of single-nucleotide polymorphisms. The cDNA 
elements are readily obtained form cDNA libraries and are typically used for organisms 
for which only a limited part of the whole genome information is available. The 
oligonucleotides or cDNA are spotted onto solid support, such as glass, by using high 
speed robotics. Sample detection for microarrays on glass involves the use of probes 
labeled with fluorescent nucleotides. Fluorescent probes are generated from control and 
test RNA samples in single round reverse transcription reactions or amplified samples 
from limited start materials in the presence of fluorescently tagged dUTP or dCTP (Cy3-
dUTP and Cy5-dUTP), which produces control and test products labeled with different 
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fluorochromes. The cDNA generated from these two populations, collectively termed the 
probe, are then mixed and hybridization to the array under a glass coverslip (Nuwaysir et 
al., 1999). The fluorescent signal is detected by using a scanner and data are analyzed 
with some specific analysis software that determines for each spot feature the ratio of 
Cy3 and Cy5, corrected for the local background.    
 
Although there is tremendous potential for proteomics, and metabolomic approaches, 
with the state of current technology, microarray based gene expression profiling is the 
most feasible means by which to rapidly, and cost effectively, interrogate the sum 
biological response to chemical and drug exposure. DNA microarrays provide a great 
platform to perform genome-wide gene expression analysis through comparison of 
virtually and two biological samples. The limitations of DNA microarray are its ability to 
study only the mRNA levels and are not as sensitive for detecting small changes in gene 
expression.  
 
I exposed zebrafish embryos at different developmental stages to a range of different 
toxicants and measured the changes in gene expression profiles by hybridization of 
cDNA to an oligonucleotide microarray. The overall aim was to establish the zebrafish 
embryo as a toxicogenomic sensor for monitoring environmental toxicants. To provide 
some knowledge for my study, this chapter presents the basic information of DNA 
microarray and toxicogenmics; adverse effects of toxins; the advance of molecular 
mechanism of these toxins. Later I will finally define the aim of my work more precisely. 
 
1.3 Model organism selection 
 
If genetic approaches are to be utilized to understand the mechanism of toxicity, simple 
whole organism systems such as the nematode, fruit fly or zebrafish may offer powerful 
advantages. First, these models enable rapid assessment of integrative system-level 
effects of chemicals and drugs. The scientific validity of using these system-based 
models developmental and neurotoxicitase conserved across species. This coupled with 
the fact is based on the assumption that the mechanism of genomes of these three 
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organisms have been completely sequenced, provides the potential to integrate 
developmental toxicity studies at the biochemical, cellular and molecular levels with 
observations at the structural and function level. This, in turn, will facilitate the 
construction of a genomics database for use in predicting developmental toxicity 
potential across species at the most fundamental level of homology. Of the three systems-
based models, zebrafish exhibit several characteristics not shared by nematodes or flies 
that we believe make the zebrafish more immediately useful for developmental toxicity 
evaluations. For example, there are significant differences in genome structure between 
vertebrates and invertebrates (Postlethwait et al., 1998; 2000). Thus, while genes may 
share functional homology across species, mechanisms of gene regulation may differ 
significantly between invertebrates and vertebrates. Also, invertebrate physiology does 
not reflect the organization and size of that in vertebrates and so precludes direct 
comparisons between invertebrate and vertebrate toxicity. In contrast, the overall 
organization of the major components of the fish are highly homologous to humans 
(Rubinstein., 2003). The zebrafish also possesses all of the classical sense modalities, 
including vision, olfaction, taste, touch, balance and hearing, and their sensory pathways 
share an overall homology with humans. Another major advantage of the zebrafish is the 
embryos develop externally and are optically transparent. Thus, using simple microscopic 
techniques, it is possible to resolve development at cell resolution in vivo across a broad 
range of developmental stages. Resolution is increased by using transgenic zebrafish 
models that express fluorescent reporter genes, thereby making it possible to visualize 
dynamic changes in gene expression and detailed morphogenetic movements as they 
occur in the live, developing embryos (Blader et al., 2003). Several additional features of 
zebrafish biology, such as small size, rapid embryonic development and short life cycle 
(Dodd, et al., 2000; Spitsbergen et al., 2003; Zon et al., 2005), make this model system 
logistically attractive for developmental toxicity studies. Zebrafish reach sexual maturity 
within 3-4 months, reproduce year round, and produce clutch sizes that range between 
100-200 embryos per mating pair. Because zebrafish adults grow to an average size of 3-
4 cm and are easy to maintain at high densities, the infrastructure and maintenance costs 
required for housing the large numbers of animals required for comprehensive studies is 
relatively low. Such features are favorable for adapting this model system to high 
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throughput assays. High throughput chemical screens have indeed proven feasible in 
zebrafish to identify novel developmentally active drugs (Peterson et al., 2004a, b). Fish 
have served as useful sentinels to detect environmental hazards, and as efficient, cost-
effective model systems for mechanistic toxicology and risk assessment for many 
decades (Harshbarger et al., 1990). 
 
1.4 Model toxicants 
 
I have chosen a number of model compounds known for their environmental relevance. 
The compounds include 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), valproic acid (VA, 
CH3(CH2)4CO2H), methyl-mercury chloride (MeHg), cadmium chloride (Cd, CdCl2 
2H2O), 1,1-bis-(4-chlorophenyl)-2,2,2-trichloroethane (DDT, (ClC6H4)2CHCCl3), 4-
chloroaniline (4CA, C6H6ClN), arsenic trioxide (As, As2O3), lead chloride (Pb, PbCl2), 
acrylamide (AA, CH=CHCONH2), aroclor 1254 (PCB), tBHQ (tert-butylhydroquinone 
(CH3)3CC6H3-1,4-(OH)2). 
 
1.4.1 TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) 
 
 
A keyword query of PubMed for ‘TCDD’ yields over 
5,580 manuscripts. Perhaps the most well studied 
environmental contaminant is TCDD. Decades of 
research have indicated that TCDD is toxic to all vertebrates studied (Peterson et al., 
1993) and it induces a broad spectrum of biological response, including disruption of 
normal hormone signaling pathways, reproductive and developmental defects, 
immunotoxicity, liver damage, wasting syndrome, and cancer (Mandal., 2005). Despite 
enormous investments, the mechanism by which TCDD and related compounds perturb 
normal homeostasis is largely unknown. The general understanding is now that most, if 
not all, of the toxicity is mediated by activation of the aryl hydrocarbon receptor (AHR) 
and its dimerization partner, the aryl hydrocarbon receptor nuclear translocator (ARNT) 
(Mimura et al., 2003; Rowlands et al., 1997). The AHR is a member of the basic helix-
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loop-helix Per-Arnt-Sim (PAS) family of transcription factors (Huang et al.,1993). This 
family of proteins includes AHR, aryl hydrocarbon receptor nuclear translocators (ARNT, 
ARNT2, and ARNT3), hypoxia inducible factor-1a (HIF1-a), endothelia-specific PAS 
protein-1 (EPAS-1/HIF2-a), single minded (SIM) and others (Carney et al., 2006). Most 
of the effects of TCDD require activation of the AHR, which results in transcriptional 
activation or the repression of a diverse array of genes (Nebert et al., 2000; Puga et al., 
2000). Several groups have established zebrafish as an outstanding model to evaluate 
TCDD toxicity and have demonstrated conservation of the AHR pathway. The essential 
roles for AHR2 and ARNT1 have recently been confirmed using morpholinos and mutant 
zebrafish (Prasch et al., 2003, 2006; Antkiewicz et al., 2006). Three signaling functions 
have been described for the AHR pathway: adaptation signaling that leads to upregulation 
of xenobiotic metabolizing enzymes, toxic signaling that leads to adverse effects from 
high affinity ligands, and developmental signaling that is required for normal 
development of certain organs and tissues. A number of associated factors including 
chaperone and transcriptional co-activator have also been identified, but their role in 
toxicity remains unknown, and most data have been collected from tissue culture studies 
(Hankinson., 2005). A number of gene expression studies have been conducted revealing 
that CYP1A1 is highly induced in target tissue. Whether induced CYP1A1 activity is 
directly related to the manifestation of signs of toxicity remains somewhat controversial. 
The mechanism of adaptive, toxic, and developmental signaling by AHR all require 
ligand activation of the receptor, tanslocation of AHR to the nucleus, and 
heterodimerization with ARNT (Walisser et al., 2004). How the AHR mediates such 
diverse biological responses through the same mechanism is not fully understood. 
 
1.4.2 MeHg (methyl-mercury) 
 
Mercury is ubiquitous in the global environment. It occurs in several chemical forms, 
including elemental mercury and both inorganic and organic mercury (ethyl-, methyl-, 
alkyl-, or phenylmercury) compounds. Approximately 70% of the mercury in the 
environment comes from anthropogenic sources, primarily emission from coal-fired 
electric power generation facilities and waste dumps (Mason et al., 1994). Mercury is 
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used in a variety of industrial applications and manufacturing processes and in medical 
devices such as sphygmomanometers. It constitutes 50% of dental amalgams and 
ethylmercury was used as a vaccine preservative. Increases in power plant emissions and 
industrial uses during the past 100 years have been accompanied by a 3-fold increase in 
environmentally available mercury. There is no question that mercury is a global 
environmental contaminant and the public is increasingly more concerned with potential 
consequences of exposure (Trasande et al., 2005). Human exposure to toxic levels of 
mercury vapor in adults causes the classic triad of erethism, tremor, and gingivitis 
(Clarkson., 1997). Children exposed to high levels of vapor, may exhibit a syndrome 
known as acrodynia or pink disease (Baughman., 2006), which can be rapidly fatal under 
high doses exposure. Chronic exposure causes central and peripheral nervous system 
damage, manifesting as a characteristic fine tremor of the extremities and facial muscles, 
emotional lability, and irritability.  
 
According to the Agency for Toxic Substance and Disease Registry of the U.S.A 
Department of Health and Human Services, mercury is listed as the third-most frequently 
found (lead and arsenic are first and second), and the most toxic substance in the United 
States (Lyn Patrick., 2002). Eighty percent of inhaled elementary mercury vapor is 
absorbed and can cross the blood-brain barrier or reach the placenta (Ozuah., 2000). 
Elemental mercury and its metabolites have the toxic effect of denaturing biological 
proteins, inhibiting enzymes and interrupting membrane transport and uptake and release 
of neurotansmitters (Clarkson., 2002). Inorganic mercury is complexed with glutathione 
in the liver and secreted in the bile as a cysteine mercury or glutathione mercury complex. 
Chronic exposure to inorganic mercury salts primarily affects the renal cortex and may 
manifest as renal failure or gastrointestinal problems. There is an enormous public 
concern over the potential link between mercury exposure and the development of autism. 
Despite or perhaps because of the lack of solid data, public concern remains high.  
 
1.4.3 As (Arsenic trioxide) 
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Arsenic is widely distributed in nature, being found in food, the soil, water and airborne 
particles. It derives from both natural and human activities (Tchounwou et al., 1999). 
More than 80% of arsenic compounds are used to manufacture products with agricultural 
applications such as insecticides, herbicides, fungicides, algicides, sheep dips, wood 
preservatives, dye stuffs and medicines. Furthermore, arsenic has been used as an 
anticancer agent in the treatment of acute promyelocytic leukemia (Rousselot et al., 1999). 
In addition, arsenic can accumulate in groundwater. It is estimated that several million 
people worldwide suffer the effects of chronic arsenic exposure resulting from the 
environmental release of arsenic (Centeno et al., 2002). Groundwater contamination 
provides the majority of worldwide arsenic exposure. Many epidemiological studies have 
confirmed that exposure to arsenic and its compounds can have adverse effects on human 
health. Inhaling arsenic can cause lung carcinomas in particular, while ingestion in the 
form of drugs or in food and water, can provoke skin, respiratory system, liver and 
bladder tumors, as well as diabetes, cardiovascular and neurological disease (Goering et 
al., 1999). The adverse effects  of continuous chronic  exposure led WHO to lower their 
recommendation to 10 µg/l. Arsenic taken up by the body is mainly in the inorganic form, 
either as arsenite [iAs(III)] or arsenate [iAs(V)] (Rossman., 2003). Arsenite [iAs(III)]  is 
more toxic than arsenate [iAs(V)], probably due to its faster rate of cellular uptake (Vega 
et al., 2001). After entering the cell, arsenate [iAs(V)] is rapidly reduced to Arsenite 
[iAs(III)]. In humans, inorganic arsenic is metabolized by methylation followed by 
excretion in the urine of iAs as well as monothylated and dimethylated forms. Methylated 
species are excreted more rapidly than unmethylated species (Marafante et al., 1987). iAs 
(III) is methylated by enzymatic transfer of the methyl group from S-adenosylmethionine 
to iAs (III) to form monomethylarsonous acid [MMA(V)]. The enzyme utilizes 
thioredoxin and NADPH as a reductant. MMA (V) can also be reduced by glutathione-S-
transferase omega class 1-1 (Zakharyan et al., 2001). Historically, the methylation of 
arsenic was considered to be a detoxification process (Vahter., 2002). However, recent 
studies show that the trivalent methylated forms MMA (III) and dimethylarsinous acid 
[DMA(III)] often exceed iAs (III) in cytotoxicity and genotoxocity. Trivalent forms 
MMA (III) and DMA (III) are more clastogenic than their pentavalent counterparts and 
are able to produce reactive oxygen species (Nesnow et al., 2002). To date, most 
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estimates of risk at low levels of exposure have been based on extrapolations from data 
on highly exposed population, however the risk at low doses of the arsenic-induecd 
carcinogenesis is controversial (Tapio et al., 2006). 
 
1.4.4 Cd (Cadmium) 
 
Cadmium is used in a variety of industries, e.g., nickel-cadmium batteries, electroplating, 
as a component of metallurgical and brazing-soldering alloys, in pigments, and as a 
stabilizer for plastic. Most of cadmium released in the environment occurs via a smelting 
other metals, notably zinc. Other sources of environmental cadmium are the burning of 
fossil fuels and waste materials, and the use of high phosphate and sewage sludge 
fertilizers (Ll’yasova et al., 2005). Environmental exposure to cadmium is a significant 
concern because it contaminates both soil and water at 534 superfund sites, and is ranked 
7 on the EPA priority list of hazardous substances. The World Health Organization has 
shown that dietary cadmium exposure has a very wide range: inhabitants of worldwide 
nonpolluted areas have a daily dietary intake of approximately 40-100 µg, while 
inhabitants of polluted areas may obtain 200 µg or more as an average daily intake (Jarup 
et al., 1998). Between 10-50 percent of cadmium fumes are absorbed through the 
respiratory tract and approximately five percent of oral cadmium is absorbed through the 
digestive tact. Iron deficiency creates a significant risk for increased cadmium exposure 
by increasing gastrointestinal absorption from five percent to as much as 20 percent (Lyn 
Patrick., 2003). Cadmium exposure has been linked to cancers of the lung, liver, 
hematopoietic system, urinary bladder, stomach and pancreas in humans (Waalker., 
2003). Epidemiological studies have found a positive correlation with elevated urinary 
cadmium levels and increased urinary calcium loss and elevated serum alkaline 
phosphatase levels, and also found a correlation between cadmium induced renal tubular 
damage and bone loss. In utero cadmium exposure studies in mice demonstrate that 
cadmium is embryotoxic, leading to mortality, cleft palate, limb malformations, 
exencephaly, and eyelid and tail malformations (Jeffrey et al., 1995). Studies in zebrafish 
reveal that cadmium is developmentally toxic, leads to localized cell death, alters muscle 
and motoneuron development and induces stress responses (Hen Chow et al., 2003; 
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Blechinger et al., 2002). The mechanisms of cadmium toxicity are not completely 
understood, but some of the cellular effects are known. Some of the specific changes that 
lead to tissue damage and death in chronic exposure have been related to oxidative stress 
and thiol depletion (Ercal et al., 2001). Cellular damage results from cadmium binding to 
sulfhydryl group in tissue, the production of lipid peroxides, and the depletion of 
glutathione.  
 
1.4.5 VA (Valproic acid) 
 
Valproic acid (VA) has been shown to possess multiple effects. It has been widely used 
for treating and preventing certain types of epileptic seizures for over twenty years 
(Ehlers et al., 1992), and is also used as mood stabilizer in bipolar affective disorders 
(Muller-Oerlinghausen et al., 2002), while VA is also known to have side effects during 
clinical treatment. The mechanisms underlying the therapeutic actions of VA are not well 
understood. One suggestion for the anti-epileptic function of VA is that VA prevents the 
stimulation of nerves by increasing the concentrations in the brain of the neurotransmitter, 
gamma-aminobutyric acid (GABA) (Johannessen et al., 2000). The common molecular 
mechanism is assumed to be depletion of inositol and inhibition of the collapse of sensory 
neuron growth cones in using VA in the therapy of bipolar disorders (Williams et al., 
2002). During the clinical treatment, one major side effect of VA is teratogenictiy (Nau et 
al., 1991). With a probability around 1-2% women treated with VA during early 
pregnancy give birth to newborns with spina bifida aperta, a severe neural tube closure 
defect. In addition, numerous other subtle malformations are observed, such as defects of 
the heart, the skeleton and the facial skull. These major and minors defects are 
collectively called the fetal valproate syndrome (Huot et al., 1987; Ardinger et al., 1988; 
Martinez-Frias., 1991). The mechanism of VA teratogenicity remains unknown however, 
a recent toxicogenomic study using VA-exposed mouse embryos and embryocarcinoma 
cells has identified VA responsive genes (Kultima et al., 2004). Several of the identified 
genes are consistent with inhibition of histone deacetylase activity as being an important 
pathway modulated by VA. 
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1.4.6 DDT (bis[4-chlorophenyl]-1,1,1-trichloroethane) 
 
 
DDT was first synthesized in 1874, and its insecticidal properties 
were described in the late 1930s. It was first used to protect 
military areas and personnel against malaria, typhus, and other vector-borne diseases. 
Commercial sales began in 1945, and DDT became widely used in agriculture to control 
insects, such as the pink boll worm on cotton, codling moth on deciduous fruit, Colorado 
potato beetle and European corn borer (Rogan et al., 2005).  Its use was banned in 
Sweden in 1970 and in the USA in 1973, largely on the basis of ecological considerations, 
including persistence in the environment and sufficient bioaccumulation and toxic effects 
to interfere with reproduction in pelagic bird (Turusov et al., 2002).  
 
In the environment, DDT breaks down to P,P’-DDE (bis[4-chlorophenyl]-1,1-
dichloroethene), an extremely stable compound that resists further environmental 
breakdown or metabolism by organisms. DDE is the form usually found in human tissue 
in the highest concentration, especially in areas where there has been no recent use of the 
parent compound. The general population is exposed to DDT mainly through food, 
whereas occupational exposures are mainly through inhalation and dermal contact. DDT 
and DDE can also be transferred from the placenta and breastmilk to fetuses and infants. 
Acute exposure to a high dose of DDT can cause death in laboratory animals.   The 
environmental impact of DDT is widely known and because of public outcry, importantly 
it continues to be widely used in other parts of the world and has been credited in saving 
millions of lives by reductions in malaria-related mortality (Schapira., 2004). Since the 
global burden of DDT persists, a mechanistic understanding of the mode of action of 
DDT remains an important goal. To date, a molecular explanation of the action of DDT 
on vertebrate development remains uncertain (Brandt et al., 1998; Eriksson., 1997).  
 
1.4.7 4CA (4-chloroaniline)  
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Chloroanilines are widely used intermediate chemicals in the production of several 
herbicides, dyes, agricultural agents and many industrial compounds. Occupational, 
agricultural or contaminated waterways are potential routes of human exposure. Exposure 
to aniline or its derivatives results in several toxicities including hematotoxicity, 
splenotoxicity, hepatotoxicity and nephrotoxicity (Chhabra et al., 1990). 
Methemoglobinemia and hemolytic anemia appear to result from hepatic 
biotransformation of aniline or a chloroaniline via N-oxidation to phenylhydroxylamine 
metabolites which then mediate hematotoxicity (McMillan et al., 1990; 1991). 
Hematotoxicity may also be a contributing factor to the splenotoxicity induced by 
anilines. Toxicity studies in zebrafish demonstrate that 4-chloroaniline is embryotoxic, 
impacting liver, kidney and gills (Burkhardt-Holm et al., 1999; Oulmi et al., 1996). There 
is only limited toxicological data for this environmental contaminant. It is less clear how 
anilines induce the toxicity and what role the parent compound or metabolites might play 
in organ directed chloroaniline toxicity. 
 
1.4.8 PCB (Polychlorinated biphenyls, Aroclor 1254) 
 
Organochlorine contaminants remain a profound health hazard because these toxicants 
are resistant to biodegradation and remain widely distributed in the environment (Giesy et 
al., 1998). Polychlorinated biphenyls (PCBs) are mixtures of man-made chemicals with 
similar chemical structures. Due to their non-flammability, chemical stability, high 
boiling point and electrical insulating properties, PCBs were used in hundreds of 
industrial and commercial applications including electrical, heat transfer, and hydraulic 
equipment; as plasticizers in paints, plastics and rubber products; in pigments, dyes and 
carbonless copy paper and many other applications. More than 1.5 billion pounds of 
PCBs were manufactured in the United States prior to cessation of production in 1977. 
Polychlorinated biphenyls (PCBs) have been reported at alarming levels in the Arctic 
environment (De-Wit et al., 2004). Several studies have reported adverse effects 
associated with PCBs, including altered stress response (Jorgensen et al., 2002; Aluru et 
al., 2004), immune functions (Maule et al., 2005) and liver metabolic response (Vijayan 
et al., 2006). PCB exposure has been associated with cognitive and motor 
 14
neurobehavioral abnormalities in both humans and experimental animal (Jacobson et al., 
2003; Branchi et al., 2005). Dopaminergic system appears to be a cellular and 
neurochemical targets for PCBs (Bemis et al., 2004; Seegal, 2003; Lee et al., 2006). 
Aroclor 1254, which consists of more than 80 PCB isomers and congeners, is classified 
as a class A carcinogen. The ability of PCBs to act as a tumor promoter may be linked to 
deregulation of several pathways including overexpression of proto-oncogenes and other 
cell cycle regulators and may embarque on a non-genotoxic route of carcinogenesis. On 
the other hand, metabolic activation of PCBs causes oxidative stress and formation of  
DNA adducts. A further complication in an assessment of Aroclor 1254 toxicity is the 
established cross-talk of certain nuclear receptors with AHR-ARNT. Thus the conflicting 
information from animal studies and epidemiological finding may well be the result of a 
complex cross-talk amongst several orphan nuclear receptors and transcriptional 
regulators (Borlak et al., 2005). 
 
1.4.9 Pb (Lead) 
 
Lead is a heavy metal common in nature. Its abundance, joined to such physical 
characteristics as ductility, high density, low chemical reactivity, easy extraction, and low 
cost, have made it broadly used since prehistory. Environmental lead (Pb) contamination 
can be traced back 5000 years to Ancient Rome (Jarup et al., 2003). It has been used in 
medicines, paintings, pipes, ammunition, vitrified ceramic, and, in more recent times, in 
alloys for welding, chemical reagent storage, electric batteries, protection against ionizing 
radiation, and as an antiknock agent in gasoline (Garza et al., 2006). Although 
environmental lead pollution has now been reduced to a remarkable extent, lead 
poisoning still occurs (Sen et al., 2002). In the United States, lead paint is a primary 
source of lead exposure and the major source of lead toxicity in children. Drinking water 
is also a major source of lead exposure, estimated to be responsible for approximately 20 
percent of the total daily exposure experienced by the majority of the U.S. population. 
One study associated the storing of food in lead-glazed containers with elevated blood 
lead levels (Rojas et al., 1994). The center for disease control currently considers lead 
poisoning the foremost environmental health threat to children in the United States (Lyn 
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Patrick., 2006). Data now indicates that low-level exposures resulting in blood lead levels 
below 100 µg/1 result in cognitive dysfunction, neurobehavioral disorders, neurological 
damage, hypertension, and renal impairment (Lyn Patrick., 2006). In addition, lead 
exposure may be a lifetime threat to certain lead exposed populations during pregnancy, 
lactation, and post-menopause (Gao et al., 2006). Furthermore, the carcinogenic potential 
of lead has recently been revised, leading to the conclusion that inorganic lead 
compounds are probably carcinogentic to human (Silbergeld., 2003). Lead is currently 
listed as one of the most hazardous substances by the Agency of Toxic Substances and 
Disease Registy. This aspect has roused once more the interest to the understanding of 
the specific mechanisms of lead actions. 
 
1.4.10 tBHQ (tert-butylhydroquinone)  
 
 
Tert–butylhydroquinone (tBHQ) is used as an 
antioxidant in cosmetic products such as lipsticks, eye 
shadows, perfumes, blushers, and skin care preparations 
at concentrations ranging from 0.1% to 1.0%; the 
chemical is also used at concentrations up to 0.02% in 
oils, fats, and meat products to prevent rancidity, and as a polymerization inhibitor for 
various polyunsaturated polyesters (CIR, 1986). tBHQ is also a major metabolite of 3-
tert-butyl-hydroxyanisole (BHA) in vivo in animals and humans (Nakamura et al., 
2003). Both tBHQ and BHA have received a lot of attention due to their ability to 
induce phase II detoxification enzymes, including glutathione S-transferase and 
NAD(P)H-quinone oxidoreductase, and their potential role in cancer prevention (Li et 
al., 2002). tBHQ was nominated for toxicity and carcinogenicity testing by the Food and 
Drug Administration. The results (Natl Toxicol Program Tech Rep Ser. 1997) suggested 
that there was no evidence of carcinogenic activity of tBHQ in F344/N rats and B6C3F 
mice. Exposure of rats to tBHQ in feed resulted in decreased incidences of mammary 
gland neoplasms. Distribution and excretion studies showed that tBHQ was found in 
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kidney and liver tissue, the metabolites were found in urine when administered orally to 
Fischer 344 rats (Ikeda et al., 1998). A high dose (400 µmol/kg) glutathione conjugates 
of tBHQ, a metabolite of the urinary tract, however, were found to be toxic to kidney 
and bladder (Peters et al., 1996). tBHQ is cytotoxic for human monocytic leukemia cell 
through disruption of mitochordiral structure and decrease of intracellular glutathione 
and ATP (Okuboa T et al., 2003). In vitro studies (Gharavi et al., 2005) showed that 
tBHQ can directly modulate the expression of Cyp1a1 through an AHR dependent 
pathway by acting as an AHR ligand. Cell culture research manifested that exposure of 
rat and human hepatocytes to BHA and tBHQ can induce Heme Oxygenase 1 (HO-1) 
and NAD(P)H:quinine oxidoreductase I (NQO-1) correlated with activation ERK1/2 
and JNK1/2 (Keum YS et al., 2006). The toxicity of tBHQ remains somewhat 
controversial according to in vivo and in vitro results.  
 
1.4.11 AA (Acrylamide) 
 
Acrylamide has received considerable attention recently 
due to its presence in virtually all baked, grilled or fried 
foods. Acrylamide, which is an important industrial 
monomer, has been manufactured in big scale since the 
1950s (Rice., 2005) mainly to produce water soluble 
polyacrylamides used as flocculents for clarifying drinking 
water, for treating municipal and industrial waster waters and as flow control agents in 
oil-well operations. Other major uses of acrylamide are in soil stabilization, in grout for 
repairing sewers and in acrylamide gels used in biotechnology laboratories (Jägerstad et 
al., 2005). The general opinion has been that the main human exposure to acrylamide is 
of occupational origin in the industrial production of polyacrylamide, while the general 
public may be exposed by drinking water that has been treated with polyacrylamide in a 
refining process (Abramsson-Zetterberg A., 2003). A maximum tolerable level of 0.1 µg 
/l acrylamide in water has been established within the European Union (Jägerstad M et al., 
2005). Data (Tareke et al., 2002) showed that the high background level of acrylamide in 
humans was due to compounds in the diet by demonstrating relatively high levels of 
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acrylamide in heat-processed foods principally by the Maillard reaction between the 
amino acid asparagines and reducing sugars (Mottram et al., 2002), especially in 
carbohydrate-rich foods such as crisps and French fries. Acrylamide is biotransformed in 
vivo to its epoxide, glycidamide, which is genotoxic in a variety of in vitro and in vivo 
test systems (Calleman et al., 1990). Acrylamide and glycidamide are detoxified by 
glutathione conjugation, and glycidamide is also detoxified by hydrolysis. Acrylamide 
can induce chromosomal aberrations, sister chromatid exchange and mitotic disturbances 
in mammalian cells in vitro. It induces structural chromosomal aberrations in vivo in both 
somatic and germ-line cells. Chromosomal aberrations and micronuclei were induced in 
mouse bone marrow and in premeiotic and postmeiotic cells in a linear dose–response 
relationship (Paulsson et al., 2003). The in vitro experiments showed that acrylamide is 
not mutagenic in bacterial cells; it is direct-acting mutagenic in mammalian cells. Based 
on the results of in vivo mammalian somatic cell assays, acrylamide appears to be clearly 
genotoxic, interfereing with spindle apparatus (polyploidy, aneuploidy) at relatively high 
doses (Carere., 2006). Several facts have confirmed and extended the earlier evidence 
that acrylamide is genotoxic in vivo and that genotoxicitiy is mediated by 
biotransformation of acrylamide to glycidamide. Cells treated with either glycidamide or 
acrylamide had more A?G transitions and G?C transversions than spontaneously 
mutated control cells, and glycidamide treated cells also had more G?T transversions 
(Besaratinia et al., 2004).  Meanwhile there are clear increases in tumors in several 
organs after exposure of Fischer 344 rats to acrylamide (Friedman et al., 1995). However, 
findings of epidemiological studies on comparative cancer incidence in human 
populations having different intensities and durations of acrylamide exposure reveal no 
increased cancer risks (Mucci et al., 2003; 2004; Pelucchi et al., 2003). Additional 
research is ongoing on the carcinogenicity and genotoxicity of acrylamide in rats and 
mice. Only neurotoxicity has been seen in both animals and humans exposed to 
acrylamide (Shipp et al., 2006). Additional study on the model of action of the 
reproductive and carcinogenic effects in rodents is needed to determine the relevance of 
these observations to human health outcomes. 
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1.5 Molecular mechanism of toxicity 
 
Previous studies in cells and animals have suggested that toxicants can interfere with all 
factors at many levels. The gene level of oxygen radicals with the concomitant oxidative 
stress responses is a very frequent effect. In addition, more specific interaction with 
signaling system and specific transcription factors, have been observed. Although there 
are lots of studies focused on the toxic effects, the mechanism through which the 
toxicants exert their toxicity, are in many cases still unclear. 
 
1.5.1 Oxidative stress and DNA damage  
 
In general, the most common modification of DNA occurs as a consequence of 
unquenched reactive oxygen species (ROS), most of which are generated during the 
reduction of molecular oxygen to water on the electron transport chain (ETC). When 
levels of ROS surpass the protective mechanism of a cell, they are capable of interacting 
with lipids, proteins, or nucleic acids (Moosmann et al., 2002). The occurrence of 
oxidative stress, caused by ROS, is believed to be a major etiological or pathogenic event 
of most degenerative processes. Several findings that neurotoxicants, e.g., 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP), dieldrin, paraquat, and rotenone are capable 
of eliciting neurodegeneration by disrupting various complexes in the ETC and 
increasing ROS production, supported the environmental toxin/oxidative stress theory of 
neurodegeneration (Betarbet et al., 2000; Corrigan et al., 2000).  
 
1.5.2 Signal transduction 
 
Signal transduction is the mechanism by which extracellular signals are transferred to the 
cytosol and nucleus of the cells. Growth factors, neurotransmitters, and hormones serve 
as first messengers and G-protein coupled receptors, growth receptors with tyrosine 
kinase activity, neurotransmitter receptor, and nitric oxide (NO) have function for second 
messenger systems. Any interference with these processes in early stages of development 
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would have the potential to have profound effects on the function of the cells as well as 
their development. In recent years, investigators have considered a number of signal 
transduction pathways as potential targets for toxins including metals, alcohols, and 
persistent environmental pollutants. Nine pesticides, 14 solvents, 10 metals or 
organometal compounds, and 6 other industrial chemicals were identified as 
developmental neurotoxicants (Anderson et al., 2000). Among metals, methylmercury 
and lead have been shown to affect several signaling pathways including calcium levels 
(Limke et al., 2003), calcium channels (Sirois et al., 2000), and protein kinase C (PKC) 
(Nihei et al., 2001). Ethanol has been shown to affect several signal transduction 
pathways such as cyclic AMP metabolism and phospholipids/PKC (Hoek et al., 1990; 
Hoffman et al., 1990). PCB (Polychlorinated biphenyls) can induce alterations in 
intracellular free Ca2+ (Kodavanti et al., 1993; 1994). The disruption of Ca2+-homeostasis 
may have a significant effect on other signal transduction pathway.   
 
1.5.3 Zinc finger transcription factors   
 
Zinc finger proteins that are structural motifs found in several classes of proteins, were 
proposed to function in eukaryotic protein-nucleic acid interaction such as gene 
expression and DNA repair (Pabo et al., 1992; Beckmann et al., 1997). Several studies 
have shown that metal such as lead (Pb) and mercury (Hg) interfered with the DNA 
binding properties of a member of zinc finger proteins family, namely specificity protein 
one (SP1), and demonstrated that the effects of these metals were mediated through 
interaction with the zinc finger domain of  SP1 ( Zawai NH., 2004). Microarray analysis 
has shown that Oct-2, a member of POU family, was a potential molecular target of lead, 
and may thus mediate some of the effects of lead on neurotransmission (Zawai NH., 
2004). 
 
1.6 Aims of this project 
 
A principal goal of this work is to establish genetic tools and techniques that will be used 
to monitor the environmental contaminants and will allow elucidation of the mechanism 
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by which environmental chemicals perturb normal vertebrate development. This work 
will pave the way for the systemic use of the zebrafish embryo in molecular toxicity and 
genetics.   
 
First, I want to establish the zebrafish as a genetic model for monitoring the 
environmental contaminations. Using genome-wide microarray in zebrafish, I wanted to 
identify gene expression changes in response to a set of model toxicants.  
 
Second, after the identification of these signature genes, I focus on a detailed expression 
of several selected genes that have been induced by toxicants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 21
2 Materials and Methods 
 
2.1 Chemicals 
 
Cadmium chloride (CdCl2· 2H2O), Methylmercury (II) chloride (CH3HgCl), DDT, (1,1-
Bis-(4-chlorphenyl)-2,2,2-trichlorethan) ((ClC6H4)2CHCCl3), 4-chloroaniline 
(ClC6H4NH2), TCDD,(2,3,7,8-tetrachlorodibenzo-p-dioxin), Lead (II) chloride (PbCl2), 
Valproic acid (CH3(CH2)4COOH), Arsenic(III)dioxide (As2O3), Acrylamide 
(CH2=CHCONH2), Aroclor 1254, tBHQ (tert-Butylhydroquinone (CH3)3CC6H3-1,4-
(OH)2) were purchased from Sigma-Aldrich company. Other general chemicals supplied 
by Car Roth GmbH & Co (Karlsruhe, Germany). 
 
2.2 Zebrafish (Danio rerio) embryos 
 
Zebrafish wild type strains AB, ABO and Tübingen were kept and bred as described 
(Westerfield., 1993) in the fish facility of the Institute of Toxicology and Genetics, 
(Forschungszentrum Karlsruhe, Germany).  
 
2.3 Enzymes 
 
All restriction endonucleases and PCR enzymes were supplied by Promega (Mannhein, 
Germany) unless otherwise stated. 
 
2.4 DNA oligonucleotides  
 
All DNA oligonucleotides were synthesized by Metabion international AG (Martinsried, 
Germany). 
 
2.4.1 DNA oligonucleotides for RT-PCR. 
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Cyp1a1 (AF057713):  F.  TGGATGAAAAGATCGGGAAG      
                                    R.  GCCAGTTTTCCTGGATTTCA 
Keratin (AI397347):   F.  GGCAGGTCGATCTGAATCAT        
                                    R.  TTGACACCACTTGTCCATCG 
BI533854:                   F.  GCAGGAATTGGAACATGTCA         
                                    R.  TTGCTTTGCTTTTATTGATTTGA 
Parv3a (BE201681):   F.  CGGACACCACTCAGCCTTAT 
                                    R.  TGTGCGCTCTCTACATGTCC 
Mmp9 (AW174507):  F.  GCCCTGATCGTGGATACAGT 
                                    R.  TTGCCTTTTCCTCTCTGCAT 
ATF3 (AW422298):   F.  GGACGTGGAGATGACAAGGT 
                                    R.  TCGGATGTCTTGTGGTGTGT 
AY050500:                 F.  ACGGTCAAACTTCTGCTGCT 
                                    R.  AAGCGCTAGAGCTCCACAG 
BI843145:                   F.  TTCTGCATTTCTTCCGGGTA 
                                    R.  ATGTTGCACTTTTGCTGACG 
BI980610:                   F.  CGCGAGTTCACTTTCATTCA 
                                    R.  GTGTCTTTTCCAGGCTTCCA 
Glutathione peroxidase I  (AW232474): F.  ATTTTTCGCGCCTCCTATTT 
                                                                 R . CCCGATGAGGAACTTTTCAA 
BG727181:                  F.  CGATTCCTCCTCCTTTTTCC 
                                     R.  CTCTTGCTCCATCCTTCCAG 
Mmp13 (AW305943): F.  ACCAGGAGACACTGGAGGTG 
                                     R.  AGGATAACTGCGCCAGAAGA 
Hsp70  (AF210640):    F.  GGCACCACCTACTCCTGTGT 
                                     R.  CACAAAGTGGTTCACCATGC 
β-actin:                         F.  CCCAGACATCAGGGAGTGAT 
                                     R.  AGGAAGGAAGGCTGGAAGAG  
 
2.4.2 Morpholino oligonucleotides 
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The morpholino oligomers were synthesized by Gene Tools (One Summerton Way, 
Philomath, OR USA). 
 
mmp9:   GAAACGCCAGGACTCCAAGTCTCAT 
mmp13: AAGCAGGTCTTCATGTTTCTCGTGC 
 
2.5 Kits 
 
Total RNA extraction kit, DNA Gel extraction kit and NucleoSpin Plasmid kit (mini 
preparation) were supplied by Macherey-Nagel (Düren, Germany). The mRNA isolation 
kit was purchased from Ambion (Europe, Huntingdon, UK). The CyScribe first strand 
cDNA labeling kit was from Amersham Biosciences (Freiburg, Germany), and the 
plasmid purification kit (Max preparation) from Qiagen (Hilden, Germany). 
 
2.6 Zebrafish (Danio rerio) Oligonucleotide library 
 
Zebrafish oligonucleotides library contain 16,228 non-redundant probes was purchased 
from the Sigma-Genosys/Compugen and printed two replicated sub-arrays per chip in the 
Microarray facility (ITG, FZK). 
 
2.7 General methods 
2.7.1 Preparation of competent E.coli using CaCl2 and transformation. 
(Molecular Cloning 1,116-118) 
2.7.2 In situ hybridization (Oxtoby et al., 1993)  
2.7.3 RT-PCR (Sambrock et al., Edn 3rd edition 2001) 
2.7.4 Microinjection (Stuart et al., 1990) 
 
2.8 Exposure of embryos to chemicals 
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2.8.1 Solution Preparation of Chemicals  
According to the information of these chemicals, the chemicals were dissolved in 
different solvents, such as, water, dimethylsulfoxide (DMSO), ethanol or toluene as stock 
solutions. Cd, 100 mg/l (H2O); Hg, 100 mg/l (H2O); DDT, 100 mg/l (0.2% ethanol); 4CA, 
100 mg/l (0.2% ethanol); TCDD, 10 µg/l (28 mg/l toluene and 0.5% DMSO); VA, 100 
mg/l (H2O); As, 50 mM (H2O); Pb, 62.5 mM (H2O); AA, 0.5 M (H2O); PCB, 50 mg/ml 
(ethanol); tBHQ, 200mM (ethanol). 
 
2.8.2 Decision on the concentration of chemicals 
 
Embryos were grown in embryo medium (60 µg/ml Instant Ocean, Red Sea Fish Pharm 
Ltd.). Using different concentrations treated embryos or larvae, according to the half 
lethality dose, reduce the concentration. Criteria of concentration decision: more than 
50% of embryos or larvae show morphological changes after treatment for at least one of 
several morphological criteria at 48 hpf. Exposure of larvae to Cd, Hg, DDT, TCDD, 
4CA and VA of 96 to 120 hpf at the same condition did not result in a strong 
morphological effect.   
 
2.8.3 Method of exposure embryos or larvae to chemicals 
 
Embryos of AB and ABO  background were harvested as described by Westerfield, and 
exposure the embryos or larvae to different concentrations of chemicals at different 
stages, meanwhile keeping the control groups in fish water or vehicle solvents. I used 
petri dishs (135 mm) to culture embryos in 100 ml vehicle control at 28.5°C.  Different 
numbers of embryos were exposed to the chemicals: between 4 to 24 hpf (600 embryos), 
24 to 48 hpf (400 embryos) and 96 to 120 hpf (200 embryos). Embryo medium alone (Cd, 
Hg, Pb, As, VA, AA) or 0.2% ethanol in embryo medium (tBHQ , 4CA, PCB, DDT) or 
the definited volume of 0.5% DMSO, 28 mg/l toluene in embryo medium (TCDD) were 
used as vehicle controls.   
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2.9 Extraction of total RNA and mRNA 
2.9.1 Total RNA extraction 
After exposure, the embryos were collected and immersed immediately in liquid nitrogen.  
Frozen embryos were ground, then lysis buffer was added and vortexed vigorously. After 
filtration, RNA was bound to silica membrane and desalted. After digestion of DNA and 
washing several times, total RNA was eluted in nuclease-free water. Then 2.5 volumes of 
ethanol (100%), 0.1 volumes of sodium acetate (3M) were added to the RNA solution 
and left at -20°C overnight, or quick by frozen in -70°C for 30 minutes. Then I recovered 
the RNA by centrifugation and washed several times with 70% ethanol. Finally it was 
dissolved in 250 µl nuclease-free water. The integrity of total RNA was examined by 
denaturing agarose gel (FA) electrophoresis and the quantity was checked by DanoDrop 
spectrometer (DanoDrop technologies, Wilmingto USA). 
 
2.9.2 mRNA extraction 
 
To the total RNA, I added 250 µl 2×binding solution, mixed thoroughly and combined 
with oligo(dT) cellulose, incubated the mixture at 65-75°C for 5 minutes and 60 minutes 
at room temperature with gentle agitation. And then the mixture was washed several 
times with washing buffer and eluted by preheated RNA storage solution. Finally after 
precipitation and recovering, the pellet was dissolved in nuclease-free water at a 250-500 
ng/µl final concentation. 
 
2.10 Microarray  
 
2.10.1 Preparing fluorescently labeled probe from mRNA 
 
mRNA (1.5-2 µg), 1 µl random nonamers, 1 µl anchored oligo (dT), 1 µl spike 7 or 8 (1 
ng/µl) and water to a total reaction volume of 11 µl in a 1.5 ml amber microcentrifuge 
tube. I mixed and incubated the reaction mixture at 70°C for 5 minutes. Then I let the 
mixture cool at room temperature for 10 minutes and spun down it shortly. Added  4 µl 
 26
5× CyScript buffer, 2 µl DTT (0.1 M), 1 µl Cy3 or Cy5 (25 nmol) respectively, and 1 µl 
reverse transcriptase (100 U/µl). The final reaction volume was 20 µl after addition of all 
the components. After mixing, the reaction was incubated at 42°C for 1.5 hours. Then 5 
µl 1 M sodium hydroxide was added and incubated at 37°C for 15 minutes to hydrolyze 
the RNA. The cDNA was neutralized with 10 µl 2 M HEPES and mixed well. 
 
2.10.2 Purification of probe with Microcon columns (Millipore 
Microcon YM-30) 
 
I added 465 µl TE (pH 7.5) buffer to the reaction mixture and centrifuged at 9000 rpm for 
12 minutes, turned the column, inserted it into a new microcentrifuge tube and 
centrifuged 4 minutes at 9000 rpm. The probes labelled with Cy3 and Cy5 were 
combined and 400 µl TE buffer were added, centrifuged at 9000 rpm for 12 minutes. TE 
buffer was added to elute probes to a final volume of 16.5 µl. 1.5 µl probe was used to 
determine the quality and quantity with a NanoDrop spectrometer. 
 
2.10.3 Hybridization on Microarray 
 
The probes were heated at 95°C for 2 minutes, cooled down on ice for 2 minutes and kept 
at room temperature for 5 minutes, then spun down and 15 µl DIG-easy hybridization 
buffer preheated at 42°C was added. The probes were put on the chips and cover slips 
were careful placed on top to avoid bubbles. The chips were placed in hybridization 
chambers and incubated at 42°C for 16-18 hours. 
 
2.10.4 Washing and scanning chips  
 
The chips that were hybridized overnight were put in wash buffer 1 (2×SSC, 0.1% SDS) 
and incubated at 42°C for 5 minutes; washed in buffer 2 (0.1×SSC, 0.1% SDS) at room 
temperature for 10 minutes with gentle agitation; washed in buffer 3 (0.1×SSC) 4 times 
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for 1 minute respectively and dipped into buffer 4 (0.01×SSC) shortly and dried by 
centrifugation. 
Arrays were scanned using the Axon model 4000B dual-laser scanner and the 
corresponding GenePix 4 software (Axon, Union City, CA). Both channels (532 nm for 
Cy3 and 635 nm Cy5) were scanned in parallel and stored as 16-bit TIFF files. The 
absolute intensity values span the range from 0 to 64,535. The scans were performed with 
a resolution of 10 µm. From each spot with a mean diameter of 100 µm, 100 data pixels 
were recorded. Individual local background area around the spots were defined, which 
included ~400 pixels and excludes neighboring spots. For each channel, the raw data was 
calculated as the median intensity of all foreground pixels with respect to all background 
pixels. Each array was scanned three times (low, medium and high scan) with different 
signal amplification factors (voltage settings of the photomultiplier tubes), but with the 
same laser power. The channels for Cy3 and Cy5 were balanced in each scan for 
approximately the same intensity profile. In the low scan no spot was saturated; in the 
high scan the signal amplification for Cy5 was set to ~80% of maximum and Cy3 
amplification was adjusted to this. The settings used in the medium scan lie between the 
low and the high scan. This method of scanning has several advantages. In the low scan 
where no spot is in saturation, it is possible to calculate the real ratio for genes levels with 
very high expression. In order not to loose these, a high scan is made; in this case, the 
information on saturated spots is lost, so the two scans complement each other. The 
medium scan produces additional values for subsequent calculation. By scanning the 
arrays three times, errors which occur while recording and which might increase the error 
factor in the normalization are averaged. However, signals from gene expressed at very 
low level will not be detected. 
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3 Microarray data analysis 
 
3.1 Printing chips 
 
The zebrafish oligonucleotides library was bought from Sigma-Genosys (The Woodlands. 
TX, USA) and Compugen (Jamesburg. NY, USA), with 43 plates (384 wells) including 
16,228 modified oligonucleotides. Upon evaluation it turned out, however, that plates 29 
to 43 had faulty anime linkers impairing the retention of the olignucleotides on the coat-
link slides. As the companies were unable to replace the defective oligonucleotides, we 
used the reduced set of intact oligonucleotides (384-well plates 1 to 28). These 
oligonucleotides were printed into CodeLink activated slides (Amersham Biosciences, 
Europe) in the microarray facility at the Institute of Toxicology and Genetics using a 
multi-axis Omnigrid 100 spotter (San Carlos. CA). The zebrafish chip was arranged in 48 
blocks with 12 rows and 4 columns (Figure 3.2). Each block was printed by one pin. Pins 
were organized in 2×12 pins (TeleChem SMP3 pins, Sunnyvale CA) in printhead to 
produce 27×27 spots in each block (Figure 3.1). The diameter of the spot is 100 µm and 
each oligonucleotide was printed twice. Before starting to print chips, the pins needed to 
be cleaned and subjected to a test print. After calibration and checking the quality of the 
test spots, 100 CodeLink slides were fixed on the printboard and the pin parameters were 
adjusted and set up in the computer, finally click the mouse and run printing programme.   
                               
    Figure 3.1 Printing process                                    Figure 3.2 The design of 48 blocks  
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3.2 Experimental design 
 
We used a Cy3 and Cy5 two-color microarray system and dye swap experiments (Figure 
3.3). For statistical analysis of data, experiments of each time point were carried out with 
at least three biological repeats. 200-800 embryos were exposed to different toxicants at 
different stages and mRNAs were labeled to hybridize two chips. 
 
                                        
 
                 Figure 3.3 Schematics of two colors microarray   
 
 
3.3 Processing raw data 
 
Arrays were scanned using the Axon model 4000B dual-laser scanner (Molecular 
Devices) and the corresponding GenePix 6 software (Union City, CA). Both channels 
control treatment 
Cyanine 3 Cyanine 5 
mRNA isolation
mRNA
Reverse transcription
cDNA
Fragmentation & mixture 
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(532 nm for Cy3 and 635 nm for Cy5) were scanned in parallel and stored as 16-bit TIFF 
files.  
 
The TIFF images were processed by the GenePix software. After opening the TIFF image 
and loading the array list file, the spots were overlaid by adjusted grids. The image 
information can be extracted from every spot pixels and transferred to a specific file with 
additional parameters, such as foreground and background pixels, Cy5 (532 nm) and Cy3 
(635 nm) intensity. The pixels of the background, in principal, are supposed to be zero. 
Nonetheless, background fluorescence is observed because of non-specific binding and 
the problems in postprocessing. Background estimation was applied to calculate 
averaging of all pixel intensities except the hybridization spot intensities. We also used a 
local background estimation to compensate background noise (Figure 3.4).  
 
                                                                         
                            
                                Figure 3.4 Background pixels 
 
3.4 Data transformation and normalization 
 
Raw data must be preprocessed before statistical analysis. In particular, preprocessing 
consists of transformation (appropriate scaling) and normalization (systematic error 
correction). The fluorescence intensities of spots are transformed using logarithmic scale  
(Figure 3.5). Differences in gene expression of raw data are represented by the Fold 
Change yred/ygreen (y means spot intensity). On the contrary, changes on logarithmic scale 
are calculated as the difference between channels, log(yred)-log( ygreen). Systematic 
multiplicative error terms become additive and are automatically eliminated by 
subtracting the channel intensities. For the normalization, we used MA-plots. M is the log 
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ratio of raw intensities and means log(yred)-log( ygreen). A represents the average 
expression level of the spot and means log(yred+ygreen)/2.  
                                                                                                                          
          
 
                              Figure 3.5 Distribution of intensities 
 
3.5 Microarray quality control 
 
3.5.1 Quality control on spot level 
 
In the processing of microarrays, abberations, like scratches, air bubbles and printing 
problems can induce influences and bias. In order to get available data, these erroneous 
signals have to be detected. If these artefacts can not be compensated, these spots or even 
the whole chip has to be discarded. We set up criteria to control the microarray quality. 
 
A normal diameter of a spot is 100 µm and stretches over 10 pixels after scanning with a 
resolution of 10 µm. If the diameter of a spot was less than 70 µm or more than 140 µm, 
it was excluded in the subsequent processing. The fluorescence intensities of spots are 
presented as foreground signals. If the foreground intensities of a spot was less than 1.75 
times intensity of its background, it was discarded. For the inconsistent spots presented 
by printing, we used the coefficient of variation (CV) to filter some defective spots.  
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If the coefficient of variation of a spot is more than 0.7, it was filtered. Additionally, a 
spot was discarded if more than 20% of its pixels are in saturation, i.e. its signals exceed 
the maximum 16-bit intensity value of 65535 (216). 
 
3.5.2 Quality control on array level 
 
For the whole chip, plotting the distribution of M values was used to evaluate the quality 
of the microarray. Basically, if the microarray has a good quality, the M values cluster 
around 0 based on the assumption that the majority of genes is not differentially regulated 
under toxic conditions (Figure 3.6). The majority of microarray experiments revealed a 
very prominent intensity dependent signal pattern mainly due to different 
physicochemical traits of the two fluorescence dyes. Application of a locally weighted 
regression smoother (LOESS) successfully suppressed this effect and was hence applied 
to the log-transformed data. 
 
3.5.2.1 Covariance 
 
The quality control measures evaluate the single chip but can also be used to compare 
different microarrays. Covariance measures how much paired signals of spots in two 
chips vary between each other. The more signal pairs differ from the mean values in the 
same direction, the more positive becomes the covariance.  
 
3.5.2.2 Correlation 
 
Scatter plots and statistical parameters are used to determine the correlation between 
chips. Visual correlation analysis is performed for the log transformed average intensities 
A, which is log (yred+ygreen)/2 and for the log transformed differences M, which is log yred-
log ygreen. Basically, the perfect correlation of average intensities A would be in an 
identity line with a 45° slope. M values are subdivided into two groups. The first group 
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includes genes with an adjusted p-value >0.05, which are considered to be genes whose 
expression is not altered. The second group includes the genes with an adjusted p-value 
≤0.05, which can be considered as the genes whose expression were changed by the 
manipulations. 
   
                         
                                       Figure 3.6 Distribution of M 
 
3.6 Statistical tests 
 
In order to get more confidence into the data, we carried out statistical tests that relate the 
changes in gene expression to variability.  
 
3.6.1 t-test 
 
The t-test is applied to relate the signal intensities to their variations and the t-test poses 
three major assumptions: normal distribution, homoscedasticity, and sufficient sample 
size. Because of the small sample size from each gene, we modified the t-test methods 
accordingly and weighted gene specific standard error and global standard error among 
all genes. 
 
3.6.2 Multiplicity 
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The number of genes in the zebrafish chip is more than 10000. If a statistical test for B 
genes is carried out with α=0.05, the probability of making one false positive is 1-(1- α)B. 
It means that we will have 500 false positive results. In order to reduce these false 
positive probabilities, we adjust the p-values for multiple testing. Adjustment is based on 
False Discovery Rate (FDR) which is the expected proportion of False Positives among 
all positive findings. 
 
3.7 Gene selection 
 
To take into account the extent and significance of gene expression as well as different or 
similar expression between all toxicants, we consider a consensus selection based on 
adjusted p value, fold change, MAD (median absolute deviation) and Pearson correlation 
to be the filters. As a result, 150 to 300 genes that were significant at an adjusted 
significance level of α equal to 0.025 were picked up for further statistical clustering and 
classification. 
 
3.8 Principal component analysis 
 
Principal component analysis is a statistical framework to exploit information from large 
datasets of high complexity by highlighting and extracting underlying patterns. We used 
this method to analyse gene expression profiles under different conditions, such as 
different toxicant exposures, different timepoints and different toxicant concentrations. A 
simple condition is an example to introduce the principle of this method.  
The example is based on a dataset comprising two corresponding variables x and y which 
represent the expression data for two treatments. 
 
 
Working with two dimensions allows visualization of the PCA algorithm. However, the 
method works accordingly with any number of dimensions T (treatments) × G (genes).  
The first step in PCA is to centre each variable by subtracting the means (x = 1.8 and y = 
1.34) from both treatment data. 
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Secondly, the Covariance Matrix is calculated. It provides the observed variances 
between and among centred variables x and y, thus  
 
                 
 
The third step, the Eigenvectors and Eigenvalues are derived for the Covariance matrix. 
A square matrix, like the Covariance matrix C, with T ×T dimensions has T Eigenvectors 
EV such that 
                  C·EV = λ ·EV  
Here, λ are the corresponding Eigenvalues. Hence, if an Eigenvector is transformed by 
the matrix C it results in a multiple of itself because the transformation only changes the 
length of the vector but do not change its direction. The Eigenvalue is the amount by 
which the original vector is scaled after multiplication by the square matrix C. The 
parameters for the covariance matrix C in the example are calculated as  
 
                  
 
The Eigenvector with the largest Eigenvalue, EV1 is the first principal component of this 
data. It explains the greatest amount of variance. EV2 is perpendicular to EV1 and means 
the remaining variation (Figure 3.7). In the next step, the Eigenvectors are sorted by their 
importance, i.e. by descending Eigenvalues. All Eigenvectors are perpendicular to each 
other. Accordingly, the data can be expressed in terms of these Eigenvectors instead of 
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expressing them in terms of the x and y axes. Therefore, the expression data is plotted 
along the Eigenvectors – the principal components (Figure 3.8). The lesser significance 
components might represent technical noise in microarray data. Therefore, the expression 
data can be normalized by ignoring Eigenvectors with small Eigenvalues. Hence, the 
dimension of the data is reduced by multiplying the original data only with a subset of the 
most important Eigenvectors. The subset of most important principal components can be 
determined in various ways. For instance, the subset has to explain at least some fixed 
percentage of variation, or can be picked up by all components whose Eigenvalues is 
greater than the average of all Eigenvalues. 
  
 
                         
      
         Figure 3.7 Eigenvectors                                        Figure 3.8 Rotation to PC-space 
 
3.9 Cluster analysis 
 
Cluster analysis is an integral part of microarray analysis. Compared with other 
multivariate statistical techniques, it extracts and summarizes information out of 
expression profile that is available for thousands of genes under various conditions. The 
basic objective of cluster analysis is to split data into different clusters that have similar 
objects. Thus, elements within the same cluster are more similar to each other than that in 
another cluster.   
 37
3.9.1 Proximity measures 
 
Clustering is based on proximity measures that quantify how far two observations are 
from each other. Proximity can be either a similarity measure or a dissimilarity measure. 
The most commonly used dissimilarity measure is the Euclidean distance which defines 
the geometrical distance of xi and yi in a space of n-dimensions. 
 
                           
 
We applied the Pearson Correlation as proximity measure to tackle the complex 
biological situation. 
                         
 
We applied also the Arcus Cosinus function to the distance measure. Besides 
transforming correlation to a dissimilarity measure, this function decreases the distance 
between a pair of highly correlated genes. Subsequently, the relationship between two 
very similar genes is attributed an even higher importance in forthcoming clustering steps. 
                       
                           d unidir = arccos (d Pear) 
                           
                           d bidir = arccos(|d Pear|) 
 
 
3.9.2 Hierarchical clustering 
 
Hierarchical clustering consists of agglomerative and divisive hierarchical clustering. 
Agglomerative hierarchical clustering is started by assigning each of the n observations 
an own cluster of size 1. The pair of observations xi and yi, which have the smallest 
distance from each other is picked up and merged into a common cluster. And then, the 
distance matrix is recalculated in order to take into account the distance of the new 
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cluster to the other observations. The sequence of identifying the two clusters with the 
highest similarity, their agglomeration, and the recalculation of the distance matrix is 
repeated until all observations aggregate in one single cluster. 
 
On the other hand, divisive hierarchical clustering is initiated by assigning all 
observations to the same cluster. And then, it is split in the two subsets with the biggest 
distance to each other.    
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4. Results 
 
4.1 The choice of exposure windows  
 
Currently, hazard assessment of chemicals for fish is based on international standards 
(ISO, ASTM) and guidelines (OECD) based on global toxicity endpoints such as 
mortality or impairment of growth and reproduction. Under increasing pressure of animal 
welfare groups, the chemical industry searches for alternatives to reduce the number of 
used organism. A significant step forward is the willingness of the ecotoxicologist 
community and of the pharmaceutical industry to apply the principles of replacement, 
reduction, and refinement in the context of regulatory environmental assessments 
(Hutchinson et al., 2003). One of the alternatives proposed is to use the early life stages 
of fish as an experimental model. In fact, the early life stage of zebrafish has become a 
standardized assay for sewage testing in Germany replacing traditional tests with adult 
fish (Braunbeck et al., 2005).  
 
The biological response to toxicants can vary at different life stages. It is largely accepted 
that vertebrates at the earliest life stages are more responsive to chemical insult 
(Grandjean et al., 2006). Evidence has been accumulating over several decades that 
industrial chemicals can cause neurodevelopmental damage and that subclinical stages of 
these disorders might be common (Grandjiean et al., 2006). The toxic effect is assessed 
through the analysis of various criteria: mortality, hatching (rate, time), and larvae 
morphology (length, weight, abnormality). The DIN standard relies on the embryonic 
stage up to 48 hpf and the selected endpoints refer to rather crude defects in 
embryogenesis such as somite development, tail detachment, heart beat, and coagulated 
eggs. The guidelines did, however, not provide good reference information about which 
stages are best suited to study gene expression profiles. An exposure for 48 hpf may also 
induce secondary effects that are not directly related to a particular chemical and may 
also be more variable from animal to animal. Also, stages may differ in their usefulness 
for evaluating gene expression profiles for classification of the toxicogenomic effect of 
different chemicals. To tackle this question, I have chosen to expose zebrafish embryos at 
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three different developmental stages. Moreover, I limited exposure to a period of 20 to 24 
hours. The 4 to 24 hpf treatment covers late blastula, gastrula and segmentation stages 
during which the overall body plan is laid down. The treatment phase between 24 to 48 
hpf coincides with organogenesis. The first neuronal circuits become active and touch-
evoked movements can be observed from this stage onwards. During the 96 to 120 hpf 
period, organogenesis has proceeded so much that the animal will be ready to feed. We 
expect that many physiological responses that also characterize the adult zebrafish are 
active by this stage.  
 
I next had to decide which concentration to use. To this end, I determined the 
concentrations that would induce in approximately 50% embryos morphologically visible 
effects. At the same time I had to keep the concentration so low that I could minimize 
lethality or apoptosis/necrosis in the treated embryos. I took different exposure windows 
into account and scored morphological changes using the criteria below: The embryos 
that had been exposed to toxicants either from 4 to 24 hpf or 24 to 48 hpf or 96 to 120 hpf 
were washed twice in fresh fish medium and cultured in the incubator (28.5°C) to 72 hpf 
and 144 hpf (from 96 to 120 hpf) respectively. Abnormal larvae were counted and the 
percent morphological defects were calculated. Accordingly, concentrations of chemicals 
were used which could cause approximately a defect in 50% of embryos. This is just an 
approximation as the effective concentration varied with respect to different 
morphological endpoints (Table 1 and 2).  
 
   Table 1 Percentage of morphological defects at 72 hpf of 4 to 24 hpf exposure group 
  Head  % Trunk  % Yolk sac % Edema % 
4CA (15 mg/l)   66.1 67.3 53.8 
DDT (5 mg/l) 27.3 63.8 68.1 25.4 
TCDD (150 ng/l) 68.2 89.3 87.4 83.2 
VA (15 mg/l) 10.1 62.7 40.6 55.3 
MeHg (50 µg/l) 72.4 67.9 61.5 63 
Cd (500 µg/l) 5.3 57.6 10 7.2 
Control (embryo water) - 1.3 - 1 
VC1 (0.2% ethanol) - 1.8 1 1 
VC2 (28 mg/l toluene, 0.5% DMSO) - 1.5 2 1.2 
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 Table 2 Percentage of morphological defects at 72 hpf of 24 to 48 exposure group 
  Head  % Trunk  % Yolk sac % Edema % 
4CA (50 mg/l) - 68 69.2 55.6 
DDT (15 mg/l) 30.2 65.1 57.3 28.4 
TCDD (500 ng/l) 73.1 91.9 78.8 80.5 
VA (50 mg/l) - 65.3 43.1 55.8 
MeHg (60 µg/l) 75.1 68.3 46.8 51.3 
Cd (5 mg/l) 2.3 62.2 11.1 9.4 
Control (embryo water) - 1.3 - 1 
VC1 (0.2% ethanol) - 1.8 1 1 
VC2 (28 mg/l toluene, 0.5% DMSO)  - 1.5 2 1.2 
 
Several hundred embryos were exposed to the 6 model compounds, TCDD; VA; MeHg; 
Cd; 4CA; and DDT at 4 to 24 hpf, 24 to 48 hpf, and 96 to 120 hpf and treated embryos 
were harvested and mRNAs were extracted. Cy3 and Cy5 labeled cDNAs were prepared 
and hybridized to the oligonucleotides array. Arrays were scanned with an Axon 4000B 
scanner. Data were normalized, and averaged from different experiments before they 
were subject to different clustering methods (see Material and methods).  
 
4.1.1 Principal component analysis 
   
Principal component analysis is a statistical framework to exploit information from large 
datasets of high complexity by highlighting and extracting underlying patterns and is 
often applied to present grouping structure of clustering results. Principal component 
analysis of the toxicogenomic profiles of embryos exposed to the 6 compounds from 4 to 
24 hours showed that similar expression profiles were induced. The profiles clustered 
closely together in the 2 dimensional plot shown in Fig. 4.1. On the other hand, the 
scatter plots of embryos treated from 24 to 48 hpf and from 96 to 120 hpf showed large 
distances between the toxicogenomic profiles of the six different chemicals. This 
indicates that the expression profiles are characteristic for each of the 6 compounds at 
these two stages (Fig. 4.1).  
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Figure 4.1 Principal component analysis of the toxicogenomic profiles derived from 
3 different embryonic stages. Embryos were exposed to 6 chemicals: TCDD: 150 ng/l 
(24 hpf), 500 ng/l (48 hpf), 500 ng/l (120 hpf); MeHg: 50 µg/l (24 hpf), 60 µg/l (48 hpf), 
60 µg/l (120 hpf); VA: 15 mg/l (24 hpf), 50 mg/l (48 hpf), 50 mg/l (120 hpf); 4CA: 15 
mg/l (24 hpf), 50 mg/l (48 hpf), 50 mg/l (120 hpf); Cd   500 µg/l (24 hpf), 5 mg/l (48 hpf), 
5 mg/l (120 hpf); DDT: 5 mg/l (24 hpf), 15 mg/l (48 hpf), 15 mg/l (120 hpf) either from 4 
to 24 hpf or from 24 to 48 hpf or from 96 to 120 hpf. The concentrations were adjusted to 
that they caused visible morphological effects but little cell or embryo death.  
 
 
4.1.2 Hierarchical cluster analysis 
 
Common objectives in microarray experiments are gene identification, class discovery, 
and class prediction. Class discovery usually refers to identifying previously unknown 
sample subtypes from the study of gene expression profiles. Class prediction is to predict 
the class membership of a new sample based on a gene expression prediction function. 
Hierarchical cluster analysis is commonly used as a method for class discovery. Cluster 
analysis techniques have been applied to organize gene expression data by grouping 
genes or samples with similar patterns of expression. In clustering samples 
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overexpression levels of multiple genes, the expression patterns of the samples in the 
same group are more homogeneous as compared to the expression patterns in the other 
group. Clustering samples is used to characterize similar/distinct samples or to discover 
new sample classes. The hierarchical clustering algorithm forms clusters in a hierarchical 
fashion resulting in a tree-like dendrogram (see microarray data analysis). 
 
The expression profiles summarize clustering results of a subset of 751 genes induced by 
the six chemicals at the three stages (Figure 4.2). The applied gene selection criteria take 
into account the extent and significance of changes in gene expression (Padj <0.025 and 
|FC|>2.0). Distinct toxicogenomic patterns were noted at the three stages. The gene 
expression patterns were less prominent in the data sets from 4 to 24 hpf treatment groups 
and only 57 genes were significantly regulated (Figure 4.3). The treatment groups from 
24 to 48 hpf and from 96 to 120 hpf induced the most diverse changes in gene expression 
(Fig. 4.2): 480 and 311 genes were regulated in 24 to 48 hpf and 96 to 120 hpf exposure 
groups by the 6 toxins, respectively (Figure 4.3). Of these groups, 4CA, MeHg and VA 
induced related but distinct gene expression patterns between 48 and 120 hpf (Figure 4.2).  
Based on the gene expression profiles of the embryos exposed to the 6 different 
chemicals at three stages, using the same criteria (Padj <0.025 and |FC|>2.0) as filters, 6 
genes are regulated in all stages; 9 genes are affected in 24 and 48 hpf treatment groups; 
4 genes are induced in both the 24 and 120 hpf treatment groups; 68 genes are 
significantly up or down-regulated in the 48 and 120 hpf treatment groups (Figure 4.3). 
This shows that there is a strong stage specific effect in responses. Thus, the stage, at 
which the toxicogenomic response is measured, has to be taken into account.  
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Figure 4.2 Expression profiles at different embryonic stages.  Hierarchical clustering 
of gene responses in embryos treated either from 4 to 24 hpf or from 24 to 48 hpf or from 
96 to 120 hpf  with 4CA: 15 mg/l (24 hpf), 50 mg/l (48 hpf), 50 mg/l (120 hpf); Cd: 500 
µg/l (24 hpf), 5 mg/l (48 hpf), 5 mg/l (120 hpf); DDT: 5 mg/l (24 hpf), 15 mg/l (48 hpf), 
15 mg/l (120 hpf)); MeHg: 50 µg/l (24 hpf), 60 µg/l (48 hpf), 60 µg/l (120 hpf); 
TCDD: 150 ng/l (24 hpf), 500 ng/l (48 hpf), 500 ng/l (120 hpf); VA: 15 mg/l (24 hpf), 50 
mg/l (48 hpf), 50 mg/l (120 hpf). The colour code indicates fold-changes ranging from 3-
fold up- (red) to 3-fold down-regulated (blue). Fold changes larger than 3-fold are not 
indicated explicitly but are subsumed as 3-fold up- or down-regulated. Genes were listed 
whose mRNA levels changed by more than 2-fold (adjusted p<0.025) in at least one of 
the treatments.  
-3 +3
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Figure 4.3 Number of genes regulated by the six model chemicals at the different 
time-points. The numbers in the different intersections indicate the number of genes that 
were induced at either one or two or all three stages. The criteria used to select genes are 
Padj <0.025 and |FC|>2.0.   
 
 
4.2 96-120 hpf exposure study 
 
Based on the comparison of the three exposure windows, there are most significant 
changes in gene expression and explicit classification of chemicals in treated embryos 
from 24 to 48 hpf and from 96 to 120 hpf. Compared with embryos treated from 24 to 48 
hpf, the exposure stage from 96 to 120 hpf has several advantages: At 96 hpf, the hatched 
larvae have completed most of the early morphogenesis and begin to swim. They also 
start to feed and hunt on the subsequent stages suggesting that they have an almost 
mature physiology and may thus have also more adult responses to toxicants.  
Experimentally, these older stages have the advantage that one needs to expose fewer 
animals to isolate sufficient RNA for a microarray experiment. For these advantages of 
the 96 to 120 hpf exposure window I focused the systematic analysis of toxicogenomics 
profiles on this stage and expanded also the repertoire of toxicants by including 
additional 5 toxicants (Pb, As, tBHQ, Acrylamide, PCB (Aroclor 1254)).  
 
48 hpf 
393 
24 hpf 
38 120 hpf 233 
9 
4
6
68
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To further evaluate the significance of the signature genes in relation to the different 
chemicals, the embryos were exposed to 11 different toxicants from 96 to 120 hpf and the 
gene expression profiles were analysed by different statistical methods. Experiments 
were repeated on a technical and biological level. Replicate hybridizations with mRNA 
from at least three independent toxicant exposures were performed.   
 
4.2.1 Analysis of gene expression profiles of 96-120 hpf exposure 
 
  
                                                                                                                    
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 4.4 Principal components analysis of 96-120 hpf treatments. Principal 
component analysis showing the similarity and differences in gene response in embryos 
treated between 96 and 120 hpf with the PCB (33 mg/l); TCDD (500 ng/l ); 4-CA (50 
mg/l ); DDT (15 mg/l ); Acrylamide (71 mg/l); Arsenic (79 mg/l); Lead (2.8 mg/l); 
Cadmium (5 mg/l); t-BHQ (1.7 mg/l); Mercury (60 µg/l); Valproic Acid (50 mg/l). The 
11 clusters are separated from each other according to their Euclidean distances.  
 
The principal component analysis reveals that the toxicogenomic responses of the 11 
different toxicants are scattered in different positions. The positions induced by t-BHQ 
and Pb are very close in two dimensions (Figure 4.4). However they are separated in 3 
dimensions. In other words, the gene expression profiles in embryos treated with the 11 
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different chemicals are characteristic for every chemical suggesting different model of 
toxic action.  
 
The expression profiles (Fig. 4.5) summarize clustering results of a subset of 199 genes 
across all 11 toxin responses. Distinct patterns of gene expression were found for each of 
the 11 compounds. However, similarities in the gene responses were also observed. One 
group of chemicals with related gene responses includes Pb, As, Cd, tBHQ, MeHg and 
VA. Another subgroup of related responses was induced by TCDD, 4CA, DDT and AA, 
whereas the PCB triggered a more distinct expression profile.  
                                                                                                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Hierarchical clustering of gene responses in embryos treated between 96 
to 120 hpf. PCB: 33 mg/l; TCDD: 500 ng/l; 4-CA: 50 mg/l; DDT: 15 mg/l; AA: 71 mg/l; 
As: 79 mg/l; Pb: 2.8 mg/l; Cd: 5 mg/l; tBHQ: 1.7 mg/l; MeHg: 60 µg/l; VA: 50 mg/l. The 
colour code indicates fold-changes ranging from 3-fold up- (red) to 3-fold down-
regulated (blue). Fold-changes larger than 3-fold are not indicated explicitly but are 
subsumed as 3-fold up- or down-regulated.  
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4.2.2 Selected response genes  
 
 
  
Table 3 Comparison of selected genes expression changes induced by the 11 
chemicals. The numbers are representative up- or down-regulated genes in response to 
Gene name  Gene ID  AA  As 
 
4CA  Cd 
 
DDT  Hg  Pb 
 
PCB 
 
tBHQ 
 
tcdd 
 
VA 
Peroxiredoxin 1 BI980610 3.9 13.6 4.1 3.1   7.7 9.9   7.5     
Thioredoxin BI864190   14.2 3.5 4.0   4.4 8.1 2.5 6.1     
Stress protein HSP70, AB062116   10.1 2.2 7.0     2.5 5.4 12.3   2.7 
Activating transcription factor 
3 AW422298   4.0   3.2   3.3 2.5 15.1 5.1   5.4 
Zinc fingers and homeoboxes 1 AI793802   2.5   2.6   2.7 2.4 4.2 2.1   2.0 
Sequestosome 1 AW343560   10.3 2.1 3.9   3.2 3.5 2.8 5.1     
unknown BG985532 2.6 8.8 2.3       4.3 2.6 2.9     
Glutathione S-transferase 
omega1 AW019036 3.0 6.3 2.1     2.6 3.5   2.2     
matrix metalloproteinase 9 AW174507   2.1   12.3   6.7 3.9 14.2 6.4     
Hsp70 AF210640   10.9   6.6     2.5 5.0 10.8   2.7 
 6-phosphogluconate 
dehydrogenase AW115782   3.3 2.0     2.2 3.4 2.0 2.1     
Likely hypoxia induced gene 1 BI892416   2.6   2.7   2.3 3.4 2.7 2.2     
Fetuin-A, AI496863   -3.6 -2.2 -3.3     -3.2 -5.0     -2.3 
unknown AW115990   3.1       3.2 2.3 5.6 4.6   3.1 
Hsp70 AF006007   7.6   6.3     2.1 4.6 10.1   2.4 
matrix metalloproteinase 13 AW305943     2.5 11.9   5.9 3.5 15.1 10.2     
Angiotensinogen precursor, BG727310     3.0 2.7   3.0 2.1 3.7 2.1     
Solute carrier family 16,me 9 BE016639     2.5 2.9   2.4 3.6 4.1     2.3 
Solute carrier family 16,me 9 BI474827     3.4 4.3   4.8 4.7 7.9     3.0 
GSH S-transferase pi AF285098 2.0 4.1       3.2 5.9   2.7     
CCAAT/enhancer binding 
protein, beta AW019436   2.1   2.3     2.4 6.9 2.3     
unknown AW117109   2.3       2.1 2.1 2.3 3.2     
unknown AI964296   2.1   2.2   2.1 2.1 2.0       
Syncollin AA566708   -2.1   -2.7   -2.3 -3.8       -2.2 
Cofilin 2 (muscle) BI883993     2.4     3.3 3.6 3.1     2.2 
unknown BG727211     3.4 2.3   3.1   2.4 2.7     
Serum/glucocorticoid regulated 
kinase 2 BI673466     2.0     2.6 2.2 3.6     2.0 
Cytochrome P450 1 A 1  AF057713     3.7   2.5     4.2 2.8 31.6   
unknown AW019018     3.6 2.8   4.9   2.5 5.9     
Suppressor of cytokine 
signaling3 BG727181     2.0 2.5   4.5   5.6 3.7     
Complement component 7 AA497156       7.4   3.4 6.2 7.3 3.7     
ADP ribosylation factor 1 AI477644       3.5 -2.2 12.4   46.3     8.0 
Gastric intrinsic factor ) AI353694 2.2 4.6         2.5     2.1   
Multidrug resistance-associated 
protein Mrp2, AW279805   2.6 2.4     2.4 2.3         
Arsenite inducible RNA 
associated protein, BM182280   5.1       2.4 2.5   2.7     
GSHS-transferase omega 2 BI979918   5.6   2.7     5.2   2.1     
Pvalb3a BE201681   -2.4   -4.3   -2.6 -5.1         
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exposure to the 11 chemicals. Blanks indicate no significant difference in gene 
expression compared with the control conditions using filters with Padj <0.025 and 
|FC|>2.0. The gene name is that of the zebrafish gene or of the closest human homologue. 
The gene ID is indicated by the GeneBank accession number. In this table, only genes 
that were regulated by at least 4 chemicals were included. The complete list is provided 
in the appendix. 
 
 
4.2.2.1 Activating transcription factor 3 
 
 
Activating transcription factor 3 (ATF3) gene, which encodes a member of the activating 
transcription factor/cAMP responsive element binding protein (ATF/CREB) family of 
transcription factors, is maintained at a low level in quiescent cells. However, ATF3 is 
rapidly induced by a wide-range of stresses including post-seizure brain, nerve axotomy 
and hepatotoxicity. In human, the 5’-flanking region of ATF3 has a number of 
transcription factor binding sites including the AP-1, ATF/CRE, NF-κB, E2F, and 
Myc/Max binding sites. Previous studies revealed that the level of ATF3 mRNA 
increases greatly in tissue culture cells after serum stimulation. Studies in the rat showed 
that the ATF3 mRNA level increased in mechanically injured liver after partial 
hepatectomy and in chemically injured liver treated with toxins such as carbon 
tetrachloride or alcohol (Liang et al., 1995). Overexpression of ATF3 prevents p53 from 
MDM2-mediated degradation and leads to increased transcription from p53 regulated 
promoters (Yan et al., 2005). According to the gene expression profiles of 96-120 hpf 
exposure embryos, ATF3 mRNA was up-regulated significantly by As, Cd, MeHg, Pb, 
PCB, tBHQ, and VA treatment (Table 3) suggesting that the zebrafish embryo responds 
in a similar way as rat hepatocytos.  
 
4.2.2.2 Antioxidant defence 
   
There are two parallel, yet interdependent enzymatic systems that combat oxidative 
damage in humans: one anti-oxidant system is based on glutathione as a reducing 
substrate, and the other system uses thioredoxin as a sulfur-based reductant. The 
glutathione system is more effective in reducing small disulfide molecules and in reacting 
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directly with reactive oxygen species (ROS), whereas thioredoxin is more effective in 
reducing the exposed disulfides of proteins (Winyard et al., 2005). Reduced glutathione 
(GSH) exists in equilibrium with its disulfide form (GSSG), and the ratio of GSH to 
GSSG could be used as an indicator of the redox status of the cell. GSH-dependent 
defence relies on the availability of GSH, and systems involved in the reduction of GSSG 
are essential. Thioredoxin is regarded as an important oxysensor within cells, whereby its 
sensing ability is mostly the result of its cysteine redox chemistry and its ability to react 
with a wide range of different proteins. Thioredoxin has the capacity to repair oxidized 
proteins by reducing protein disulfides at the expense of the oxidation of its own redox- 
active cysteine residues. The redox-active cysteine residues are reduced by thioredoxin 
reductase. 
 
4.2.3 Genes grouped according to gene ontology 
 
4.2.3.1 Glutatione and thioredoxin 
 
Table 4A Glutathione and thioredoxin system 
Gene name Gene ID  AA  As 
 
4CA  Cd  Hg  Pb 
 
PCB 
 
tBHQ 
 
VA 
Peroxiredoxin 1 BI980610 3.9 13.6 4.1 3.1 7.7 9.9   7.5   
Thioredoxin BI864190   14.2 3.5 4.0 4.4 8.1 2.5 6.1   
Glutathione S-transferase omega 1 AW019036 3.0 6.3 2.1   2.6 3.5   2.2   
Glutathione S-transferase pi AF285098 2.0 4.1     3.2 5.9   2.7   
Glutathione S-transferase omega 2 BI979918   5.6   2.7   5.2   2.1   
Thioredoxin interacting protein BI892352       2.0         2.0 
glutathione peroxidase AW232474         -4.2         
 
Peroxiredoxin 1, thioredoxin, glutathione S-transferase omega 1 and 2, and glutathione S-
transferase pi were up regulated by 9 chemicals (Table 4A). It is clear that many 
antioxidant genes were up-regulated in embryos exposed to different toxicants, 
surprisingly, these antioxidant genes were not regulated significantly by DDT- and 
TCDD-exposed embryos. In addition, in contrast to thioredoxin, the gluthathion system 
shows a very versatile response to different toxicants.  
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The induction of antioxidant gene expression by different chemicals administrated at 96-
120 hpf revealed that the genes of the glutathione and thioredoxin systems were triggered 
significantly by 7 out of 11 toxins.  Especially, the four different heavy metals and tBHQ 
induced a response of these antioxidant pathway genes. Surprisingly, glutathione 
peroxidase (AW232474) was down regulated robustly by MeHg-exposed embryos (Table 
4A).  
 
4.2.3.2 Transporter 
Table 4B Transporter and related genes 
Gene name Gene ID As 4CA Cd Hg Pb PCB VA 
Solute carrier family 16 member 9 (1) BE016639   2.5 2.9 2.4 3.6 4.1 2.3 
Solute carrier family 16 member 9 (2) BI474827   3.4 4.3 4.8 4.7 7.9 3.0 
Solute carrier family 16  member 6 AW421040       2.9 4.0 4.6 2.9 
Solute carrier family 2  member 5 AI477656 2.1       2.1 2.5   
Solute carrier family 6 member 8 BI980828     2.0   2.2 2.4   
Solute carrier family 43, member 2 BI887324           2.1   
Solute carrier family 3 BG985518           2.1   
Solute carrier family 20 (phosphate)member 1 BI890772           2.2   
BF157011             -3.1 Solute carrier family 6 (GABA), member 1 
BI563084             -2.1 
 
 
Solute carrier family 6 (SLC6) consists of the transmembrane transporters for 
neurotansmitters, and SLC6 members are thus of fundamental importance for proper 
signaling between neurons.  These transport processes are mediated by distinct classes of 
membrane transport protein that have key roles in controlling the neurotransmitter 
concentration in the synaptic cleft. These transporters can be classed as intracellular 
vesicular transporters that are responsible for sequestering transmitters from the 
cytoplasm into synaptic vesicles, and plasma membrane transporters that are responsible 
for sequestering released transmitter from the extracellular space.  
 
SLC6 is a family of plasma membrane Na+-Cl- coupled transporter, which is the largest 
SLC family and includes transporters of dopamine, 5-HT, norepinephrine, glycine and 
GABA (Gether et al., 2006). SLC6 transporters operate as Na+ dependent co-transporters 
that use the transmembrane Na+ gradient to couple downhill transport of Na+ with uphill 
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transport of their substrate from the extracellular to the intracellular environment. It is 
well established that neurotransmitter transporters have roles in several neurological and 
psychiatric diseases. Furthermore, the SLC6 family of transporters is a target of several 
pharmaceutical compounds. For example, GAT-1, which is one member of the SLC6 
family, is the target of the antiepileptic drug tiagabine (Schousboe et al., 2004). 
Interestingly, the member 1 of the SLC6 family, which is responsible to transport GABA, 
was down regulated by VA (valproic acid) (Table 4B), which has been widely used for 
treating and preventing certain types of epileptic seizures, and is also used as mood 
stabilizer in bipolar affective disorders. It is tempting to speculate that this specific 
induction by VA is linked with the mechanism of antiepileptic capability.  
 
Solute carrier family 16 (SLC16s) which is a transmembrane protein with 12 
transmembrane domains is the cotransporter of monocarboxylate, such as lactate, 
pyruvate and ketone bodies. Lactic acid transport across the plasma membrane is 
fundamental for the metabolism of lactic acid and pH regulation of all cells, removing 
lactic acid produced by glycolysis and allowing uptake by those cells utilizing it for 
gluconeogenesis or as a respiratory fuel. Rapid transport of lactic acid transport across the 
plasma membrane is of fundamental importance to all mammalian cells under hypoxic 
conditions when they become glycolytic. To date, no data are available on the properties 
of member 6 and 9 although member 6 distribution in human tissues has been subject to 
Northern blot analysis (Halestap et al., 2004).   
 
4.2.3.3 Heat shock proteins 
 
Table 4C Heat shock proteins and chaperones 
 
Gene name Gene ID As CA Cd Pb PCB tBHQ VA 
AB062116 10.1 2.2 7.0 2.5 5.4 12.3 2.7 Stress protein HSP70 
AF210640 10.9   6.6 2.5 5.0 10.8 2.7 
Hsp70 (2) AF006007 7.6   6.3 2.1 4.6 10.1 2.4 
Heat shock protein HSP 90-alpha AF068773 2.6             
Heat shock cognate 70 kDa protein BM024785 3.0             
DnaJ (Hsp40) homolog, family A, member 1 BI891737 3.6         3.6   
Ahsa1 protein BM103957 2.2         2.1   
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Heat shock proteins 70 (Hsp70s) assist a wide range of folding processes, including the 
folding and assembly of newly synthesized proteins, refolding of misfolded and 
aggregated proteins, membrane translocation of organellar and secretory proteins, and 
control of the activity of regulatory proteins. Hsp70s have housekeeping function in the 
cell in which they are built in components of folding and signal transduction pathways, 
and quality control functions, in which they proof-read the structure of proteins and repair 
misfolded conformers. All these activities are based on the property of Hsp70 to interact 
with hydrophobic peptide segments of proteins in an ATP-dependent way. 
Overexpression of Hsp70 leads to increased resistance against apoptosis-inducing agents 
such as tumor necrosis factor-α, staurosporin and doxorubicin, while downregulation of 
Hsp70 levels by antisense technology leads to increased sensitivity towards these agents 
(Mayer et al., 2004).  
 
In vertebrates, hsp70s consist of stress inducible (hsp70) and heat shock cognate (hsc70). 
In fact, a PCR based study revealed the hsp70 gene exhibited strong heat-inducible 
expression during several stages of zebrafish embryonic development. This gene was also 
specifically expressed during normal lens development under non stress conditions. 
Zebrafish hsc70 is expressed in the developing CNS and a fraction of somites during 
development and exhibits only a slight increase in expression following heat shock. 
However, it is strongly induced during fin regeneration (Krone et al., 2003). Vertebrates 
express three hsp90 genes, hsp90a, hsp90a2, and hsp90b. The expression of hsp90a and 
hsp90a2 is restricted primarily to cells in the pre-somitic paraxial mesoderm, somites and 
pectoral fin buds in zebrafish embryos (Krone et al., 2003; Etard et al., in preparing). 
 
The 96-120 hpf microarray data revealed that hsp70s were up regulated strongly by 6 out 
of 11 chemicals (Table 4C). The induction of hsp70 expression by exposure to the three 
heavy metals was coincident with previous studies however hsp70 has not been regulated 
significantly by MeHg exposure. The same case was found in DDT and TCDD exposed 
embryos.  
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4.2.3.4 Metalloendopeptidase  
 
Table 4D Metalloendopeptidase genes 
Gene name Gene ID As 4CA Cd Hg Pb PCB tBHQ VA 
Matrix metalloproteinase 9 AW174507 2.1   12.3 6.7 3.9 14.2 6.4   
Matrix metalloproteinase 13  AW305943   2.5 11.9 5.9 3.5 15.1 10.2   
Tissue inhibitor of metalloproteinase 3  BM023829           2.5   2.0 
  
 
The development of a multicellular organism is dependent upon an extracellular matrix 
(ECM), which facilitates the organization of cells into more complex functional units: 
tissue and organs. The ECM is the glue that holds cells together, and provides texture, 
strength and integrity to the tissues. The cleavage of ECM molecules is carried out by 
specialized proteinases. Among these are the matrix metalloproteinases, a family of zinc- 
and calcium-dependent endopeptidases that have specificity for a subset of ECM 
molecules (Thiennu., 2001).  
 
The activities of matrix metalloproteinases are controlled by a combination of proteolytic 
pro-enzyme activation steps and inhibition by endogenous inhibitors like α2-
macroglobulin and the tissue inhibitors of metalloproteinases. (Zhang et al., 2003) 
Interestingly, only two members, MMP9 and MMP13 of zebrafish matrix 
metalloproteinases were strongly regulated by 7 (As, 4CA, Cd, Hg, Pb, PCB, and tBHQ ) 
out of 11 chemicals (Tab. 4D). On the other hand, the transcription levels of MMP9 and 
MMP13 were not induced significantly by AA, DDT, and TCDD administration.  
 
4.2.3.5 Transcription activity related genes 
 
Suppressors of cytokine signaling (SOCS) form a family of proteins that regulate the 
strength and duration of the cytokine signaling cascade. Eight SOCS family members 
have been identified thus far, and these include CIS and SOCS1-7. Molecules in this 
family contain a SH2 domain and a segment called SOCS box located near the C terminal 
end. Both of these domains are thought to be required for proper function, which is to 
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bind to the cytokine receptor or associated JAKs (Janus-kinases) and to attenuate signal 
transduction directly and by targeting the receptor complex for ubiquitin-mediated 
degradation in proteasomes. SOCS3 has been regarded as a negative regulator of 
inflammation and inhibitor of the angiotensin-activated JAKs-STAT (signal transducer 
and activator of transcription) pathway. SOCS3 is not only regulated by cytokines, 
including inflammatory cytokines such as tumor necrosis factor and IL-1, but also by Toll 
like receptor ligands such as lipopolysaccharide. There is increasing evidence that 
SOCS3 is critical in the pathogenesis of autoimmune disease (Gan et al., 2005). The 
expression of SOCS3 was up regulated strongly by 5 (4CA, Cd, MeHg, PCB, tBHQ) out 
of 11 chemicals (Table 4E). This suggests that these chemicals induce cytokine signaling 
in some form. 
 
Table 4E Transcription activity related genes 
 
Gene name  Gene ID  As 
 
CA  Cd  Hg  Pb 
 
PCB 
 
tBHQ 
 
VA 
Activating transcription factor 3 AW422298 4.0   3.2 3.3 2.5 15.1 5.1 5.4 
Zinc fingers and homeoboxes 1 AI793802 2.5   2.6 2.7 2.4 4.2 2.1 2.0 
CCAAT/enhancer binding protein (C/EBP) beta AW019436 2.1   2.3   2.4 6.9 2.3   
BG727181   2.0 2.5 4.5   5.6 3.7   Suppressor of cytokine signaling 3 
BI878700     2.2 2.7   3.4 3.1   
Interferon regulatory factor 1 BI326597   2.1 2.7 2.1       2.3 
Interferon regulatory factor 7 BE605965   2.3       7.9   6.8 
 
The interferon-regulatory factor (IRF) family of transcription factors was initially found 
to be involved in the induction of genes that encode type I interferons. IRFs have been 
shown to have functionally diverse roles in the regulation of the immune system with 
their interaction with toll-like receptors and other pattern-recognition receptors. The 
mammalian interferon-regulatory factor (IRF) family comprises nine members: IRF1-
IRF9. Each IRF contains a well conserved DNA binding domain of ~120 amino acids; 
this is located at the amino terminus and forms a helix-turn-helix motif. This region 
recognizes a consensus DNA sequence that is known as interferon (IFN)-stimulated 
response element. The carboxy-terminal regions of IRFs, except IRF1 and IRF2, show 
homology to the C-terminal domains, which mediates the response to the cytokine 
transforming growth factor-β. IRF1 has the function to activate promoters in type I 
interferon genes. IRF7 is expressed in small amounts in most cells and is strongly 
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induced by type I IFN mediated signaling. IRFs have been shown to have functionally 
diverse roles in the regulation of the immune system. The crucial involvement of IRFs in 
innate and adaptive immune responses has been attention with the discovery of their role 
in immunoregulation by Toll-like receptors (Honda et al., 2006). The expression of 
interferon regulatory factor 1 and 7 were induced strongly by 4CA, Cd, MeHg, PCB, and 
VA. These gene expression profiles suggest that the immune system has been induced by 
these toxicants. 
 
The CCAAT/enhancer binding proteins (C/EBP) are a family which consists of six 
members sharing numerous structural and functional features. The prototypic C/EBP is a 
modular protein, containing a carboxy-terminal leucine-zipper dimerization domain, a 
DNA binding domain and an N-terminal activation domain. Dimerization via the leucine 
zipper region, with homo- or heterotypic C/EBPs or other transcription factors is a 
prerequisite for DNA binding and subsequent gene activation. All the members, with the 
exception of C/EBPε, are expressed in multiple cell types but protein levels vary with 
developmental stage and tissue examined (Lekstrom-Himes., 2001). C/EBPβ has both 
positive and negative functions in regulation of cell division and transcription by 
interaction with other transcription factors. The expression level of this gene was up 
regulated significantly by As, Cd, Pb, PCB, and tBHQ exposures (Table 4E). Therefore, 
overexpression C/EBPβ should induce a wide range of changes in gene expression. 
 
4.2.3.6 Monooxygenase 
 
Cytochrome P450s (Cyp 450s) form a large and diverse superfamily of genes that code 
for enzymes involved in the oxidative metabolism of various xenobiotics and endogenous 
molecules. The expression of many Cyp450 genes is modulated by xenobiotics, and the 
regulation can take place at different levels ranging from transcriptional activation to 
protein stabilization. The transcriptional activation of Cyp450 genes has been widely 
studied. A number of xenobiotic activated receptors that act as specific transcription 
factors, have been discovered. The components of the aryl hydrocarbon receptor2 (AHR2) 
and aryl hydrocarbon receptor nuclear translocator1 (ARNT1) signaling pathway have 
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been identified and functionally characterized for mediating TCDD developmental 
toxicity in zebrafish embryos (Carney et al., 2006). The expression of cytochrome 
p4501A1 and p4501B is mediated through AHR2/ARNT1 signaling pathway via 
induction by the aromatic hydrocarbons like TCDD. In agreement, the microarray results 
revealed that mRNA level of Cyp4501A1 was up regulated by exposure to 4CA, DDT, 
PCB, tBHQ, and TCDD.  Moreover, the expression of Cyp4501B and aryl hydrocarbon 
receptor2 was also up-regulated by TCDD.  
 
4.3 Confirmation of microarray data  
 
The number of genes regulated significantly by the 11 toxicants exceeds 540 for the 
exposure regimen between 96 to 120 hpf. The changes in expression of these genes were 
scored as statistically significant different with Padj<0.025, |FC|>2 (See 3 chapter). To 
obtain a rough idea of the number of false positives, I used the semi quantitative reverse 
transcriptase polymerase chain reaction (RT-PCR) to confirm these expression changes 
for selected genes that were induced by different toxins in the microarray studies.  As a 
second method, whole mount in situ hybridization was applied to confirm the microarray 
data and to study the gene expression patterns.  
 
4.3.1 RT-PCR (Reverse transcriptase polymerase chain reactions) 
 
The microarray data were confirmed by previously observed induction of cyp 1a1 and 
hsp 70 in zebrafish embryos exposed to TCDD and Cd respectively (Tanguay et al; 
Krone et al., 2003). In order to evaluate the proportion of significantly regulated genes, 
cyp 1a1 and hsp 70 were used as reference genes while the β-actin served as an 
amplification control. For the remaining 12 genes that were checked by RT-PCR, no 
expression data from exposure studies were available. Using semi quantitative RT-PCR 
the differential expressions of these genes compared with vehicle controls were analyzed 
in replicated experiments (Figure 4.6). The keratin type I gene (AI397347) transcription 
was down regulated 2.6 times, and, cyp 1a1 (AF057713) was up regulated 37.7 fold in 
microarray experiment with cDNA from TCDD treated larvae. These changes in gene 
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expression were confirmed by RT-PCR indicating a clear correlation with the microarray 
data (Figure 4.6).   
 
The microarray data indicated that the expression of parvalbumin3a (BE201681), matrix 
metalloproteinase 9 (AW174507) and 13 (AW305943), thioredoxin (BI864190) and 
Hsp70 were altered in zebrafish embryos exposed to Cd. The expression of the four genes, 
parvalbumin3a, matrix metalloproteinase 9 and 13, thioredoxin were clearly found to be 
regulated by Cd exposure also with the RT-PCR method. The inductions of 12 genes in 
embryos exposed to 7 toxicants between 96 to 120 hpf were confirmed and showed a 
correlation with the microarray data (Figure 4.6). The gene (BM183152) which is the 
zebrafish heterogeneous nuclear ribonucleoprotein A/B and was up regulated by TCDD 
exposure has not been amplified successfully by RT-PCR.  
 
 
 
Figure 4.6 RT-PCR analysis confirms selected gene responses. Embryos were exposed 
with the indicated toxins (500 ng/l TCDD; 15 mg/l  DTT; 5 mg/l Cd; 60 µg/l MeHg; 50 
mg/l VA; 50 mg/l 4CA; 79 mg/l As) between 96 and 120 hpf. cDNA was synthesized and 
subjected to PCR with gene specific primers. The number of temperature cycles (cycle 
numbers) for every set of amplification is indicated. The column “Fold change” 
summarizes the results from the microarray experiments for comparison with the RT-
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PCR results shown in the right panel. β-actin mRNA was used as a toxin insensitive 
reference. Cont, vehicle-treated embryos, Treat, toxin treated embryos.   
 
4.3.2 In situ hybridization 
 
Selected genes, like cytochrome p450 1A1 (cyp1a1) (AF057713), parvalbumin 3a 
(BE201681), matrix metalloproteinase 9 (mmp9) (AW174507), matrix metalloproteinase 
13 (mmp13) (AW305943), thioredoxin (BI864190) and glutathione peroxidase 1 
(AW232474) were amplified by RT-PCR and subcloned into plasmid (pGEMT easy, 
pCS2+). After confirmation by sequencing, the antisense RNA probes were labeled with 
digoxigenin or fluorescein and used for in situ hybridization on whole mounts.  
 
Low levels of cyp 1a1 mRNA are expressed normally in the heart and liver (Tanguay et 
al., 2003). cyp 1a1 mRNA levels were strongly elevated in the vasculature, heart and 
liver after exposure of embryos to TCDD for one hour just after fertilization (Tanguay et 
al., 2003). A similar induction was observed in embryos treated from 4 to 48 hpf with 
150 ng/l TCDD. Interestingly, cyp 1a1 mRNA is highly induced in the vasculature but it 
was not triggered in heart and liver (Figure 4.7 A, B). Glutathione peroxidase 1 mRNA is 
expressed in the gut (Figure 4.7 C) but its expression was completely abolished in 
embryos exposed to MeHg (Figure 4.7 D), in agreement with the microarray data and the 
RT-PCR analysis.  
 
The expression of parvalbumin 3a mRNA in 24 hpf occurs in mucous cells, the olfactory 
placode, otic vesicle and anterior pituitary. Its expression can be found in the anterior 
lateral line neuromast at 36 hpf. At 72 hpf, all mature neuromasts in both the anterior and 
posterior lateral line systems robustly express parvalbumin 3a. In anterior neuromast, 
parvalbumin 3a is expressed in both sensory hair cells and supporting cells (Hsiao et al., 
2002). Interestingly, parvalbumin 3a expression is decreased dramatically in the 
neuromasts of the anterior and posterior lateral line (19 embryos with decreased 
expression out of 20 embryos examined) after exposure of embryos to Cd (500 µg/l) from 
4 to 72 hpf (Figure 4.7 E, F), in agreement with the microarray data and the PCR results.  
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Additional expression domains of thioredoxin were noted after treatment of embryos with 
Cd (500 µg/l) from 4 to 72 hpf and from 96 to 120 hpf. The exposed embryos reveal high 
levels of thioredoxin transcripts in the neuromasts of the anterior and posterior lateral line 
and olfactory epithelium (Figure 4.7 G, H). Higher magnification indicates that 
thioredoxin mRNA is specifically expressed in the hair cells while no expression was 
detected in support and mantel cells (12 embryos with increased expression out of 13 
embryos) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 In situ hybridization A, B: Vehicle control (A) and 150 ng/l TCDD-treated 
embryos (B) (48 hpf) hybridized to a cytochrome P450 1A1 antisense probe. TCDD 
treated embryos showed increased levels of cytochrome P4501A1 mRNA in blood 
vessels (24/25 embryos) (arrow, primary head sinus, arrow head, intersegmental vessel). 
C, D: 72 hpf control and 60 µg/l MeHg exposed embryos hybridized to the glutathione 
peroxidase 1 probe. Embryos showed a reduction of mRNA levels in the gut (14/15) 
(arrow). E, F: Control embryo (E) and 500 µg/l CdCl2-treated embryo (F) hybridized to a 
parvalbumin 3a antisense mRNA.  parvalbumin 3a mRNA levels are down-regulated in 
the hair cells and support cells of the lateral line organ in response to Cd exposure (19/20 
embryos). At the right corner is a high magnification of one neuromast. Eya mRNA is 
expressed in both hair cells and support cells (blue).  parvalbumin 3a mRNA is expressed 
also in both hair cells and support cells (red). G, H: Control embryo and 500 µg/l CdCl2-
treated embryos hybridized to a Thioredoxin antisense probe. Embryos showed an 
increased expression of mRNA levels in the lateral line (12/13 embryos) (arrow). The 
right corner is the high magnification of one neuromast. Thioredoxin mRNA expression 
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can be detected only in the hair cells. Embryos were treated from 4 hpf to 72 hpf and 
were then fixed for in situ processing. Embryos are oriented anterior to the left and dorsal 
up (A to H) or view onto dorsal (C, D). Scale bar represents 220µm. 
 
4.4 Gene expression profiles of different exposure doses 
 
The assessment of hazardous chemicals is currently predominantly based on the 
morphological endpoints or lethality in 50% of cases. In fact, many severely adverse 
effects may be induced by toxicants at concentrations lower than the EC50. In particular, 
low dose chronic exposure over longer time periods may cause serious pathological 
effects.  
 
The doses of the toxicants to which embryos were exposed in the initial experiments, 
were adjusted so that the chemicals caused a morphological toxic effect among 
approximately 50 percent of total treated embryos. Exposure to the lower doses (see 
appendix A) did not cause morphologically visible defects in most cases. I wanted to 
know whether I could still measure changes in the expression profiles in response to these 
low doses.  I exposed embryos from 96 to 120 hpf to either 50 percent (4CA, Cd, TCDD, 
VA, MeHg) or 10 percent (4CA, DDT, Cd, TCDD, VA, MeHg) or 1 percent (4CA, DDT, 
Cd, VA) of the original concentration.   
 
4.4.1 Comparing gene expression profiles at lower doses 
 
 
The gene expression profiles at different cadmium concentrations revealed that the 
number of significant gene responses decreased with the reduced concentrations. For 
instance, the number of induced genes (Padj <0.025 and |FC|>2.0) were decreased from 
121, 49 to 30 at 5 mg/l, 2.5 mg/l, and 0.5 mg/l Cd, respectively. Although, the fold-
induction of specific genes tended to be reduced with decreasing cadmium concentrations, 
many genes retained an induction at 10× lower concentration. For example, the 
expression of GTP cyclohydrolase 1 (AJ311846) was down-regulated 3.3-, 2.7-, and 2.6-
fold by administration of 5 mg/l, 2.5 mg/l, and 0.5 mg/l Cd, respectively. The mRNA 
level of thioredoxin (BI864190) was up-regulated 4-, 2.9-, and 2.2-fold by 5 mg/l, 2.5 
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mg/l, and 0.5 mg/l Cd, respectively. Furthermore, the expression of arginase II 
(BF717769) and heat shock cognate 70 (AF210640) were regulated by exposure to 5 
mg/l and 2.5 mg/l Cd. However, they were not induced significantly with 0.5 mg/l Cd 
(Table 5A). Similarly, an induction of MMP9 and MMP13 transcription was only found 
when embryos were exposed to 5 mg/l Cd. It is clear that the number of induced genes 
but also the foldness of induction was higher at high concentrations. Moreover, these data 
suggest that thresholds exist for the induction of particular genes.  
    
Table 5A Comparing genes expression at different doses 
Name   ID  Cd (5 mg/l)  Cd (2.5 mg/l)  Cd (0.5 mg/l) 
GTP cyclohydrolase 1 AJ311846 -3.3 -2.7 -2.6 
Thioredoxin BI864190 4.0 2.9 2.2 
unknown AW019526 -2.5 -2.0 -2.1 
unknown BI887138 2.5 2.5 2.5 
Ribosomal protein S17 BI474700 8.6 8.5 4.8 
Parvalbumin3a /oncomodulin A BE201681 -4.3 -5.7 -4.5 
Solute carrier family 16, member 9 BE016639 2.9 2.4 2.5 
Peroxiredoxin 1 BI980610 3.1 2.8 2.3 
arginase, type II BG891983 3.1 2.3 2.1 
Alpha-2-HS-glycoprotein AI496863 -3.3 -2.7 -2.9 
sequestosome 1 AW343560 3.9 3.1 2.5 
Arginase, type II BF717769 2.9 2.1   
heat shock cognate 70-kd protein AF210640 6.6 2.9   
unknown AI353541 2.8 2.5   
unknown BG727177 2.2 2.1   
Sulfide quinone reductase-like  BI882244 3.6 3.0   
uncoupling protein 2 AJ243250 2.3 2.5   
Tripartite motif-containing 62 BI878269 2.2 2.4   
Collagen, type VII, alpha 1 AI601501 -2.3 -2.3   
Total Regulated genes number 121 49 30 
 
The microarray results of MeHg exposures at different doses showed explicitly that the 
number of induced genes were 144, 14, and 5 in embryos treated with 60 µg/l, 30 µg/l, 
and 6 µg/l MeHg respectively. Moreover, the mRNA levels induced by MeHg exposures 
were correlated with the concentration of MeHg. For example, the expression level of 
peroxiredoxin (BI980610) was up-regulated 7.7-, 4.6-, and 3.6-times by 60 µg/l, 30 µg/l, 
and 6 µg/l MeHg significantly. Furthermore, the mRNA of MMP13 (AW305943) was 
triggered by MeHg exposures at 60 µg/l and 30 µg/l doses but it was not induced by 6 
µg/l MeHg. Similarly, the expression of parvalbumin3a (BE201681) was repressed by 60 
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µg/l and 30 µg/l but not by 6 µg/l MeHg. The same pattern of expression was found for 
glutathione peroxidase2 (AW232474) and glutathione peroxidase4a (BI896246) genes in 
response to the different MeHg concentrations (Table 5B). Additional 131 response genes 
were scored in embryos exposed to 60 µg/l MeHg. Examples are MMP9 (AW174507), 
ATF3 (AW422298), and C/EBPα. The gene expression profiles demonstrated that 
specific gene responses can be identified successfully at low concentrations of toxicants 
that do not cause significant morphological effects.   
 
Table 5B Comparing genes expression at different doses 
Name or Human Homology Gene   ID  Hg (60 µg/l)  Hg (30 µg/l)  Hg (6 µg/l) 
Ribosomal protein S17 BI474700 6.9 4.2 2.2 
Peroxiredoxin BI980610 7.7 4.6 3.5 
Glutamate-cysteine ligase BG304082 2.4 2.1   
Matrix metalloproteinase 13  AW305943 5.9 2.8   
ATP-binding cassette, sub-family C. 2 AW279805 2.4 2.2   
Parvalbumin 3a /oncomodulin A BE201681 -2.6 -2.3   
Glutathione S-transferase omega 1 AW019036 2.6 2.7   
Apical early endosomal glycoprotein precursor BG302634 3.0 2.4   
Glutathione peroxidase 2  AW232474 -4.2 -3.0   
Glutathione peroxidase 4a BI896246 -2.6 -2.8   
Glutathione S-transferase pi AF285098 3.2 2.2   
Suppressor of cytokine signaling 3 BG727181 4.5 2.4   
unknown AI397362   2.8 2.7 
The total number of regulated genes 144 14 5 
 
 
TCDD is a persistent, lipophilic environmental contaminant that bioaccumulates in fish, 
which is the most potent and the prototype inducer for the study of the common aryl 
hydrocarbon receptor mediated gene regulation. In fact, the microarray results of TCDD 
exposed embryos at different concentrations revealed that cytochrome p450 1a1 
(AF057713) is a very sensitive marker gene that can be induced significantly by 50 ng/l 
TCDD. Furthermore, the expression of cytochrome P4501B (BG738243) was up-
regulated by TCDD at 500 ng/l and 250 ng/l doses but no significant induction was found 
at 50 ng/l TCDD (Table 5C). Zebrafish aryl hydrocarbon receptor2 (AF063446) was up-
regulated 1.9 and 1.8 times by exposures to 500 ng/l and 250 ng/l TCDD, respectively but 
no significant induction could be demonstrated at 50 ng/l. In this case, the parameters to 
choose significant response genes were |FC|>1.5 Padj<0.025. The reason is that the fold-
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changes of transcription factors were not so large that they could be picked up under a 
higher exclusion limit of fold changes. The majority of genes with a high fold-change 
should be representative gene targets of the signaling pathways. For example, cyp450 1a1 
and cyp450 1b are regulated directly by the AHR2/ARNT1 signaling pathway.  
 
Table 5C Comparison of gene expression at varying concentrations 
Name or Human HomoloGene  ID  TCDD (500 ng/l)  TCDD (250 ng/l)  TCDD (50 ng/l) 
Cytochrome P450 1A1 AF057713 31.6 29.5 5.0 
Keratin 15 AI397347 -2.2 -2.4   
Similar to SULT6B1 AI959735 2.8 2.3   
cytochrome P450 1B BG738243 12.9 11.3   
unknown BM183152 3.3 3.0   
unknown BM101698 2.2 2.3   
unknown AI397362   2.8 2.7 
unknown AI384221 2.1     
Forkhead box Q1 AW566603 2.1     
Gastric intrinsic factor AI353694 2.1     
Cytochrome c oxidase subunit IV isoform 2  BI672330 2.3     
unknown AI353244   -2.1   
Arrestin domain containing 3 BF157296   -2.1   
unknown BI326783   -2.2   
unknown AI958860   -2.1   
Apical early endosomal glycoprotein precursor BG302634   3.3   
Arginase, type II BG891983   -2.2   
unknown AW019312     2.1 
The total numbers of regulated genes 10 13 3 
 
 
The principal component analysis shows explicit clusters of different toxicants but shows 
similar Eigenvalues between different exposure doses of one chemical. For example, the 
scatter plots of TCDD and VA are clustered far from the position of the other 
toxicogenomic patterns but the toxicogenomic patterns induced by the three different 
doses are close to each other (Figure 4.8) indicating similarity of gene responses.  
 
 
 
 
 
 
 
 
 
 65
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Principal component analysis of low doses exposure. Principal component 
analysis showing gene responses in embryos treated between 96 and 120 hpf with 4CA 
(Base, 50 mg/l, Low1, 25 mg/l, Low2, 5 mg/l, Low3, 0.5 mg/l); Cd (Base, 5 mg/l, Low1, 
2.5 mg/l, Low2, 0.5 mg/l); DDT (Base, 15 mg/l, Low1, 1.5 mg/l, Low2, 0.15 mg/l); 
MeHg (Base, 60 µg/l, Low1, 30 µg/l, Low2, 6 µg/l); TCDD (Base, 500 ng/l, Low1, 250 
ng/l, Low2, 50 ng/l); VA (Base, 50 mg/l, Low1, 25 mg/l, Low2, 5 mg/l, Low3, 0.5 mg/l); 
As ( Base, 79 mg/l, Low, 7.9 mg/l) and Pb (Base, 2.8 mg/l, Low 0.28 mg/l). The 8 
clusters are separated from each other but the gene expression profiles induced by the 
same chemical at different concentrations are similar as expected.  
 
 
Hierarchical clustering of gene response (Figure 4.9) in embryos treated between 96 to 
120 hpf with TCDD in different doses shows similar patterns of gene inductions but the 
foldness of induction of the genes decreased at lower doses. For example, cytochrome 
p450 1A1 (AF057713) was induced 32, 30 and 5-times by 500 ng/l, 250 ng/l and 50 ng/l 
TCDD, respectively, compared with vehicle treatments. The mRNA level of Cyp4501B 
(BG738243) was up-regulated 13 and 11 times in 500 ng/l and 250 ng/l TCDD treated 
embryos while Cyp4501B mRNA was not significantly increased by 50 ng/l TCDD.  
While Cd, TCDD, MeHg and Pb show significant gene responses at the lowest 
concentrations tested, the other compounds did not trigger very strong responses at the 
lowest concentrations suggesting that these are below the no-effect-concentrations 
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(NOEC). To establish the NOEC however precisely, I would need to carry out a much 
more fine grained dose response analysis which was unfortunately not possible due to the 
enormous cost involved to carry out such an analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Gene expression profiles of low doses. Expression profiles of induction in 
embryos treated between 96 and 120 hpf with the 4CA (50 mg/l, Low1, 25 mg/l, Low2, 5 
mg/l, Low3, 0.5 mg/l);  Cd (5 mg/l, Low1, 2.5 mg/l, Low2, 0.5 mg/l); DDT (15 mg/l, 
Low1, 1.5 mg/l, Low2, 0.15 mg/l); MeHg (60 µg/l, Low1, 30 µg/l, Low2, 6 µg/l); TCDD 
(500 ng/l, Low1, 250 ng/l, Low2, 50 ng/l); VA (50 mg/l, Low1, 25 mg/l, Low2, 5 mg/l, 
Low3, 0.5 mg/l); As (79 mg/l, Low, 7.9 mg/l); and Pb (2.8 mg/l, Low 0.28 mg/l). The 8 
clusters indicated explicitly but sub-clusters that induced by one chemical in different 
doses showed similar correlation with each other.  
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4.5 Gene expression profiles of mixture 
 
In the environment, organisms are rarely exposed to individual chemicals, and 
assessment of toxic effect has therefore to take into account the co-occurrence of diverse 
contaminants with different toxic potentials. Toxicologists are thus faced with the 
enormous task to assess complex chemical mixtures that may have synergistic 
toxicological effects on the ecosystem.  
 
Chemicals may behave different in mixtures leading to independent, additive, synergistic 
or antagonistic toxic effects. If two or more chemicals have different target sites in 
different processes, their effect can be expected to be independent. Mixtures of chemicals 
with a common targets site and the same mode of action act according to concentration 
additively. If the components of the mixture interact with each other, they might cause 
antagonistic or synergistic effects (Escher et al., 2002). A series of studies, where the full 
concentration effect curves of a large number of single compounds and mixtures of 
compounds, with similar and dissimilar mode of action, are performed previously. The 
effect of mixtures, however, has not been assessed in gene expression profiles.  
 
Next, it was tested whether synergistic effects of compound mixtures can be observed in 
gene expression profiles. To provide proof-of- principle, I exposed embryo between 96 to 
120 hpf to a mixture of low concentrations of Cd (50 µg/l), Pb (280 µg/l), MeHg (6 µg/l), 
and As (7.9 mg/l). About twofold more genes (167) were significantly regulated by 
administration of the mixture in comparison to the sum of the genes significantly 
regulated in response to exposure with the individual toxins (Figure 4.10). Moreover, in 
most cases the induced mRNAs levels were higher in response to the mixture than the 
changes in gene expression levels triggered by individual chemicals. For instance, the 
mRNA levels of heat shock protein 70 genes (AB062116, AF210640, AF006007) were 
dramatically up regulated by the mixture compared with the control but they were not 
significantly regulated by individual toxins. In the case of peroxiredoxin (BI980610), the 
mixture induced a strong increase by 16 times in transcript level, while mRNA levels 
were up-regulated 3-, 3.5- and 10-times by As, MeHg and Pb, respectively, while 
peroxiredoxin mRNA was not significantly regulated by Cd. Parvalbumin3a (BE201681) 
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mRNA was down regulated 4.3-, 3.5- and 5.5-fold by Cd, Pb and the mixture, 
respectively, but it was not significantly affected by As and MeHg. Antioxidant defence 
systems, like the glutathione and thioredoxin systems were up-regulated strongly by the 
mixture (Table 6).   
 
 
 
 
 
                                                                                                               
                                                                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Gene expression profiles of mixture. Embryos were exposed either to Cd 
(50 µg/l) or MeHg (6 µg/l) or As (7.9 mg/l) or Pb (280 µg/l) alone or to a mixture of Cd, 
(50 µg/l); MeHg (6 µg/l); As (7.9 mg/l); Pb (280 µg/l). The mixture shows a strongly 
increased response with respect to the degree of changes of individual genes. The blank 
indicates the missing data.  
 
In summary, the number of genes regulated by the mixture was more than additively 
increased. Interestingly, the expression of some genes while affected by individual 
chemicals was not significantly altered by the mixture suggesting antagonistic effects. 
For example, period homolog2 (BG303941) was up-regulated by As, Cd, and Pb but it 
was not induced significantly by exposure to the mixture. However, this needs to be 
verified by an independent method. 
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Table 6 Comparing selected genes expressions at mixture 
Name or Human homology Gene  ID  As  Cd  Hg Pb  Mixture 
Peroxiredoxin  BI980610 2.7   3.5 9.6 15.5 
Gastric intrinsic factor  AI353694 2.0   2.4 3.3 5.1 
kruppel-like factor 2a (klf2a) AF392992 -2.1 -4.8     -3.9 
Period homolog 2 (Drosophila) BG303941 2.4 2.1   3.5   
Ribosomal protein S17 BI474700   4.3 2.2   10.5 
Parvalbumin 3a / Oncomodulin A BE201681   -4.3   -3.0 -5.5 
uncoupling protein 2 (ucp2 gene homologue).  AJ243250   2.1   2.2 4.5 
CCAAT/enhancer binding protein (C/EBP), beta AW019436 -2.3       4.0 
Suppressor of cytokine signaling 3 BI878700 -4.9       2.6 
Matrix metalloproteinase 13 (collagenase 3) AW305943   3.2     4.1 
Arrestin domain containing 3 BF157296   2.5     2.7 
unknown BI888424   2.1     2.1 
Complement component 7 AA497156   4.1     10.1 
Stathmin 1/oncoprotein 18 BI891936   -2.2     -3.2 
Solute carrier family 16 member 9 BE016639   3.3     3.5 
Solute carrier family 16 member 6 AW421040   4.0     4.3 
unknown AW019503   2.2     4.3 
gelsolin AF175294   -2.1     -2.8 
DnaJ (Hsp40) homolog, subfamily A, member 1 BI891737   2.3     4.7 
unknown BQ618331   2.5     3.2 
unknown BI325662   -2.1     -3.1 
unknown AL591382   2.5     2.3 
Keratin 25D AI397347   -2.2     -2.4 
Solute carrier family 16  member 9 BI474827   2.7     2.8 
unknown BI886268   -2.3     -2.6 
Parvalbumin BI845755   -3.0     -4.1 
ornithine decarboxylase AF290981   2.1     2.9 
Activating transcription factor 3 AW422298   2.1     10.2 
Alpha-2-HS-glycoprotein AI496863   -3.2     -6.7 
Suppressor of cytokine signaling 3 BG727181   2.2     2.2 
thymidylate synthase AY005804   -2.3     -2.7 
Thioredoxin BI864190       4.7 14.4 
unknown BM182280       2.1 5.5 
Glutathione S-transferase omega 2 BI979918       3.7 4.2 
unknown AW115782       2.8 4.5 
glutathione S-transferase pi AF285098       4.3 6.0 
Complement component 3 AI588354       2.1 4.0 
 
 
4.6 Blind test study 
 
Taken together my results suggest that individual chemicals induce characteristic patterns 
of gene expression. As an independent verification, I carried out blind tests to identify the 
chemicals by their induced gene expression profile. This was also intended to verify and 
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to assess the reproducibility of the patterns of expression that were deduced in the 
previous experiments. The blind test paradigm, the wet part of the microarray analysis 
was done by one person and the gene expression profile was calculated and compared by 
a second person without knowledge of the chemicals used. Fourteen out of 15 chemicals 
were unambiguously identified. In the case of 4CA, close matches were scored to the 
4CA, the DDT and the AA response profiles (Figure 4.12). Thus it was in the same group 
(Figure 4.11).      
   
 
 
                                                                                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Gene expression profiles of blind tests. Embryos were treated between 96 
and 120 hpf with 4CA (50 mg/l); Cd (5 mg/l); DDT (15 mg/l); MeHg (60 µg/l); TCDD 
(500 ng/l); VA (50 mg/l); As (79 mg/l); Pb (2.8 mg/l); PCB (33 mg/l); AA (71 mg/l); 
tBHQ (1.7 mg/l). All the blind tests were done with the same concentration as in the 
original experiments. 
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Figure 4.12 Euclidean distance of blind tests Embryos were exposed from 96 to 120 
hpf with the test compounds (Test). The table gives the Euclidian distances between the 
expression profiles of the test compounds and the 11 toxins. The yellow label indicates 
the correct match. An ambiguous score was obtained in the case of 4CA (grey boxes) 
with three closely matching expression profiles.  
 
 
4.7 Molecular mechanism of toxicity 
 
Chemicals can induce proximal and distal gene expression changes in the exposed 
organism, only some of which play an important role in the toxic mechanism. Other gene 
responses may be adaptive, protecting the organism from the harmful impact of the 
chemicals. The functional characterization of these changes in signatures of gene 
expression will allow a greater understanding of the mechanism by which individual 
toxicants lead to physiological perturbations. According to the microarray data, matrix 
metalloproteinase (MMP) 9 and 13 are highly induced in embryos treated with cadmium 
and methylmercury. I thus embarked on a more detailed investigation of MMP 9 and 13 
to assess their role in the observed teratological effects of Cd and MeHg treatment. 
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4.7.1 Methylmercury induces morphological changes at very low 
concentrations in the zebrafish embryo 
 
Defects and morphological changes were observed in embryos that were exposed to 
methylmercury either from 4 to 48 hpf or 4 to 72 hpf or 4 to 96 hpf. Abnormal fin shapes 
and pigmentation were detected, especially the tail fin revealed a difference compared 
with a control embryo (Figure 4.13 A, C). 43 out of 50 exposed embryos (50 µg/l) 
showed abnormal fin shapes at 72 hpf. The pigmentation in the ventral tail near the end 
of the notochord forms a gap in control embryos. This gap in pigmentation was not 
evident in embryos treated with methylmercury (31/50 embryos) (Figure 4.13 A, C).  
 
In a parallel study, it was shown that this gap was also closed in zebrafish mutants or 
knock-down embryos, in which the Shh signaling pathway is impaired. Interestingly, a 
GFP transgene is specifically expressed in this gap of pigmentation. Expression of the 
transgene is also dependent on a functional Shh signalling pathway. Hadziev et al 
(submitted) suggested that this region is implicated as growth zone from which the tail fin 
grows out during late embryogenesis and larval stages. I investigated next whether the 
expression of the transgene would also be affected by administration of MeHg.  
Transgenic embryos (–2.4shh:gfp ABC line 15 ) were exposed to MeHg 50 µg/l from 4 to 
48 hpf and GFP fluorescence was monitored in live embryos at 96 hpf. MeHg exposure 
abolished the expression of the transgene. From these data it is tempting to speculate that 
MeHg interferes with the Shh signaling pathway. (Figure 4.13 B, D). 
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Figure 4.13 Morphological changes in tail fin pigmentation of embryos exposed to 
methylmercury from 4 to 48 hpf. A,C: The treated embryo (A) and control embryo (C) 
show a different tail fin shape and pigmentation. The embryos exposed to 50 µg/l 
methylmercury lack the gap in pigmentation characteristic of normal embryos (arrow). 
B,D: When the same embryos were observed under a fluorescence microscope, it is clear 
that the MeHg treatment abolished also the expression of the transgene -2.4shh:gfpABC 
line 15 (Arrow in B, D).  
 
 
4.7.2 Methylmercury toxicity study 
 
 
Matrix metalloproteinases (MMPs) are a subfamily of the large metzincin family of 
metalloendopeptidases characterized in part by their requirement for zinc. Currently, 
there are more than 20 characterized mammalian matrix metalloproteinases and 
numerous homologues in other organisms have been detected (Bosman et al., 2003). 
Matrix metalloproteinases were initially named according to their perceived substrate 
specificity. For example, MMP-1, 8 and 13 are also known as collagenase; MMP-2 and 9 
as gelatinase; MMP-3, 10 and 11 as stromelysin; MMP-7 and 26 as matrylisin. Generally, 
it is accepted that MMPs in combination can degrade the entire extracellular matrix. 
MMPs play an essential role in many physiological events, including development, 
hormone dependent tissue remodeling, and tissue repair. They also play a key role in 
pathological conditions such as inflammation, tumor invasion, and metastasis. Most of 
the MMPs are secreted proteins that typically contain a secretory signal sequence, a pro 
domain that maintains the zymogen status, and a catalytic domain that contains a zinc 
binding site consensus sequence.  
A 
C D
B
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4.7.2.1 Matrix metalloproteinase 9  
 
In mammals, MMP9 is mainly expressed in neutrophils and eosinophils, where it serves 
as a key marker for their differentiation (Dahlen et al., 1999). In zebrafish, MMP9 
transcription was first detected in unfertilized eggs, indicating a maternal contribution. In 
12 hpf embryos, the expression domain of MMP9 localized to the posterior region of the 
developing notochord. By 16-somites (17 hpf) MMP9 expression has vanished in the 
anterior mesoderm of the embryo. By 24 hpf, discrete MMP9 positive cells appeared to 
be present in the coalescing circulatory system of the embryo and become concentrated 
around the anterior yolk sac and the head of the embryo and in single cells along the 
length of the tail in circulation, similar to that observed with other myeloid markers. 
During the 48 to 72 hpf period, the expression of MMP9 remained concentrated in 
macrophages, which are highly motile, large, round cells with cytoplasmic phagosomes 
that act as a bacterial defense mechanism, in the head region around the eye and to a 
lesser extent in the tail of embryo. In adult zebrafish, strong MMP9 expression was found 
in the spleen (Yoong et al., 2006).  
 
Interestingly, the additional MMP9 expression domains were detected after zebrafish 
embryo was treated either from 4 to 24 hpf or from 4 to 48 hpf or from 4 to 72 hpf with 
60 µg/l MeHg. In embryos exposed between 4 and 24 hpf, the expression of MMP9 
appeared to be increased in the skin around the whole body (Figure 4.14 B). By 48 hpf, 
MMP9 expression had vanished in the skin but it was increased in the finfold of the trunk 
and tail (Figure 4.14 D). In embryos treated between 4 and 72 hpf, the expression of 
MMP9 was detected in individual cells presumably macrophages and the strong level of 
transcripts along the dorsal and ventral fin especially in the tail was maintained (Figure 
4.14 F). When observed at higher optical resolution, several MMP9 expression areas are 
detectable around the tail fin. First, the MMP9 mRNA was evident along the edge of the 
tail finfold. The second group of expressing cells accumulated at the end of tail. Finally, 
an interesting finding was that there was strong expression of MMP9 mRNA in the three 
tail neuromasts, which are localized close to the gap of pigmentation in untreated 
embryos (Figure 4.14 G, H).  
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Figure 4.14 MMP9 expression pattern in control and MeHg treated embryo. Staged 
embryos that are separated as control embryos (A, C, E) and embryos treated with 50 µg/l 
MeHg either from 4 to 24 hpf (B) or 4 to 48 hpf (D) or 4 to 72 hpf (F, G, H) were 
analyzed using a DIG-labeled MMP9 probe (sites of MMP9 expression shown with 
arrows). All the embryos are orientated in a lateral view with the anterior to the left and 
the dorsal side up and MMP9 expression indicated with arrows. G, H: High magnification 
tail fin of the treated embryos, MMP9 expression indicated with arrows. Three 
neuromasts (G, arrow) between the tail fin gap and some other cells around tail fin were 
induced to express MMP9 mRNA (H, arrow).  
 
 
4.7.2.2 Matrix metalloproteinase 13   
 
A point mutation in MMP13 causes the Missouri variant of spondyloepimetaphyseal 
dysplasia, a human syndrome with abnormailities in development and growth of 
endochondral skeletal elements (Kennedy et al., 2003). MMP13 is expressed by both 
terminal hypertrophic chondrocytes and osteoblasts, and its substrates include both Col1 
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and Col2. Furthermore, MMP13 can synergize with MMP9 in degradation of collagen 
(Engsig et al., 2000). The two major components of the extracellular matrix of cartilage, 
collagen type II and aggrecan, were studied as in vitro substrates for MMP13. The 
degradation of collagen type II and aggrecan is a coordinated process, in which MMP13 
works synergistically with MMP9. Mice lacking both MMP13 and MMP9 had severely 
impaired endochondral bone, characterized by diminished ECM remodeling, prolonged 
chondrocyte survival, delayed vascular recruitment and defective trabecular bone 
formation (resulting in drastically shortened bones) (Stichens et al., 2004).  
 
I first investigated the expression pattern of MMP13 in normal zebrafish embryos. At 24 
hpf embryos, discrete MMP13 positive cells appeared to be present in the circulatory 
system of the embryo and were concentrated around the anterior yolk sac (Figure 4.15 A, 
B). By 48 hpf, the expression of MMP13 was revealed as positive cells around the eye 
and at the posterior yolk extension (Figure 4.15 E). At 48 hpf embryo, MMP13 
transcription was found at the ventral head and in the circulatory system (Figure 4.15 G). 
 
Embryos exposed to MeHg either from 4 to 24 hpf or from 4 to 48 hpf or from 4 to 72 
hpf had a drastically increased expression of MMP13. In embryos treated from 4 to 24 
hpf, the number of MMP13 expressing cells was increased (Figure 4.15 C, D). Embryos 
treated until 48 hpf had increased expression of MMP13 mRNA along the fin folds and 
around the eye. A lot of positive cells were concentrated at the ventral and posterior 
aspects of the eye (Figure 4.15 F). In embryos treated until 72 hpf, the expression of 
MMP13 still remains in macrophages, which appeared in the circulatory system and 
concentrated around the eye. Furthermore, MMP13 expression was strongly increased 
along the tail fin (Figure 4.15 H). 
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Figure 4.15 MMP13 expression pattern Whole mount in situ hybridization. Staged 
zebrafish embryos that are separated as control embryos (A, B, E, G) and embryos treated 
with 50 µg/l MeHg either from 4 to 24 hpf (C, D) or 4 to 48 hpf (F) or 4 to 72 hpf (H) 
were analyzed using a DIG-labeled MMP13 probe. The sites of MMP13 expression are 
shown with arrows. In (A, C, and E-F) embryos are orientated in a lateral view with the 
anterior to the left and the dorsal side up. The embryos in (B and D) are orientated in a 
dorsal view with the anterior up.  
 
 
4.7.2.3 MMP9 and MMP13 double in situ hybridization 
 
The previous studies suggested that MMP9 and MMP13 are expressed in macrophages. I 
wished to assess whether the two genes are indeed co-expressed and carried out double in 
situ hybridization. In 48 hpf control embryos, MMP13 expression was detectable in cells, 
which localized around the eye and in the ventral tail (Fig. 4. 16 A, C blue). In 
comparison to MMP13, fewer cells expressed MMP9 and the expression of MMP9 was 
restricted to cells in the circulation system (Figure 4.16 C).   
 
In 48 hpf embryos treated with MeHg, the MMP13-positive cells were found around the 
eye and along the vasculature. Furthermore, some MMP13 expressing cells were 
localized in the fin fold or in the tail immediately adjacent to the fin fold (Figure 4. 16 B, 
D, E, F). However, the cells that expressed MMP9 mRNA localize to the tail fin. These 
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MMP9 positive cells (red) were different from the MMP13 positive cells (Figure 4. 16 E, 
F). Taken together MMP9 and MMP13 appear to be expressed in distinct populations of 
cells. The identity of these cells needs to be determined in detail by additional experiment 
which was beyond the scope of this work. 
 
After exposure of the embryos to MeHg until 72 hpf, the number of cells that expressed 
MMP13 and MMP9 mRNA were drastically increased (Figure 4. 17 B, D, F, G, H). 
These results supported the microarray data. Further this shows that the MMP9 and 
MMP13 genes are induced in a highly restricted pattern in embryos. 
 
 
 
 
Figure 4.16 MMP9 and MMP13 expression pattern. Embryos at the indicated stages 
that are separated as control (A, C) and treated with 50 µg/l MeHg from 4 to 48 hpf (B, D, 
E, F) were hybridized with fluorescein labeled MMP9 antisense probe and digoxygenin 
labeled MMP13 antisense probe. All the embryos are orientated in a lateral view with the 
anterior to the left and dorsal up. MMP9 and MMP13 expressing cells are indicated with 
arrows. 
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Figure 4.17 MMP9 and MMP13 expression pattern. Whole mount in situ hybridization 
analysis. Control embryos (A, C, E) and embryos treated with 50 µg/l MeHg from 4 to 72 
hpf (B, D, F, G, H) were hybridized with fluorescence labeled MMP9 antisense probe and 
digoxygenin labeled MMP13 antisense probe. In (A, B, C, D, G, H) embryos are 
orientated in lateral view with the anterior to the left and the dorsal side up, MMP9 
expression is indicated with black arrows and MMP13 expression indicated with white 
arrows. In (E, F) embryos are orientated in a dorsal view with anterior is up. 
 
4.7.3 Cadmium toxicity study 
 
 
A previous study in zebrafish revealed that cadmium exposure leads to localized cell 
death, alters muscle and motoneuron development and induces stress responses (Chow et 
al., 2003). I showed here that cadmium alters the expression of a number of genes that 
may play a role in the response of the embryos to Cd exposure. To elucidate the 
mechanism of cadmium responses of the embryos, several Cd-regulated genes, like 
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MMP9, MMP13, Thioredoxin and parvalbumin 3a were focused on key studying the 
expression patterns by in situ hybridization. 
 
4.7.3.1 Matrix metalloproteinase 9 (MMP9) 
 
The expression of MMP9 is altered in embryos treated with cadmium from 4 to 24 hpf, 
from 4 to 48 hpf and from 4 to 72 hpf (Figure 4.18). By the 4 to 24 hpf exposure, the 
expression of MMP9 was induced in the skin and macrophages (Figure 4.18 B). At 48 
hpf, the induction of MMP9 was concentrated in the margin of the tail finfolds besides 
the expression in macrophages (Figure 4.18 D). By 72 hpf, the majority of MMP9 mRNA 
was detected along the side of tail fin (Figure 4.18 F).  
 
 
 
 
Figure 4.18 MMP9 expression in embryos treated with Cd. Staged embryos that are 
separated as control embryos (A, C, E) and embryos treated with 500 µg/l cadmium 
either from 4 to 24 hpf (B) or 4 to 48 hpf (D) or 4 to 72 hpf (F) were analyzed using a 
DIG-labeled MMP9 probe. All the embryos are orientated in a lateral view with the 
anterior to the left and the dorsal side up and MMP9 expression indicated with arrows.  
 
 
4.7.3.2 Matrix metalloproteinase 13 (MMP13) 
 
The transcription level of MMP 13 regulated by exposure of embryo to cadmium either 
from 4 to 24 hpf or from 4 to 48 hpf or from 4 to 72 hpf was revealed in Figure 4.19. At 
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24 hpf exposure, the number of MMP 13 positive macrophages was higher than in control 
embryo (Figure 4.19 A, B, C, D). In addition, a group of positive cell was detected in the 
end of the yolk extension of exposed embryos. After 48 and 72 hpf exposure, the 
expression of MMP13 was detectable in the vasculature but the majority of positive cells 
can be found around the eyes especially, at the posterior side of the eyes (Figure 4.19 E, F, 
G, H) 
 
       
 
Figure 4.19 MMP13 expression pattern in embryos treated with Cd. Staged control 
embryos (A, B, E, G) and embryos treated with 500 µg/l cadmium either from 4 to 24 hpf 
(C, D) or 4 to 48 hpf (F) or 4 to 72 hpf (H) were analyzed using a DIG-labeled MMP13 
probe. The embryos are orientated in a lateral view with the anterior to the left and dorsal 
up and mmp13 expression indicated with arrows (A, C, E, F, G, H). The embryos (B, D) 
are in dorsal view with the anterior up and MMP13 positive cells indicated with arrows.  
 
4.7.3.3 Parvalbumin 3a 
 
The lateral line is a sensory system in fish and amphibians and responds to changes in the 
motion of water. It is involved in a large variety of behaviors, from prey detection to 
predator avoidance, school swimming and sexual courtship. It has disappeared in 
terrestrial tetrapods, with the exception of its internal counterpart, the inner ear. The 
lateral line comprises a set of sensory organs, the neuromasts (Figure 4.20) arranged on 
the body surface in species-specific patterns. Neuromasts comprise a core of 
mechanosensory hair cells, surrounded by support cells, and are innervated by sensory 
neurons that are localized in cranial ganglia called anterior and posterior lateral line 
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ganglia. The neuromasts on the head form the so-called anterior lateral line system, the 
ganglion of which is located between the ear and the eye, while the neuromasts on the 
body and tail, including those on the caudal fin, form the posterior lateral line system. Its 
ganglion is just posterior to the ear (Ghysen, et al., 2004). The neuromasts of the 
posterior lateral line are deposited at regular intervals by a primordium, which originates 
from a placode that is just posterior to the otic placode, and migrates along the horizontal 
myoseptum. The path followed by the primordium is defined by the expression of a 
zebrafish homolog of the chemokine stromal-derived factor 1 (SDF1), which the 
primordium detects through the expression of its receptor Cxcr4b. Knockdown of either 
the ligand or the receptor results in a similar strong defect in migration of the posterior 
lateral line primordium (Davie et al., 2002; Li et al., 2004).  
 
 
                                     
Figure 4.20 Scheme of a neuromast illustrating the different cell types. The cupula is 
secreted by the support cells 
 
The mechanosensory hair cells of the inner ear sensory epithelia are commonly lost 
through aging, as well as noise- and drug-induced trauma. In particular, 
mechanoreceptive hair cells are extremely sensitive to ototoxicity, like aminoglycoside 
antibiotics, including neomycin (Harris et al., 2003). Recent studies revealed that the 
heavy metal copper can trigger the death of hair cells in the neuromasts of exposed 
zebrafish larvae (Hernardes et al., 2006; Linbo et al., 2006). While the exact mechanisms 
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of ototoxicity remain unknown, it appears to involve both known apoptotic cell death 
pathways and the formation of free radicals.  
 
Given the fact that copper ions can induce loss of hair cells and the observation that a 
number of genes are specifcally expressed and induced in the neuromasts, I investigated 
whether neuromasts are present in Cd treated embryos. The fluorescent dye 2-[4-
(dimethylamino)styryl]-N-ethylpyridinium iodide (DASPEI; molecular probes, Eugene, 
OR) is a dye to stain specifically hair cells in neuromasts of living embryos. The embryos 
were incubated in fish medium containing 0.005% DASPEI for 20 min and anesthetized 
in 10 µg/ml methanesulfonate salt, rinsed in fresh fish medium and then analyzed under a 
fluorescence microscope. The hair cells in the neuromasts were strongly stained with 
DASPEI in control embryos (Figure 4.21 A). The hair cells revealing high fluorescence 
intensity can be separated into two groups. One group is formed by the 18 anterior 
neuromasts around the eye; the other group of neuromasts is located along the horizontal 
myoseptum comprising 7-9 neuromasts of the posterior lateral line. The embryos treated 
with 500 µg/l cadmium from 4 to 96 hpf showed a decrease of fluorescence intensity in 
both anterior and posterior lateral line neuromasts. Interestingly, the neuromasts in 
treated embryos were deposited at the correct location (Figure 4.21 B). In other words, 
the number of hair cells in the anterior and posterior lateral line was decreased by 
cadmium exposure while the migration of the primordium depositing the neuromasts 
does not seem to be affected. To investigate the defect in the lateral line in more detail, I 
chose parvalbumin 3a and thioredoxin for further study.  
 
Parvalbumin 3 is a prominent Ca2+ binding protein. Oncomodulin, the mammalian 
orthologue of parvalbumin 3 has been reported to be expressed in hair cells. In a previous 
study, parvalbumin 3 and related proteins have been suggested to be involved in the Ca2+ 
buffering capacity of different types of hair cells (Heller et al., 2002). According to this 
notion, Ca2+ signaling serves distinct purposes in different parts of a hair cell. The Ca2+ 
concentration in stereocilia regulates adaptation and, through rapid transduction channel 
reclosure, underlies amplification of mechanical signals. In the presynaptic active zones, 
Ca2+ mediates the exocytotic release of afferent neurotransmitters. At efferent synapses, 
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Ca2+ activates the K+ channels that dominate the inhibitory postsynaptic potential. A 
copious supply of diffusible Ca-binding protein buffer can isolate the three signals by 
restricting the spread of free Ca2+ and limiting the duration of its action.  
 
The expression of parvalbumin 3a in embryos treated with cadmium revealed that the 
expression of parvalbumin 3a mRNA was reduced in both the anterior and posterior 
lateral line (Figure 4.21 C, D). The DASPEI staining showed that the number of hair cells 
in neuromasts was decreased drastically in Cd-treated embryos. The parvalbumin 3a 
mRNA level may then be reduced as a consequence of the less of hair cell. It remains to 
be tested whether the putative Ca2+ buffering protein parvalbumin 3a could be the direct 
trigger of Cd toxicity in hair cell.    
 
 
 
 
Figure 4.21 The embryos were stained with DASPEI and hybridized with DIG 
labeled anti parvalbumin 3a probe. Embryo were treated with 500 µg/l cadmium from 4 
to 96 hpf (B) or the vehicle control (A) were stained with 0.005% DASPEI (2-[4-
(dimethylamino)styryl]-N-ethylpyridinium iodide) in fish medium for 20 min, 
anesthetized and rinsed in fresh fish medium and then analyzed under a fluorescence 
microscope. The embryos exposed to 500 µg/l cadmium from 4 to 72 hpf (D) or control 
embryos (C) were fixed and hybridized with the anti parvalbumin 3a (or oncomodulin A) 
probe. The fluorescein stained hair cells in the neuromasts and the expression of 
parvalbumin mRNA are indicated by arrows 
 
 
4.7.4 Thioredoxin 
 
 
Thioredoxin, a small, ubiquitous thiol [sulfydryl(-SH)] protein, is one of the most 
important regulators of redox balance and redox-controlled cell functions. The biological 
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properties of thioredoxin rely, largely, on their reduction oxidation activity, which is the 
ability to transfer reducing equivalents to disulfide groups in target proteins. The key to 
the redox activity of thioredoxin is the presence of two cysteine residues separated by two 
amino acids in its active site. These cysteines exist as dithiols [-(SH2)] in the reduced 
form and a disulfide (-S2) in the oxidized form. Thioredoxin is oxidized when it transfers 
reducing equivalents to disulfide groups in target proteins and it is reduced back to the 
dithiol form by an NADPH-dependent flavoprotein, thioredoxin reductase (Burke-
Gaffney et al., 2006). In humans, multiple thioredoxins exist: thioredoxin 1, thioredoxin 2 
and thioredoxin-like molecules. 
 
The biological activities of thioredoxin can be categorized as antioxidant, growth 
promoting, anti-apoptotic and inflammation modulating. The principle intracellular 
antioxidant property of thioredoxin results from its ability to act as a cofactor that 
maintains several thioredoxin peroxidase enzymes in a reduced, active form (Watson et 
al., 2004). Mechanisms of thioredoxin induced growth are multifaceted and include 
activation of transcription factors and increasing sensitivity of cells to cytokines and 
growth factors. At least 64 redox-regulated transcription factors have been identified. A 
number of these have critical thiol moieties and are known to be regulated, at least in part, 
by the thioredoxin system. Of particular note are p53, NF-κB, AP-1, Nrf2, GR, and ER, 
each of which is thiol dependent and has been implicated in processes such as cell 
proliferation and apoptosis. Thioredoxin’s effects on apoptosis might relate to its ability 
to bind to and inhibit apoptosis signal regulating kinase 1 (ASK1). Thioredoxin 
overexpression provides protection against oxidative stress and reduces the induced 
toxicity of certain xenobiotics (Chen et al., 2002).  
 
 
The glutathione and thioredoxin systems appear to act in parallel sharing the task to 
control the redox balance in the cell. Glutathione is present at millimolar concentrations 
in cells and functions along with several peroxidases and glutathione S-transferases to 
provide a primary protection against ROS and electrophiles. In addition, glutathione can 
reduce protein disulfides and sulfenic acids by nonenzymatic and enzymatic reactions. 
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The redox state of the glutathione and thioredoxin systems appears to be independently 
controlled. Thioredoxin is maintained in a reduced state, even under conditions resulting 
in glutathione depletion and oxidation (Nkabyo et al., 2002).  
 
Cd induces a homolog to mammalian thioredoxins strongly. To date, nothing is known 
about thioredoxins in zebrafish. I thus investigated the pattern of expression of this 
thioredoxin in detail by using whole mount in situ hybridization. At 20 hpf, the 
expression of thioredoxin is detected in neural cells of the trunk forming two lateral rows 
of scattered cells (Figure 4.22 A, B). The distribution and shape of the cells suggests that 
these cells are a subclass of ventral interneurones. This expression in the neural tube of 
the trunk vanishes and at later stages a different pattern of expression is observed. The 
expression pattern of thioredoxin at 48 hpf is found in discrete groups of cells at the 
midbrain/hindbrain boundary, ventral thalamus, and olfactory epithelia. In addition, 
individual positive cells can be found in the hindbrain (Figure 4.22 C, D). In summary the 
expression pattern suggests that this thioredoxin like protein has very special activities in 
a restricted number of neuronal cells. In addition the expression appears to be modulated 
during development.  
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Figure 4.22 The embryos hybridized with DIG labeled anti thioredoxin probe. 
Staged zebrafish embryos (A, B(20 hpf), C, D(48 hpf)) were analyzed using a DIG-
labeled anti thioredoxin probe. The embryos are orientated in a lateral view with the 
anterior to the left and the dorsal side up and thioredoxin expression indicated with 
arrows (A, C). The embryos (B, D) are in dorsal view with the anterior to the up. 
 
 
According to my microarray data, thioredoxin mRNA transcription was up-regulated 
drastically in embryos exposed to Cd. Moreover, in addition to Cd as inducer,  
thioredoxin (BI864190) transcription levels were up-regulated by several other chemicals 
including As, 4CA, MeHg, Pb, PCB, and tBHQ suggesting that thioredoxin induction is a 
general response to a variety of toxins.  
 
Next, I investigated whether the pattern of thioredoxin expression is changed in response 
to MeHg or whether the changes in levels are due to an up-regulation only in the 
expressing cells? The expression of thioredoxin was analysed in embryos treated with 
MeHg from 96 to 120 hfp followed by in situ hybridization (Figure 4.23). In 120 hpf 
control embryos, the expression of thioredoxin was detected in the olfactory epithelia, 
ventral thalamus and several positive cell groups around the hindbrain (Figure 4.23 A). 
The expression of thioredoxin mRNA was up-regulated dramatically in the olfactory 
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epithelia and ventral thalamus in MeHg treated embryos (20/20 exposur embryos). 
Surprisingly, several additional expression domains were detected: The anterior and 
posterior lateral line, cell groups in the hindbrain, the epithelia of mouth and swimming 
bladder expressed the gene in MeHg treated embryo. (Figure 4.23 B, C, D, E).  
 
 
 
 
Figure 4.23 Thioredoxin expression pattern in 120 hpf MeHg treated embryos (B, C, 
D, E) and controls (A). The 120 hpf control embryos (A) or treated with 60 µg/l MeHg 
from 96 to 120 hpf were fixed and hybridized with DIG labeled anti thioredoxin probe. 
Arrows indicate the thioredoxin expression. Lateral views (A, B) and transverse sections 
(C, D, E) of treated embryos (20/20 treatment embryos). 
In the dorsal view of a lateral line neuromast, the positive cells were arranged at the 
boundary of the neuromast and the skin epithelia around the hair cells in the middle of the 
neuromasts (Figure 4.24 D). The expression of eya 1 and parvalbumin 3a was visualized 
by two-color in situ hybridization. In the dorsal and lateral view, the mRNAs of eya 1 and 
parvalbumin 3a were detected in both hair cells and supporting cells (Figure 4.24 B, E). 
But it is not clear whether the two genes are expressed in mantel cells.  
The expression of thioredoxin mRNA was induced in the anterior and posterior lateral 
line after exposure of embryos to Cd from 4 to 72 hpf. As shown by Daspei staining 
(Figure 4.21) the number of hair cells is reduced in Cd-treated embryos. The thioredoxin 
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mRNA was strongly expressed in the remaining hair cells in Cd treated embryos. (Figure 
4.24 C, F). It remains to be established whether the hair cells that were induced to express 
thioredoxin mRNA by Cd exposure are cells that survived the impact of Cd or whether 
these are newborne hair cells in an attempt to regenerate the neuromast.  
    
 
Figure 4.24 Gene expression pattern in neuromast. The staged embryos were fixed 
and hybridized with dig labeled anti (AI397347, panel A, D), anti parvalbumin 3a (panel 
B, E) and anti thioredoxin (panel C, F) or with fluorescein labeled anti eya 1 (panel B, E)  
RNA probe. At 72 hpf control embryos (A, B, D, E) or treated with cadmium from 4 to 
72 hpf (D, F) embryos were revealed three genes expression patterns in neuromasts. A, D 
showed gene AI397347, arrows, arrowhead, short-arrow, and black arrow indicate the 
mantle cells, the support cells, hair cells, and the cilia respectively. B, E showed eya 1 
(red) and parvalbumin 3a (blue), arrows and arrowhead indicate the hair cells and support 
cells. C, F showed thioredoxin, arrows indicate the hair cells. Embryos are oriented 
anterior to the left and dorsal up (A-C) or view onto dorsal (D-F).  
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5 Discussion 
  
In summary, this thesis work reveals that: 1) Stage-specific toxicogenomic responses. 2) 
The toxicogenomic responses triggered by different toxicants are highly specific. 3) 
Toxicants induced tissue specific genes expression. 4) The genomic responses are very 
sensitivity to toxicants insult. 5) Complex synergy effects are evident in toxicogenomic 
responses to compound mixtures. 
 
5.1 Traditional approachs for assessing toxicity 
 
For their many advantages as model organism, zebrafish have been used in a variety of 
applications to assess environmental toxicity. For example, zebrafish assays have been 
used to directly monitor water, soil, and waste water quality for ecotoxicity studies 
(Ruoppa et al., 1988; Vitozzi et al., 1991). Furthermore, zebrafish have also been used to 
assess risks of toxicity, to predict toxicity associated with petroleum products and by-
products, to evaluate working conditions in the petrochemical and mining industries, and 
to study the effects of polychlorinated biphenyls, dioxin and other toxicants (Lele et al., 
1996; Andersson et al., 2001; Andreasen et al., 2002; Ton et al., 2006). Moreover, a 
number of guidelines from the Organization of Economic Cooperation and Development 
(OECD) recommend zebrafish as a model for aquatic toxicity testing. In the DarT (Danio 
rerio embryo toxicity test. Nagel R., 2002), embryos are briefly (48 hours) exposed to the 
test substance, followed by analysis of several parameters, such as somite formation, 
development of organs, pigmentation, edema formation, tail length, heartbeat and 
movement. This assay is considered as a pain-free in vitro test and is therefore accepted 
as a replacement for animal experiments in Germany. DarT correlates well with the acute 
fish toxicity tests but it has low sensitivity for assessment of low dose exposure effects. 
Other readouts need to be developed to assess the adverse effects of low dose exposure.  
 
5.2 Gene expression profile and toxicogenomics 
 
In the last decade, a new paradigm has emerged among toxicologist which is based on the 
assumption that by knowing the molecular mechanism of toxicity of compounds one 
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would be able to predict the risk emanating from novel compounds. Understanding the 
mechanism of action of toxicants in living organism will help to develop predictive 
simulation models of toxic effects to link molecular biomarkers with population level 
effects, and then to anticipate the ecologic risk for new chemicals. In fact, gene 
expression is a unique way of characterizing how cells and organisms adapt to changes in 
the external environment. The measurements of gene expression levels upon exposure to 
a chemical can be used both to provide information about the mechanism of action of the 
toxicant and to form a sort of genetic signature for the identification of toxic products. 
Toxicogenomics uses global gene expression analyses to detect expression changes that 
influence, predict or help define, and classify chemicals’ toxicity. Especially, it is 
believed that toxicogenomics could accelerate the detection of toxic liabilities by 
replacing long-term exposure experiments for the selection of clinical candidates. Thus 
pharmaceutical companies have started to build their own database in the hope of 
predicting the potential toxicity of compounds (Khor et al., 2006). 
 
5.3 Exposure windows and chemical classification 
 
The gene expression profiles indicated that the biological response to toxicants is varying 
at different life stages. From 4 to 24 hpf exposures, the number of response genes is less 
than that induced at later stages. Moreover, the gene expression profiles of embryos 
treated between 4 to 24 hpf are less characteristic than those of the later stages. These 
early stages appear thus to be unsuitable to classify chemicals. One hypothesis is that, 
embryos do not activate or repress genes as efficiently in response to toxicants at this 
stage because organ systems have not matured sufficiently. Surprisingly, at this stage, the 
gene expression profiles show much higher statistical variation. In other words, the gene 
induction varys between different experiments and there may be also a higher variability 
in the response of individual embryos within one experiment. Another explanation is thus 
this higher variation in gene responses, which will lead to averaging out of specific gene 
responses. Moreover no data exist from mouse embryos at equivalent embryonic stages 
as these gastrula and blastula stages are very difficult to analyse in mammals. Thus 
comparative material is missing to support my conclusion.  
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Irrespective of the causes, my results indicate that the exposure window from 4 to 24 hpf 
is not useful to derive gene expression profiles complex enough for chemical 
classification. The other two exposure windows, from 24 to 48 hpf and from 96 to 120 
hpf, in principle, can be used to study the gene expression profiles and classify the 
different toxicants.  
 
The exposure window, from 96 to 120 hpf was chosen to study the gene expression 
profile and predict the toxicity for several reasons. At 96 hpf, the hatched larvae have 
completed most of the early morphogenesis and begin to swim. They also start to feed 
and hunt on the subsequent stages suggesting that they have an almost mature physiology 
and may thus have also more adult responses to toxicants.  Experimentally, these older 
stages have the advantage that one needs to expose fewer animals to isolate sufficient 
mRNA for a microarray experiment.  
 
The gene expression profiles of 11 toxicants were analysed by different statistical 
methods. Principal component analysis and hierarchical clustering of the gene responses 
induced by the 11 chemicals allowed separation of the toxicants by their gene response 
pattern. Comparison of the expression profiles of the 11 chemicals revealed three more 
closely related sub-groups: As, Pb, VA, Hg, Cd, and tBHQ belonged to the first group; 
TCDD, 4CA, DDT, and AA represent a second sub-group while PCB formed its own 
group.  
 
Irrespective of these similarities, it was possible to identify toxicant-specific patterns. The 
verification of the toxicogenomic profiles in blind test experiments underscores this 
finding. Fourteen out of 15 chemicals were unambiguously identified. In the case of 4CA, 
similar Euclidean distances were found to DDT and AA response profiles thereby not 
allowing unambiguous identification of the chemicals.  But, all three chemicals belong to 
the same subgroup. These results indicated that gene expression profiles can be used to 
classify different chemicals by their toxicogenomic profiles. This information may be 
useful to pick up signature for predicting the toxicity of unknown or novel chemicals. 
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In principle, the heavy metals may be expected to induce a similar response. Analysis of 
the induced gene ontologies suggests that Cd, As, Pb, and MeHg induce indeed similar 
responses. The transporter system genes such as solute carrier family 16 (BE016639, 
BI474827), heat shock protein genes such as Hsp70 (AB062116, AF210640, AF006007, 
except MeHg) and genes with ontologies related to transcription factors such as ATF3 
(AW422298), Zinc fingers protein 1 (AI793802), and C/EBP beta (AW019436) were 
significantly up regulated by the heavy metals. In addition, genes encoding proteins 
involved in antioxidant responses (Winyard et al., 2005), for example, peroxiredoxin 1 
(BI980610), thioredoxin like protein (BI864190), and glutathione S-transferase omega 1 
(AW019036), and metalloproteinases such as MMP9 (AW174507) and MMP13 
(AW305943) were triggered by heavy metals exposures. 6-phosphogluconate 
dehydrogenase (AW11578), Arginase type II (BF717769, BG891938), and ribosomal 
protein S17 (BI474700) genes were up regulated by most of these heavy metals. On the 
other hand, GTP cyclohydrolase 1 (AJ311846), Amylase alpha (BM103972) Keratin 6 
(BE016992), and Keratin 13 (BE200701) were down regulated by Cd and Pb exposures. 
Most of above response genes were found to be regulated by VA and tBHQ also. 
Interestingly, the Ca 2+ buffering gene parvalbumin 3a (BE201681) was only responsive 
to heavy metal exposure and cytochrome p450 1a (AF057713), solute carrier family 6 
(BF157011, BI563084) were found in tBHQ and VA exposures respectively.  
Irrespective of these similarities of the first group, some specific response genes for each 
chemical can be found to identify the properties of the toxicants. For example, 
glutathione peroxidase (AW232474) was only repressed by MeHg; heat shock protein 
90-alhpa (AF068773) was only triggered by As; serum amyloid a (BI883516) was 
induced by Cd; unknown gene (AI958489) was down regulated by Pb; solute carrier 
family 6 (BF157011, BI563084) was specifically down regulated by VA.  
 
A number of genes I found also showed to be induced by Cd, As, and Hg in other studies 
in mouse and zebrafish (Bartosiewicz et al., 2001; Lam et al., 2006; Liu et al., 2003), for 
example, Hsp70, Hsp90 a, glutathione S-transferase Pi, and thioredoxin etc. However, 
many new response genes were found to be induced specifically by heavy metals in my 
work. The reasons could be that the gene numbers on the respective microarrays were 
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different. For example, Bartosiewicz used 148 genes including xenobiotic metabolizing 
enzymes and only 9 genes were regulated by Cd in mice. A chip with 588 genes has been 
used in a Hg vapour exposure study and 23 genes were shown to be regulated (Liu et al., 
2003). The same micoarray as ours was used to study the As toxicgenome of the adult 
zebrafish liver and more than 1700 genes were found to be regulated (Lam et al., 2006). 
These results are not comparable to those of the whole animal study used here. 
Furthermore, different concentrations, different forms of the chemicals, and different 
exposure times were used for these experiments, for example, 15 mg/l As (V) was used to 
expose adult fish for 24, 48, and 96 hours and 4 livers for each time point were analysed. 
 
It has been shown that VA is a selective inhibitor of histone deacetylases and selectively 
reduces histone deacetylase 2 protein level (Gurvich et al., 2005; Menegola et al., 2006; 
Kawai et al., 2006). However my data do show that VA causes also the production of 
reactive oxygen species suggesting a further mechanism of teratogenesis by VA.  
 
The monooxygenases were regulated significantly by TCDD, 4CA, DDT, AA. However, 
heat shock protein, transcription factors, and transporter related genes were not induced 
significantly by this group. The patterns of gene induction indicated that the 3 chemicals 
4CA, DDT, and TCDD use the AHR/ARNT signaling pathway which regulates very 
specifically certain response genes, for example, cytochrome P450 1a (AF057713) was 
up regulated by the 3 chemcials. In addition, CA and TCDD induced cytochrome p450 1c 
(BG738243) while, aryl hydrocarbon receptor 2 was triggered by TCDD. In fact, TCDD 
is a very specific toxicant for interacting with AHR. Several studies (Andreason et al., 
2002, 2006; Handley-Goldstone et al., 2005; Bemis et al., 2007) have shown that the 
target genes, CYP 1a1, CYP 1c1, and AHR are specifically induced by TCDD. In 
regenerative growth of zebrafish, TCDD induced many genes including genes involved in, 
matrix metabolism, FGF signaling pathway, and many development related genes 
(Andreason et al., 2006). A study (Handley-Goldstone et al., 2005) with a zebrafish adult 
heart cDNA chip, showed that several sarcomeric genes, such as cardiac troponin T2, and 
genes involved in mitochondrial energy transfer were affected by TCDD. 
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Different experimental conditions could affect the response to toxicants. While, a large 
number of genes inducing xenobiotic metabolism related genes, metabolism related genes, 
and DNA damage and repairing related genes, were regulated by 4CA. The other 
members of subgroup 2, DDT, TCDD, and AA induced fewer genes and they form a 
group of chemicals within subgroup 2 with distinct transcription profiles. One reason 
could be that these chemicals act very specifically on a limited number of targets. In fact, 
the effects of TCDD may only be mediated by activation of the AHR/ARNT receptor 
complex (Andreason et al., 2002). On the other hand, the chemicals may have been 
applied at doses that are subacute. The latter is a critical issue for comparison of toxic 
effects and is not only dependent on the initial concentration but also on the penetrance 
and modification of a specific chemical in the embryo.  
     
In fact, CYP 1a1 was triggered by PCB but the induction was weaker than by TCDD. 
Previous studies have shown that PCBs and their hydroxylated metabolites interact with 
hormonal systems or through binding to AHR, induce AHR-dependent genes (Ulbrich et 
al., 2004) or cause alterations in intracellular free Ca2+ and affected second messengers 
(Kodavanti et al., 1993, 1994; Zawia NH., 2004). However, how PCBs do affect gene 
expression is still not clear. My results demonstrated that PCB exposure triggered 
changes in expression of genes from several different gene ontology groups, such as 
apoptosis (Mcl-1a), protein kinases (MKK3, Jun protein 2), genes involved in DNA 
repair (APEX nuclease, MutS) and antioxidants (peroxiredoxin 1, thioredoxin), 
transporters (solute carrier family 16, 6), heat shock proteins (Hsp 70), monooxygenases 
(Cyp 1a1, Cyp 2a4), metalloproteinases (MMP9, MMP13), oxidative stress and 
transcription related genes (ATF 3, ATF 5). In addition, metabolic enzymes such as 
arginase type II, 6-phosphogluconate dehydrogenase, delta-5 fatty acid desaturase, 
ribonucleotide reductase, and phosphoenolpyruvate carboxykinase 1 were induced 
strongly.  
 
Interestingly, many cytoskeletal genes were down-regulated by the heavy metal group 
and PCB, for example, keratin 6 and keratin 13 were repressed by Cd and Pb; keratin 25 
was regulated by Pb, TCDD, and VA; tubulin beta was repressed by MeHg and VA. 
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Moreover, genes encoding metabolic enzymes were altered in the expression levels by 
most chemicals except DDT and TCDD, for example, GTP cyclohydrolase 1 was down 
regulated by Cd, Pb, PCB, and tBHQ; 6-phosphogluconate dehydrogenase was up 
regulated by As, CA, Hg, Pb, PCB, and tBHQ. These enzymes included energy 
metabolising enzymes, like pyruvate dehydrogenase kinase; protein metabolising 
enzymes, like arginase, and fatty acid metabolising enzymes, like delta5/delta6 fatty acid 
desaturase. This suggests that these chemicals disturb the normal metabolism of the 
embryo.  
 
In previous studies (Blechinger et al., 2002; Krone et al., 2003), the Hsp70 gene has been 
promoted as a marker gene for heavy metal identification. However, it is not a unique 
response gene to heavy metal exposures as it can also be regulated by other toxicants. 
The expression of Hsp70 mRNA was not regulated significantly by MeHg even though 
some studies suggested Hsp70 expression can be induced by Hg exposure (Krone et al., 
2003). My data suggest that Hsp70 related genes can be candidates as a signature gene 
for the first chemical group and PCB. 
 
5.4 Low dose and synergistic effects 
 
Specific gene expression profiles can be detected at low doses even though one cannot 
observe morphological defects. Thus expression profiles are more sensitive to detect the 
impact of chemicals than conventional endpoints. Toxicogenomic responses were 
triggered by TCDD, Cd, DDT, CA and VA at concentrations that did not exhibit changes 
in morphology. Thus the response of the genome appears to be more sensitive to toxic 
insult than morphogenesis. A crucial question is whether the gene responses that are not 
obviously correlated with pathological alterations are indeed deleterious to the animal. 
For example, TCDD was shown to induce a battery of genes in the mouse paw (including 
homologues of genes we scored in our study) without obvious teratological consequences 
to paw development (Bewis et al., 2007). Future work will need to address whether the 
low-level effects on gene expression could be correlated with and hence used to predict 
chronic effects of long term exposure.  
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The lowest concentration of MeHg (6 μg/l) triggered significant changes in gene 
expression. In addition, we noted also teratological effects on movement and tail 
development at these low concentrations (L.Y. and J.R.K., unpublished) indicating that 
these low concentrations of MeHg cause acute toxicity in the zebrafish embryo. 
Disturbingly, the blood serum levels of humans can be in the same concentration range 
http://www.cdc.gov/exposurereport/pdf/factsheet_mercury.pdf. The zebrafish embryo 
may be much more susceptible to MeHg. However, defining the blood serum levels that 
are regarded as save in humans, is an active area of research.  
 
Contaminants are seldom present as a single chemical and usually comprise a complex 
mix. Application of a mixture of MeHg, Cd, As and Pb at low concentrations resulted in 
synergy effects with more than additive numbers of genes affected and also novel 
patterns of gene expression changes. Clearly, some of the genes affected by exposure to 
the mixture would be induced or repressed by higher concentrations of the individual 
chemical. Examples are thioredoxin and hsp70. Thus, it appears that the threshold, at 
which induction occurs, is lowered. This is congruent with previous studies of mixture 
effects that support the notion of “concentration addition”, in which a component of the 
mixture can be replaced by an equipotent concentration of another compound (Escher et 
al., 2002). However, the patterns of gene expression changes induced individually by the 
4 chemicals differed suggesting that other effects have to be taken also into account that 
can not be explained by an additive mechanism of action. For example, glutathione S-
transferase omega 1 and Jun dimerization protein 2 (BI326453) induced by individual 
chemicals were not activated significantly by the mixture.  
 
5.5 The mechanism of toxicity 
 
Gene expression profiles represent a primary level of integration between environmental 
factors and the genome, which ultimately guides the response of an organism to external 
changes. Thus, the analysis of gene expression changes is a powerful tool both to 
diagnose major stressors and to analyze the mechanism of the stress responses. The early 
stress response genes induced by toxicants include transcription factors, heat shock 
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proteins and chaperones, and antioxidants activity related genes. Strikingly, Hsp70 
related genes are often up-regulated by toxicants. In fact, HSP70 is the major inducible 
heat shock protein and is involved in many cellular activities, which include control of 
protein synthesis, folding and translocation, moreover HSP70 is also associated with 
protection against apoptosis with an inhibition of cytochrome c release from 
mitochondria (Water et al., 2006). HSP70 can prevent the onset of apoptosis caused by 
overexpression of apoptosis signal-related kinase1 (ASK1) (Park et al., 2002).  In 
addition, HSP70 can bind directly to apoptosis protease activating factor1 (APAF1) 
which is essential in the formation of the apoptosome. Binding of HSP70 to the caspase 
activation recruitment domain of APAF1 prevents the formation of the apoptosome, and 
prevents activation of caspase 9 and 3 (Water et al., 2006).  
 
Antioxidants related genes, such as thioredoxin, thioredoxin reductase, and glutathione S-
transferase can adjust the activation of a kinase that is upstream of c-Jun N-terminal 
kinase (JNK), for example apoptosis signal-related kinase (ASK1) (Saitoh et al., 1998). 
In fact, JNK, p38, and extracellular signal-regulated kinases (ERKs) are all involved in 
stress signaling (Kyriakis et al., 2001) moreover the activation of JNK seems to involve 
an oxidative stress-related pathway. 
 
Many antioxidant related genes are regulated significantly by the heavy metal group and 
PCB. In addition, several protein kinase genes were altered by PCB, for example, MAP 
kinase interacting kinase 2 (BI533884), MKK 3 (mitogen activated protein kinase kinase 
3) (AB030889), MMMNK1 map kinase interacting kinase (BI705604), and cell division 
control protein 2 (BI888928). Previous studies have shown that second messengers and 
hormone systems can be interfered with by exposure to PCB. Moreover, the down-stream 
signaling components, like AP-1 and NF-kB interact with different protein kinases. The 
gene induction profile demonstrated that AHR/ARNT signaling pathway and MAP 
kinase pathway were significantly induced by PCB. This could be the reason that many 
tissues, organs, especially the nervous system, were affected by PCB. The induction of 
CNS (central nerve system) defects by heavy metals, especially causing mental 
retardation and permanent cognitive deficits, is a major public health problem. Until now, 
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the mechanism of heavy metals leading to CNS deficits is not clear, but investigators 
suggested that these metals have the ability to substitute for calcium and zinc to cause 
many toxic effects (Lidsky et al., 2003; Zawia., 2004). In fact, the heat shock proteins 
and several transcription factors regulated by heavy metals, could be the cues to study the 
molecular mechanism.     
 
Metalloproteinase and transcription activity related genes were also up regulated by this 
group. Several transcription factors, including ATF3 and C/EBP beta were induced by the 
toxicants (As, Cd, Hg, Pb, VA, PCB, and tBHQ). Strikingly, the induction of 
metalloproteinase expression was associated with the up-regulation of ATF3 expression. 
In agreement, study suggested that the sequences of Hsp70 and MMP13 genes have 
ATF3 binding sites and the expression can be regulated by ATF3 (Okamoto et al., 2006). 
Misregulation of these metalloproteases may be part of the toxic mechanism of these 
chemicals.  
 
The expression of parvalbumin 3a, which is a Ca2+ buffer in hair cells, was down-
regulated specifically by heavy metal exposure. The mechanism of regulation of 
parvalbumin 3a is not known. It could be associated with an effect of heavy metal ions 
on Ca2+ homeostasis. Is there a relation of the reduction of the number of hair cells 
induced by heavy metals with the parvalbumin3 a or thioredoxin or other gene regulation? 
The hypothesis is that heavy metal ions change the ion balance of these cells and trigger 
expression or activity of transcription factors which regulate expression of these genes. 
To confirm this suggestion, further experiments need to be done. In particular, it may 
help to systematically analyse, which transcription factors are up or down regulated in the 
hair cells in response to toxicants. 
 
Cytochrome p4501a1 is one of the xenobiotic metabolizing enzymes, which is induced 
by polyhydrogenated aromatic hydrocarbons via activation of the aryl hydrocarbon 
receptor signaling pathway. Although a great deal is known about AHR driven 
transcriptional regulation, much less is known about the mechanism by which TCDD 
causes toxicity and disease (Mandal PK., 2005). The expression of Cyp4501a1 was up-
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regulated significantly by the second group of toxicants especially by TCDD. Part of the 
toxicity of this group may thus be linked to AHR mediated signaling, even though some 
studies suggested that TCDD causes cellular effects that are independent of this signaling 
pathway (Tan et al., 2002). Besides the induction of cyp4501a1 and cyp4501b1, several 
heat shock proteins and antioxidant-related genes were up-regulated by 4CA. Therefore, 
the toxicity of 4CA most likely involves other mechanism like induction of reactive 
oxygen species. In fact, the p45 NF-E2 related factor Nrf2, which is a basic leucine 
zipper family transcription factor involved in the regulation of antioxidant response 
element (ARE) mediated gene transcription, is believed to play an important role in 
detoxification by regulating many phase II detoxification enzymes (Voelker et al., 2007). 
Heat shock proteins and antioxidant related genes are main targets for Nrf2 (Kwak et al., 
2003; Khor et al., 2006). A study suggested that transcriptional regulation of Nrf2 is 
mediated via activation of the AHR (Miao et al., 2005). However, the gene expression 
profiles revealed that the antioxidant and heat shock protein genes were not significantly 
regulated by TCDD and DDT. This suggests that these genes are induced by an AHR 
independent mechanism in the zebrafish embryo.  
 
5.6 signature genes 
 
Signature genes can be used as markers for identification of chemicals or groups of 
chemicals by comparing response patterns. In fact, a number of investigations define the 
suitability of CYP4501B1 for use as a mechanistically based biomarker in molecular 
epidemiology studies of human populations exposed to dioxins and related chemicals that 
bind AHR (Landi et al., 2003; Baccarelli et al., 2004). But the induction of cyp4501b1 
expression was found to be regulated by 4CA also in gene expression profile. Based on 
the expression profiles, I think, glutathione peroxidase gene should be a candidate as a 
biomarker for identification MeHg, while solute carrier family 6 (SLC6 ) gene can be as a 
biomarker of VA. The parvalbumin 3a gene can be a candidate for assessment heavy 
metal toxicity. 
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Although, gene expression profiling of in vitro system, like cell lines, is a useful tool for 
understanding the mechanism through which a compound exerts its toxicity, there are 
disadvantages of these in vitro systems for toxicogenomic studies. Previous studies 
demonstrated that cultured liver cell lines expressed very low or undetectable levels of 
phase I metabolizing enzymes compared with liver slices or liver (Boess et al., 2003). 
Hence, cell lines which are used for predicting the toxicity of a compound could lead to 
misinterpretation of results. Another limitation of applying in vitro systems in 
toxicogenomic studies for the prediction of chronic toxicity is loss of function with long 
term cultivation of primary cell/tissue culture. In addition, the local microenvironment of 
the tissue and complex interactions between adjacent tissues are difficult to be modeled 
in in vitro system. Therefore, these in vitro systems can not replace whole animal test 
systems entirely. Although, there are still some caveats and challenges in utilization of 
toxicogenomics, it is believed that toxicogenomics could offer additional values 
compared to conventional toxicology methods. Toxicogenomics of zebrafish embryos 
offer an ethically acceptable methods band on a vertebrate for classification and potential 
prediction of toxicity of chemicals. 
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Appendix 
 
Table 1. Summary of microarray experiments. Embryos were either treated from 4 to 24 
or from 24 to 48 or from 96 to 120 hpf. Arrays : total number of microarray hybridization. 
Number in brackets indicated the number of independent biological repeats. 
 
Toxin Stage Concentration Arrays 
 4-CA    24 hpf    15 ppm               15 mg/l                118 µM 8 (3) 
   48 hpf    50 ppm               50 mg/l                390 µM 6 (3) 
  120 hpf  50 ppm               50 mg/l                390 µM 8 (3) 
  120 hpf  25 ppm               25 mg/l                195 µM  4 (1) 
  120 hpf    5 ppm                  5 mg/l                  39 µM 4 (1)  
  120 hpf    0.5 ppm             0.5 mg/l                 3.9 µM   4 (1)  
 DDT   24 hpf   5 ppm                  5 mg/l                  14 µM  6 (3)  
  48 hpf  15 ppm              15 mg/l                   42 µM   6 (2)  
  120 hpf   15 ppm              15 mg/l                   42 µM    8 (3)  
  120 hpf   1.5 ppm            1.5 mg/l                  4.2 µM    4 (1)   
  120 hpf    0.15 ppm         0.15 mg/l                0.42 µM   4 (1)   
 Cd   24 hpf    0.5 ppm            0.5 mg/l                  2.7 µM    8 (4)  
   48 hpf    5 ppm                 5 mg/l                   27 µM   8 (3)  
  120 hpf   5 ppm                 5 mg/l                   27 µM   8 (3)  
  120 hpf   2.5 ppm            2.5 mg/l                13.5 µM    4 (2)  
  120 hpf   0.5 ppm            0.5 mg/l                  2.7 µM    4 (2)  
  120 hpf  50 ppb               50 µg/l                 0.27 µM 4 (2) 
 TCDD    24 hpf    150 ppt              150 ng/l               0.47 nM   8 (3)  
   48 hpf    500 ppt              500 ng/l                 1.6 nM    4 (2)  
  120 hpf   500 ppt              500 ng/l                 1.6 nM    8 (3)  
  120 hpf    250 ppt              250 ng/l                 0.8 nM   4 (1) 
  120 hpf   50 ppt                  50 ng/l               0.16 nM    4 (2)  
 VA  24 hpf    15 ppm               15 mg/l                12.9 µM    8 (3) 
   48 hpf    50 ppm               50 mg/l                  43 µM    8 (3)  
  120 hpf  50 ppm               50 mg/l                  43 µM    8 (3)  
  120 hpf  25 ppm               25 mg/l               21.5 µM    4 (1)  
  120 hpf  5 ppm                  5 mg/l                 4.3 µM    4 (1)  
  120 hpf  0.5 ppm              0.5 mg/l              0.43 µM    4 (1)  
 Hg    24 hpf    50 ppb                50 µg/l                0.20 µM   8 (3)  
   48 hpf    60 ppb                60 µg/l                0.24 µM    6 (2)   
  120 hpf  60 ppb                60 µg/l                0.24 µM    10 (3)  
  120 hpf  30 ppb                30 µg/l                0.12 µM   4 (2)  
  120 hpf  6 ppb                   6 µg/l               0.024 µM    4 (2)  
 As 120 hpf  79 ppm               79 mg/l                400 μM    8 (3)  
  120 hpf  7.9 ppm             7.9 mg/l                  40 μM    4 (1)   
 Pb   120 hpf  2.8 ppm             2.8 mg/l                  10 μM    8 (3)  
  120 hpf  0.28 ppm          0.28 mg/l                   1 μM    4 (1)  
 PCB   120 hpf  33 ppm               33 mg/l                100 μM    8 (3)  
 AA  120 hpf  71 ppm               71 mg/l                   1 mM    8 (3)  
 t-BHQ   120 hpf 1.7 ppm              1.7 mg/l                  10 μM    8 (3)   
 Mixture   120 hpf Pb,1 µM; Cd,0.27 µM; As,40 µM; Hg,0.024 µM  6 (3)   
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Table 2. Summary of gene responses of embryo exposed to different concentrations of Cd. 
Only genes whose expression is twice up or down regulated with Padj≤0.025 were listed. 
 
 
Name   ID 
 
Cd(5mg/l)
 
Cd(2.5mg/l) 
 
Cd(0.5mg/l)
GTP cyclohydrolase 1 AJ311846 -3.3 -2.7 -2.6 
Thioredoxin BI864190 4.0 2.9 2.2 
unknown AW019526 -2.5 -2.0 -2.1 
unknown BI887138 2.5 2.5 2.5 
Ribosomal protein S17 BI474700 8.6 8.5 4.8 
oncomodulin A BE201681 -4.3 -5.7 -4.5 
Solute carrier family 16, member 9 BE016639 2.9 2.4 2.5 
Peroxiredoxin 1 BI980610 3.1 2.8 2.3 
arginase, type II BG891983 3.1 2.3 2.1 
Alpha-2-HS-glycoprotein AI496863 -3.3 -2.7 -2.9 
sequestosome 1 AW343560 3.9 3.1 2.5 
Arginase, type II BF717769 2.9 2.1   
heat shock cognate 70-kd protein AF210640 6.6 2.9   
unknown AI353541 2.8 2.5   
unknown BG727177 2.2 2.1   
Sulfide quinone reductase-like  BI882244 3.6 3.0   
uncoupling protein 2 AJ243250 2.3 2.5   
Tripartite motif-containing 62 BI878269 2.2 2.4   
Collagen, type VII, alpha 1 AI601501 -2.3 -2.3   
unknown AW154517   2.1 2.9 
Ribonucleotide reductase M2 polypeptide U57965   -2.9 -2.9 
Karyopherin alpha 2 BI878593   -2.4 -2.3 
unknown AI330535   4.5 2.6 
Ornithine decarboxylase antizyme 2 BI982208   2.8 2.7 
unknown AW420321   2.2 2.1 
Solute carrier family 16, member 9 BI474827   3.5 2.9 
unknown BI886268   -2.2 -2.3 
Parvalbumin BI845755   -3.9 -2.0 
unknown AW115990   2.9 2.4 
Protein tyrosine phosphatase type IVA, 3 BM095161   2.4 2.3 
hydroxysteroid 11-beta dehydrogenase 2 AW154688   2.8 2.7 
phosphoenolpyruvate carboxykinase 1  BG727092   2.2 2.3 
Lactate dehydrogenase A BI983171   2.8 2.3 
unknown AI106316   2.4 2.3 
CCAAT/enhancer binding protein 
(C/EBP), beta AW019436 2.3     
Tumor necrosis factor, alpha-induced 
protein 9 BI878750 2.3     
Solute carrier family 43, member 2 AI331043 2.2     
Mannose receptor, C type 2 BI533854 3.8     
Matrix metalloproteinase 9 AW174507 12.3     
unknown BG728693 2.1     
Lysosomal-associated membrane protein AI793516 2.6     
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2 
membrane protein, palmitoylated 1 AW128294 2.3     
topoisomerase (DNA) II alpha BM156751 -2.2     
Solute carrier family 6, member 8 BI980828 2.0     
guanine nucleotide binding protein (G 
protein), alpha transducing activity 
polypeptide 2 AY050500 -3.1     
Matrix metalloproteinase 13 AW305943 11.9     
Amylase, alpha 2B BM103972 -2.2     
Solute carrier family 43, member 2 AW117094 2.0     
unknown BI878214 3.1     
DnaJ (Hsp40) homolog, subfamily B,4 BM156904 2.5     
unknown AI353803 -2.4     
unknown BF717646 -2.1     
Interferon regulatory factor 1 BI326597 2.7     
pyruvate dehydrogenase kinase, 
isoenzyme 2 BM101544 2.7     
unknown BI880567 2.0     
unknown BE605735 2.5     
unknown AI964296 2.2     
cytochrome P450, family 2 AF283813 3.1     
heat shock cognate 70-kd protein AB062116 7.0     
unknown AI641534 3.1     
MAP kinase-interacting serine/threonine 
kinase 2 BI839784 2.9     
MAP kinase-interacting serine/threonine 
kinase 2 BI533884 2.8     
Complement component 4B, BI672168 4.0     
CD44 antigen AW344023 2.4     
Keratin 13 BE200701 -2.4     
elastase 2 BI705588 -2.4     
guanylate kinase 1 BI670894 -2.1     
hatching enzyme 1 AI877922 -2.0     
Inner centromere protein antigens BI704423 -2.5     
MCM3 minichromosome maintenance 
deficient 3  BI889166 -2.1     
unknown BM096075 2.7     
unknown AW420509 2.3     
unknown BI887230 -2.1     
Complement component 7 AA497156 7.4     
MAP kinase-interacting serine/threonine 
kinase 2 AI657551 2.4     
unknown BM036361 2.1     
unknown BM186492 2.1     
unknown BG727211 2.3     
angiotensinogen BG727310 2.7     
Immunoglobulin-like domain containing 
receptor 1 BF157317 2.0     
Suppressor of cytokine signaling 3 BI878700 2.2     
Stathmin 1/oncoprotein 18 BI891936 -2.5     
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retinoblastoma binding protein 4 AW116425 -2.1     
Glutathione S-transferase omega 2 BI979918 2.7     
unknown BE606169 5.0     
Apolipoprotein D BM101644 -2.0     
Deoxycytidine kinase AW059347 -2.6     
Claudin 7 AF260240 2.1     
complement component factor B U34662 2.0     
unknown AI793733 -2.1     
unknown AI330865 3.1     
CD99 antigen-like 2 BI888934 -2.1     
unknown AI330404 3.1     
thioredoxin interacting protein BI892352 2.0     
unknown AW280037 2.4     
arginase, type II AW018735 2.3     
unknown BI705262 3.3     
Ubiquitin-conjugating enzyme E2T AW420785 -2.1     
unknown BI325662 -2.6     
unknown BG891932 2.1     
unknown AI477644 3.5     
unknown AW078445 2.3     
unknown BI883516 5.5     
unknown BI892060 2.0     
hypoxia induced gene 1 BI892416 2.7     
Solute carrier family 16, member 9 BI474827 4.3     
Parvalbumin BI845755 -3.6     
unknown AW419887 2.1     
unknown AW280086 2.3     
activating transcription factor 3 AW422298 3.2     
Zinc fingers and homeoboxes 1 AI793802 2.6     
Chemokine (C-X-C motif) ligand 3 BI845861 2.8     
vitellogenin 1 BI841891 2.1     
unknown BM072227 -2.0     
unknown AW019018 2.8     
unknown AI397362 2.5     
unknown BI896258 -2.4     
Cyclic AMP-regulated phosphoprotein AI544565 2.4     
Keratin 6 BE016992 -3.1     
unknown BM184056 2.9     
Suppressor of cytokine signaling 3 BG727181 2.5     
Immunoglobulin superfamily, member 2 BE605911 2.8     
membrane protein, palmitoylated 1 BF158097 2.0     
Syncollin AA566708 -2.7     
heat shock cognate 70-kd protein AF006007 6.3     
Ubiquitin-conjugating enzyme E2D 4 BM072375 2.2     
vitellogenin 1 BM036395 2.2     
unknown BI843139 2.7     
unknown BI430332 2.1     
apolipoprotein Eb AJ236882 2.2     
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unknown BI867672 2.5     
unknown AI354073 2.2     
unknown BI533153 2.0     
apolipoprotein Eb BI878442 2.0     
unknown AI354170 -2.1     
membrane protein, palmitoylated 1 BI839240 2.1     
Arrestin domain containing 3 BF157296   2.1   
6-phosphofructo-2-kinase/fructose-2,6-
biphosphatase 4 BI888564   2.0   
cell division cycle 2 BI888928   -2.1   
DNA-damage-inducible transcript 4 BI843145   2.7   
unknown AI588580   2.1   
4-aminobutyrate aminotransferase AI882774   2.7   
unknown AW454405   -2.0   
unknown AI793855   -2.8   
keratin 4 AF134850   -2.1   
unknown AL591382   2.1   
unknown BG727339   2.1   
ataxin 2-binding protein 1-like AI958253   -2.0   
annexin A1b AI331515   2.7   
unknown BM005448   2.5   
unknown AW116170   -2.2   
proliferating cell nuclear antigen AF140608     -2.0 
unknown AI397362     2.7 
collagen type II, alpha-1 U23822     -2.0 
Acyl-Coenzyme A oxidase 1 BM183246     -2.3 
 
 
 
Table 3. Summary of gene responses of embryos exposed to different concentrations of 
MeHg. Only genes whose expression is twice up or down regulated with Padj≤0.025 
were listed. 
 
Name or Human HomoloGene   ID 
 
Hg(60µg/l)
 
Hg(30µg/l) 
 
Hg(6µg/l) 
Ribosomal protein S17 BI474700 6.9 4.2 2.2 
Peroxiredoxin BI980610 7.7 4.6 3.5 
Glutamate-cysteine ligase BG304082 2.4 2.1   
Matrix metalloproteinase 13  AW305943 5.9 2.8   
ATP-binding cassette, sub-family C. 2 AW279805 2.4 2.2   
oncomodulin A BE201681 -2.6 -2.3   
Glutathione S-transferase omega 1 AW019036 2.6 2.7   
Apical early endosomal glycoprotein 
precursor BG302634 3.0 2.4   
Glutathione peroxidase 2  AW232474 -4.2 -3.0   
glutathione peroxidase 4a BI896246 -2.6 -2.8   
glutathione S-transferase pi AF285098 3.2 2.2   
Suppressor of cytokine signaling 3 BG727181 4.5 2.4   
unknown AI397362   2.8 2.7 
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unknown BM185062 -2.5     
unknown AW420476 -2.7     
unknown AI957831 -2.3     
unknown BI886601 -2.1     
Zinc finger and SCAN domain 
containing 1 AI667275 -2.2     
unknown BG306925 -2.3     
Complement component 6 BI474371 3.6     
Tubulin, beta 4 BM186665 -2.8     
unknown BI979388 -2.4     
Natriuretic peptide precursor A BE693172 2.1     
unknown AA542597 -2.0     
Complement component 3 AW116558 2.3     
unknown BI891316 -2.0     
Thioredoxin BI864190 4.4     
Prosaposin AI722545 -3.1     
unknown AI558658 -3.1     
matrix metalloproteinase 9 AW174507 6.7     
Protein disulfide isomerase-associated  BI885320 -2.1     
unknown BG728693 2.0     
unknown AW117109 2.1     
Lysosomal-associated membrane 
protein 2 AI793516 2.5     
unknown BI889335 -2.2     
strongly similar to KIAA1143 protein BI350885 -2.3     
Amylase, alpha 2B; pancreatic BM103972 -2.1     
unknown BI878214 2.2     
Cylindromatosis  BE016427 -3.1     
unknown BI886668 -2.3     
Myeloperoxidase AF349034 2.5     
unknown BM182366 -2.2     
Interferon regulatory factor 1 BI326597 2.1     
Cofilin 2 (muscle) BI883993 3.3     
unknown AI964296 2.1     
unknown AW171394 -2.1     
unknown AI641534 2.0     
Cholinergic receptor, nicotinic, gamma 
polypeptide AI793818 2.9     
Complement component 4B BI672168 5.3     
CD44 antigen AW344023 2.2     
unknown AI721719 -2.1     
unknown BI980805 -2.1     
unknown AW420546 2.1     
unknown BI844137 -2.0     
unknown BM096075 2.2     
Diaphorase (NADH)  AI722339 -2.1     
Complement component 7 AA497156 3.4     
unknown BM182280 2.4     
unknown AI641239 2.1     
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D component of complement (adipsin) AW174653 2.0     
unknown BG727211 3.1     
angiotensinogen BG727310 3.0     
Suppressor of cytokine signaling 3 BI878700 2.7     
Selenoprotein P, plasma, 1 AF322071 -2.7     
unknown AW279682 -2.0     
Sirtuin BI876457 -2.0     
Nuclear RNase III Drosha BG303805 -2.1     
Deiodinase, iodothyronine, type I BF717782 -2.9     
unknown AW115782 2.2     
Solute carrier family 16, member 9 BE016639 2.4     
unknown BI886819 -2.2     
unknown BI887093 -2.3     
unknown BI318394 -2.1     
B-factor, properdin U34662 3.9     
unknown AW343746 -2.2     
unknown BI890893 -2.2     
transketolase BI865881 -2.1     
Nephronophthisis 1 AW466634 -3.0     
Solute carrier family 16, member 6 AW421040 2.9     
unknown AI584430 2.0     
Sulfide quinone reductase-like BI882244 3.1     
Serum/glucocorticoid regulated kinase| BI673466 2.6     
unknown BG303804 -2.3     
unknown BG891932 3.3     
unknown AI477644 12.4     
unknown AW058848 -2.1     
Hypoxia up-regulated 1 AW116343 2.2     
unknown BI886290 2.1     
Proteasome 26S subunit AI415997 -2.1     
unknown AW019023 2.3     
unknown BI981043 2.4     
unknown BI889194 -2.6     
Zinc finger protein 581 AI723212 -2.2     
unknown BE558041 2.0     
Prostate cancer antigen-1 BI708772 -2.2     
Leucine zipper transcription factor-like 1 BI879148 -2.0     
Hypoxia up-regulated 1 BI876732 2.3     
TH1-like (Drosophila) AW174469 -2.2     
Complement component 3 AF047415 2.9     
CCAAT/enhancer binding protein 
(C/EBP) 1 AF306857 2.6     
unknown BI878747 -2.2     
hypoxia induced gene 1 BI892416 2.3     
Solute carrier family 16, member 9 BI474827 4.8     
Prostate cancer antigen-1 BI673635 -2.3     
unknown BI892110 2.7     
unknown AW128255 -2.6     
unknown BI887764 -2.0     
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RAN binding protein 9 AW059129 -2.1     
transaldolase 1 BI896473 2.2     
Thiopurine S-methyltransferase BM025250 2.2     
Claudin 23 BI888493 2.0     
Activating transcription factor 3 AW422298 3.3     
Zinc fingers and homeoboxes 1 AI793802 2.7     
unknown AW115990 3.2     
Chemokine (C-X-C motif) ligand 3 BI845861 3.8     
unknown BI474299 2.2     
unknown BG303490 -2.9     
Sequestosome 1 AW343560 3.2     
unknown AW019018 4.9     
Lectin, galactoside-binding, soluble, 1 BM155827 2.1     
unknown AI397362 3.2     
Fibronectin 1 BG302581 2.9     
unknown BI867917 -2.2     
unknown BM036297 -2.3     
Cyclic AMP-regulated phosphoprotein AI544565 2.4     
Ribosomal protein L30 BE605410 -2.2     
unknown BI982778 -2.6     
Immunoglobulin superfamily, member 2 BE605911 2.2     
unknown AI974163 2.7     
unknown AI974189 2.1     
Tubulin, beta 4 BI864873 -2.4     
unknown BI705720 -2.5     
Syncollin AA566708 -2.3     
ceruloplasmin AF336125 2.0     
cryptochrome 5 AB042254 2.2     
unknown BI673353 -2.1     
Mucin 6, gastric AW077600 2.3     
Thioredoxin-like 4B BI672089 -2.3     
unknown BI880385 -2.1     
unknown AW116284 2.1     
unknown AA495102 2.2     
complement component c3a AF047413 2.4     
fibrinogen, gamma polypeptide BI878442 2.4     
Cofactor of BRCA1 AI959391 -2.2     
unknown AW019312   2.2   
unknown BI843539     2.2 
Gastric intrinsic factor AI353694     2.4 
 
 
 
 
Table 4. Summary of gene responses of embryos exposed to different concentrations of 
TCDD. Only genes whose expression is twice up or down regulated with Padj≤0.025 
were listed. 
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Name or Human HomoloGene  ID 
 TCDD 
(500ng/l) 
 TCDD 
(250ng/l) 
 TCDD 
(50ng/l) 
Cytochrome P450 1A1 AF057713 31.6 29.5 5.0 
Keratin 15 AI397347 -2.2 -2.4   
Similar to SULT6B1 AI959735 2.8 2.3   
cytochrome P450 1C1 BG738243 12.9 11.3   
unknown BM183152 3.3 3.0   
unknown BM101698 2.2 2.3   
unknown AI397362   2.8 2.7 
unknown AI384221 2.1     
Forkhead box Q1 AW566603 2.1     
Gastric intrinsic factor AI353694 2.1     
Cytochrome c oxidase subunit IV 
isoform 2  BI672330 2.3     
unknown AI353244   -2.1   
Arginase, type II BF717769   -2.0   
Arrestin domain containing 3 BF157296   -2.1   
unknown BI326783   -2.2   
unknown AI958860   -2.1   
Apical early endosomal glycoprotein 
precursor BG302634   3.3   
Arginase, type II AW018735   -2.1   
Arginase, type II BG891983   -2.2   
unknown AW019312     2.1 
 
 
 
Table 5. Summary of gene responses of embryos exposed to 50 µg/l Cd or 6µg/l MeHg 
or 7.9mg/l As or 280µg/l Pb alone or to a mixture of them. ID, gene bank accession 
number. 
 
 
Name or Human homoloGene  ID  As  Cd  Hg Pb 
 
Mixture 
Peroxiredoxin  BI980610 2.7   3.5 9.6 15.5 
Gastric intrinsic factor  AI353694 2.0   2.4 3.3 5.1 
kruppel-like factor 2a (klf2a) AF392992 -2.1 -4.8     -3.9 
Period homolog 2 (Drosophila) BG303941 2.4 2.1   3.5   
Ribosomal protein S17 BI474700   4.3 2.2   10.5 
Oncomodulin BE201681   -4.3   -3.0 -5.5 
uncoupling protein 2 (ucp2 gene 
homologue).  AJ243250   2.1   2.2 4.5 
CCAAT/enhancer binding protein 
(C/EBP), beta AW019436 -2.3       4.0 
Suppressor of cytokine signaling 3 BI878700 -4.9       2.6 
Matrix metalloproteinase 13  AW305943   3.2     4.1 
Arrestin domain containing 3 BF157296   2.5     2.7 
unknown BI888424   2.1     2.1 
Complement component 7 AA497156   4.1     10.1 
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Stathmin 1/oncoprotein 18 BI891936   -2.2     -3.2 
Solute carrier family 16 member 9 BE016639   3.3     3.5 
Solute carrier family 16 member 6 AW421040   4.0     4.3 
unknown AW019503   2.2     4.3 
gelsolin AF175294   -2.1     -2.8 
DnaJ (Hsp40) homolog, subfamily 
A, member 1 BI891737   2.3     4.7 
unknown BQ618331   2.5     3.2 
unknown BI325662   -2.1     -3.1 
unknown AL591382   2.5     2.3 
Keratin 25D AI397347   -2.2     -2.4 
Solute carrier family 16  member 9 BI474827   2.7     2.8 
unknown BI886268   -2.3     -2.6 
Parvalbumin BI845755   -3.0     -4.1 
ornithine decarboxylase AF290981   2.1     2.9 
Activating transcription factor 3 AW422298   2.1     10.2 
Alpha-2-HS-glycoprotein AI496863   -3.2     -6.7 
Suppressor of cytokine signaling 3 BG727181   2.2     2.2 
thymidylate synthase AY005804   -2.3     -2.7 
Thioredoxin BI864190       4.7 14.4 
unknown BM182280       2.1 5.5 
Glutathione S-transferase omega 2 BI979918       3.7 4.2 
unknown AW115782       2.8 4.5 
glutathione S-transferase pi AF285098       4.3 6.0 
Complement component 3 AI588354       2.1 4.0 
zinc-finger protein (KROX-24) gene M81109 -2.3         
btg-b anti-proliferative cofactor AB036784 -2.2         
unknown BM102367 -2.2         
Jun dimerization protein 2 BI326453 -4.1         
z64phr 6-4 photolyase AB042254 2.4         
unknown BI533153 -2.0         
Similar to Mucin (MUC3) AI959644   -2.6       
unknown AW076901   -2.1       
Brachyependymin beta and gamma 
chains (Epd) gene M89643   -2.2       
Na+/K+ ATPase alpha1A1 subunit AY028629   -2.1       
Cofilin 2 (muscle) BI883993   2.5       
6-phosphofructo-2-kinase/fructose-
2,6-biphosphatase 4 BI888564   2.1       
cytochrome P450 monooxygenase 
CYP2K6 AF283813   2.4       
Dehydrogenase/reductase (SDR 
family) member 1 AI496835   -2.2       
Alanyl (membrane) aminopeptidase AI497338   -2.4       
Keratin 13 BE200701   -2.3       
Eukaryotic translation initiation 
factor 4A, isoform 1 BI876856   -2.3       
FBJ murine osteosarcoma viral 
oncogene homolog B BE605888   -2.1       
unknown AW342722   -2.6       
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cytochrome P450 1A1 AF057713   2.1       
unknown BI896258   -2.7       
Phosphoenolpyruvate 
carboxykinase 1 BG727092   2.3       
Tripartite motif-containing 62 BI878269   2.1       
unknown BG304024   2.1       
apoE gene AJ236882   2.1       
MCM5 minichromosome 
maintenance deficient 5, AW058902   -2.0       
unknown AI106316   2.4       
unknown BI843539     2.2     
unknown AI397362     2.7     
ATP-binding cassette, sub-family C 
member 2 AW279805       2.2   
guanylate cyclase-activating protein 
3 AY044457       2.1   
20 beta-hydroxysteroid 
dehydrogenase AF298898       2.4   
Glutathione S-transferase omega 1 AW019036       5.0   
Na+/K+ ATPase alpha subunit 
isoform 3 (atp1a1a.2) AF286374       -2.2   
heat shock protein hsp90alpha AF068773         2.6 
Similar to 60S ribosomal protein 
L27a BI841063         2.1 
unknown BM103939         2.1 
brain-type fatty-acid binding protein AF237712         -2.4 
heat shock cognate 70 kDa protein 
(hsp70) gene AF006006         2.6 
Solute carrier family 2 member 5 AI477656         2.6 
unknown AI626751         2.0 
Heme oxygenase (decycling) 1 AI722432         2.8 
Tyrosyl-tRNA synthetase AW777876         2.6 
Collagen, type IX, alpha 3 AI601714         -2.5 
unknown AI658234         -3.1 
liver-basic fatty acid binding protein AF254642         -2.5 
Solute carrier family 27 (fatty acid 
transporter), member 2 AI884099         -2.3 
unknown AW117109         3.1 
BTG family, member 3 BI979982         2.0 
Zinc finger, A20 domain containing 
2 BE201929         2.3 
Membrane protein, palmitoylated 1, 
55kDa AW128294         2.6 
unknown AW420559         2.2 
strongly similar to coiled-coil-helix-
coiled-coil-helix domain containing 
2 AW117105         2.1 
ATP synthase, H+ transporting, 
mitochondrial F1 complex, delta 
subunit BM186095         4.4 
Thioredoxin-like 1 BI886187         2.2 
cone transducin alpha subunit AY050500         -2.4 
 138
(gnat2) 
DnaJ (Hsp40) homolog, subfamily 
B, member 4 BM156904         4.5 
Arginase, type II BF717769         3.2 
unknown BI890954         -2.1 
putative cellular retinol-binding 
protein AF448140         -2.1 
Ankyrin repeat domain 11 AW115851         -2.6 
Macrophage migration inhibitory 
factor BM183259         -2.2 
Optineurin AW280217         2.4 
proliferating cell nuclear antigen 
(PCNA) AF140608         -2.6 
HSP70 stress protein HSP70 AB062116         12.8 
MAP kinase interacting 
serine/threonine kinase 2 BI839784         3.5 
ATP-binding cassette, sub-family A 
(ABC1), member 1 AW421006         2.7 
unknown BM005308         2.3 
MAP kinase interacting 
serine/threonine kinase 2 BI533884         2.6 
Alpha-2-macroglobulin BI326783         -2.5 
green-sensitive opsin 1 (grops1) AF109369         -2.5 
ribonucleotide reductase protein R2 
class I U57965         -3.1 
unknown BM182744         2.6 
Collagen, type I, alpha 2 AI331605         -2.1 
Hairy and enhancer of split 5  BM072241         -2.0 
Heat shock 60kDa protein 1 
(chaperonin) BG985703         2.3 
presenilin-2 (ps2) AF178539         2.6 
transcription factor stat3.  AJ005693         2.2 
unknown BI704181         -2.4 
Similar to mitochondrial C1-
tetrahydrofolate synthase AW777642         2.4 
unknown AW420509         5.6 
Alanine-glyoxylate 
aminotransferase 2-like 1 AW154396         -2.4 
Dihydrodiol dehydrogenase 
(dimeric) BI708067         2.4 
Brain protein I3| BM083968         2.0 
unknown BG727310         3.0 
Galactosamine (N-acetyl)-6-sulfate 
sulfatase BI984280         2.3 
Retinoblastoma binding protein 4 AW116425         -2.2 
Growth and transformation-
dependent protein BM071848         2.2 
unknown BI878191         2.0 
Hsp70 gene AF210640         8.7 
unknown AI957593         5.3 
Fetuin B BI885905         -4.0 
unknown AL719902         -2.5 
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Collagen, type IX, alpha 2 AI558471         -2.4 
CD63 antigen (melanoma 1 
antigen) AW019276         2.6 
unknown BM024785         2.3 
unknown AI641660         2.4 
unknown AI793855         -2.7 
unknown BM072346         2.7 
CD99 antigen-like 2 BI888934         -2.3 
Similar to pleckstrin homology 
domain containing, family M AI641731         2.2 
unknown BI983434         -2.7 
Tribbles homolog 2 (Drosophila) BI886711         2.5 
unknown AI477982         -2.1 
F-box protein 32 BG303968         3.9 
unknown BM182911         -2.0 
unknown AW280037         3.0 
Arginase, type II AW018735         3.5 
unknown BE016756         2.8 
BCL2-associated X protein BI891654         2.0 
Keratin 6 irs AI477659         -2.3 
unknown BI983410         2.4 
Follistatin-like 1 AI884233         3.2 
Prostaglandin-endoperoxide 
synthase 2 AW077995         2.6 
S100 calcium binding protein A4 AW595487         -2.2 
mismatch repair protein Msh6 
(msh6) AF412834         -2.2 
Tat-interacting protein Tip30 (tip30) AF329850         2.6 
strongly similar to cardiac muscle 
alpha actin proprotein AI601793         -2.0 
unknown AW078445         4.0 
Collagen, type XIV, alpha 1 
(undulin) AI584441         -2.7 
intestinal fatty acid binding protein 
(IFABP) AF180921         -2.9 
unknown BI879661         -2.3 
Alpha-2-macroglobulin BI326782         -2.5 
unknown BI896473         3.1 
unknown AW419887         3.8 
unknown AW280086         2.9 
activator of heat shock 90kDa 
protein ATPase homolog 1 BM103957         2.4 
Zinc fingers and homeoboxes 1 AI793802         5.7 
unknown AW115990         7.6 
Collagen, type I, alpha 1 BI671608         -2.2 
unknown BM071885         -2.6 
MINDIN2 AB006085         -2.1 
red-sensitive opsin (rdops) AF109371         -2.2 
Mcl1b (mcl1b) AF441284         2.2 
unknown BM072227         -2.3 
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Procollagen-proline, 2-oxoglutarate 
4-dioxygenase  AW059030         2.5 
Sequestosome 1 AW343560         15.4 
unknown AI331606         -3.0 
unknown BG799399         -2.4 
Prestin (motor protein) BG727321         2.2 
unknown BI882313         -2.2 
unknown BI982778         -2.5 
Serine (or cysteine) proteinase 
inhibitor, clade A AW018949         -3.1 
Syncollin AA566708         -3.2 
dopachrome tautomerase (dct) AF280090         -2.0 
inducible 70 kDa heat shock protein 
(hsp70) gene AF006007         11.9 
unknown AI722353         3.3 
Alpha-2-macroglobulin AI957415         -2.0 
RasGEF domain family, member 1B AI723236         2.4 
putative delta-6 fatty acyl 
desaturase (Fadsd6) AF309556         -3.1 
ferritin heavy chain (fth1) AF295373         2.2 
cell death regulator Mcl-1a AF302805         2.3 
unknown AI878489         2.7 
unknown BI883251         -2.4 
unknown BM035545         2.0 
Cardiomyopathy associated 3 BG728392         4.3 
 
 
 
 
Table 6. Summary of gene responses of embryos exposed to 11 different chemicals. Only 
genes whose expression is twice up or down regulated with Padj≤0.025 were listed. 
 
Gene name  Gene ID  AA  As  CA  Cd 
 
DDT  Hg  Pb 
 
PCB  tBHQ 
 
TCDD  VA 
Peroxiredoxin 1 BI980610 3.9 13.6 4.1 3.1   7.7 9.9   7.5     
Thioredoxin BI864190   14.2 3.5 4.0   4.4 8.1 2.5 6.1     
Stress protein HSP70, AB062116   10.1 2.2 7.0     2.5 5.4 12.3   2.7 
Activating transcription 
factor 3 AW422298   4.0   3.2   3.3 2.5 15.1 5.1   5.4 
Zinc fingers and 
homeoboxes 1 AI793802   2.5   2.6   2.7 2.4 4.2 2.1   2.0 
Sequestosome 1 AW343560   10.3 2.1 3.9   3.2 3.5 2.8 5.1     
unknown BG985532 2.6 8.8 2.3       4.3 2.6 2.9     
Glutathione S-transferase 
omega 1 AW019036 3.0 6.3 2.1     2.6 3.5   2.2     
matrix metalloproteinase 9 AW174507   2.1   12.3   6.7 3.9 14.2 6.4     
Hsp70 AF210640   10.9   6.6     2.5 5.0 10.8   2.7 
 6-Phosphogluconate 
dehydrogenase AW115782   3.3 2.0     2.2 3.4 2.0 2.1     
Likely ortholog of mouse 
hypoxia induced gene 1 BI892416   2.6   2.7   2.3 3.4 2.7 2.2     
Fetuin-A, AI496863   -3.6 -2.2 -3.3     -3.2 -5.0     -2.3 
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unknown AW115990   3.1       3.2 2.3 5.6 4.6   3.1 
Hsp70 AF006007   7.6   6.3     2.1 4.6 10.1   2.4 
Matrix metalloproteinase 
13 (collagenase 3) AW305943     2.5 11.9   5.9 3.5 15.1 10.2     
Angiotensinogen precursor, BG727310     3.0 2.7   3.0 2.1 3.7 2.1     
Solute carrier family 16 
member 9 BE016639     2.5 2.9   2.4 3.6 4.1     2.3 
Solute carrier family 16 
member 9 BI474827     3.4 4.3   4.8 4.7 7.9     3.0 
Glutathione S-transferase pi AF285098 2.0 4.1       3.2 5.9   2.7     
CCAAT/enhancer binding 
protein (C/EBP), beta AW019436   2.1   2.3     2.4 6.9 2.3     
unknown AW117109   2.3       2.1 2.1 2.3 3.2     
unknown AI964296   2.1   2.2   2.1 2.1 2.0       
Syncollin AA566708   -2.1   -2.7   -2.3 -3.8       -2.2 
Cofilin 2 (muscle) BI883993     2.4     3.3 3.6 3.1     2.2 
unknown BG727211     3.4 2.3   3.1   2.4 2.7     
Serum/glucocorticoid 
regulated kinase 2 BI673466     2.0     2.6 2.2 3.6     2.0 
Cytochrome P450, family 
1, subfamily A, polypeptide 
1 AF057713     3.7   2.5     4.2 2.8 31.6   
unknown AW019018     3.6 2.8   4.9   2.5 5.9     
Suppressor of cytokine 
signaling 3 BG727181     2.0 2.5   4.5   5.6 3.7     
Complement component 7 AA497156       7.4   3.4 6.2 7.3 3.7     
unknown AI477644       3.5 -2.2 12.4   46.3     8.0 
Gastric intrinsic factor 
(vitamin B synthesis) AI353694 2.2 4.6         2.5     2.1   
Multidrug resistance-
associated protein Mrp2, AW279805   2.6 2.4     2.4 2.3         
Arsenite inducible RNA 
associated protein, BM182280   5.1       2.4 2.5   2.7     
Glutathione S-transferase 
omega 2 BI979918   5.6   2.7     5.2   2.1     
Pvalb3a BE201681   -2.4   -4.3   -2.6 -5.1         
unknown AI330865   2.2   3.1       3.1 3.6     
unknown BI896473   2.2       2.2 2.5   2.0     
Arginase, type II BF717769     2.2 2.9     2.2 4.1       
Interferon regulatory factor 
1 BI326597     2.1 2.7   2.1         2.3 
Complement factor B 
precursor U34662     2.7 2.0   3.9     4.6     
Arginase, type II BG891983     2.6 3.1     2.5 4.9       
similar to UP|Q86V31 
(Q86V31) ARPP-21 
protein AI544565     2.5 2.4   2.4   2.3       
Opsin 1 (cone pigments), 
short-wave-sensitive AF109373     -2.0         -2.6 -2.7   -2.7 
GTP cyclohydrolase 1 
(dopa-responsive dystonia) AJ311846       -3.3     -2.3 -2.2 -2.1     
Guanine nucleotide binding 
protein alpha transducing 
activity polypeptide 2 AY050500       -3.1     -2.2   -3.6   -2.7 
unknown BM096075       2.7   2.2   4.3 2.6     
similar to human ribosomal 
protein S17 BI474700       8.6   6.9   4.3     4.7 
Suppressor of cytokine 
signaling 3 BI878700       2.2   2.7   3.4 3.1     
unknown BG891932       2.1   3.3   3.0 2.7     
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unknown BM184056       2.9     2.1 3.2 2.2     
unknown BE605911       2.8   2.2 2.8 2.1       
Natriuretic peptide 
precursor A BE693172           2.1 2.1 2.1     2.2 
Solute carrier family 16  
member 6 AW421040           2.9 4.0 4.6     2.9 
Solute carrier family 2  
member 5 AI477656   2.1         2.1 2.5       
GTP binding protein 1 AW154231   2.9           2.7     2.1 
DnaJ (Hsp40) homolog, 
subfamily B, member 1, BM156904   3.5   2.5         4.1     
unknown AW420509   4.5   2.3     3.3         
30S ribosomal protein S11, BM101516   2.6           4.3     2.4 
Thiopurine S-
methyltransferase BM025250   3.5       2.2 2.6         
V-maf musculoaponeurotic 
fibrosarcoma oncogene 
homolog F (avian) BI887732   2.3         2.4 2.3       
Delta-5/delta-6 fatty acid 
desaturase AF309556   -2.3           -3.5     2.1 
Cardiomyopathy associated 
3 BG728392   4.6           9.9 2.3     
unknown AW280037     2.1 2.4       6.1       
Arginase, type II AW018735     2.8 2.3       4.1       
Interferon regulatory factor 
7 BE605965     2.3         7.9     6.8 
Red-sensitive opsin AF109371     -2.2         -2.2 -3.3     
unknown AI974163     2.7     2.7     2.7     
unknown BG728693       2.1   2.0   2.3       
Lysosomal-associated 
membrane protein 2 AI793516       2.6   2.5   2.0       
Membrane protein, 
palmitoylated 1 AW128294       2.3     2.1 2.2       
Solute carrier family 6 
member 8 BI980828       2.0     2.2 2.4       
Amylase, alpha 2B; 
pancreatic BM103972       -2.2   -2.1 -2.1         
CPG DNA METHYLASE AI641534       3.1   2.0     3.2     
Complement component 
4B BI672168       4.0   5.3     6.5     
Sulfide quinone reductase-
like (yeast) BI882244       3.6   3.1         2.3 
Uncoupling protein 2 AJ243250       2.3     3.4 2.7       
Parvalbumin isoform 2a BI845755       -3.6     -3.2       -2.6 
unknown AI397362       2.5   3.2     2.8     
Keratin 6  BE016992       -3.1     -2.0   -2.5     
Fibrinogen, gamma 
polypeptide BI878442       2.0   2.4     2.1     
Collagen, type VII, alpha 1 AI601501       -2.3       -2.7 -2.0     
Complement component 6 BI474371           3.6   2.2 2.2     
unknown BI981043           2.4   2.4 2.0     
unknown BE558041           2.0   3.1 2.5     
F-box protein 32 BG303968             2.4 8.3     2.8 
Ornithine decarboxylase 
antizyme 2 BI982208             2.7 3.1     2.2 
Keratin 25D AI397347             -2.5     -2.2 -2.8 
unknown BI888548 2.5             3.4       
Alanyl (membrane) 
aminopeptidase  AI497338 2.0   2.1                 
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ATP synthase, H+ 
transporting, delta subunit BM186095   3.0         2.4         
unknown AI958860   2.3           2.3       
similar to Cyp2a4 protein [ AW421020   -2.2           -2.4       
unknown AI641239   2.0       2.1           
Selenoprotein P, plasma, 1 AF322071   -2.1       -2.7           
Carbonyl reductase 1 AF298898   2.2         2.1         
Fetuin B BI885905   -2.1           -2.9       
DnaJ (Hsp40) homolog, 
subfamily A, member 1 BI891737   3.6             3.6     
unknown BG302934   -2.0           -2.5       
unknown BQ618331   2.4         2.5         
Tat-interacting protein 
Tip30, AF329850   2.8         2.2         
 similar to NADH 
dehydrogenase subunit 4 AW078445   2.9   2.3               
unknown AI965077   3.1         2.8         
Ahsa1l protein BM103957   2.2             2.1     
unknown BI879928   2.1           2.4       
Eph-like receptor tyrosine 
kinase rtk5 AJ005026   2.9         4.2         
Complement component 3 AI588354   4.9         2.9         
Beta-2-microglobulin L05383   3.1         3.8         
unknown AI878489   2.9           2.9       
Rh50-like protein, AF209468   -2.3           -2.2       
unknown AW826221     2.2         2.2       
unknown BE017917     -2.5         -2.0       
Ribonucleotide reductase 
M2 polypeptide U57965     -2.2         -2.7       
unknown BM036361     2.1 2.1               
unknown BG883326     2.1               2.6 
unknown AW421018     2.5         7.8       
Cytochrome P450, family 
1, subfamily A, polypeptide 
1 BG738243     3.1             12.9   
unknown AW232171     2.1         4.1       
unknown BI867396     2.2         3.3       
Phosphoenolpyruvate 
carboxykinase 1 (soluble) BG727092     2.4         3.7       
Mannose receptor, C type 2 BI533854       3.8         2.9     
 similar to UP|Q13641 
(Q13641) 5T4 oncofoetal 
antigen precursor  AW117094       2.0       2.5       
unknown BI878214       3.1   2.2           
Pyruvate dehydrogenase 
kinase, isoenzyme 2 BM101544       2.7       2.1       
unknown BI887138       2.5     2.4         
unknown BI880567       2.0       2.0       
MAP kinase interacting 
serine/threonine kinase 2 BI839784       2.9     2.0         
MAP kinase interacting 
serine/threonine kinase 2 BI533884       2.8       2.3       
unknown AW344023       2.4   2.2           
Keratin 13 BE200701       -2.4     -2.2         
 Ela2 protein  BI705588       -2.4     -3.8         
unknown BI889166       -2.1       -2.9       
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 DNA replication complex 
GINS protein PSF2, BI887230       -2.1       -2.7       
Retinitis pigmentosa 9 
protein AI657551       2.4       2.8       
Stathmin 1/oncoprotein 18 BI891936       -2.5       -2.8       
Apolipoprotein D BM101644       -2.0     -2.1         
Deoxycytidine kinase AW059347       -2.6       -2.8       
unknown AI793733       -2.1       -2.1       
Thioredoxin interacting 
protein BI892352       2.0             2.0 
unknown BI705262       3.3 2.2             
unknown BI325662       -2.6       -2.3       
unknown AW419887       2.1     2.3         
unknown AW280086       2.3       7.8       
Chemokine (C-X-C motif) 
ligand 3 BI845861       2.8   3.8           
Vitellogenin 1 BI841891       2.1             2.1 
Ubiquitin-conjugating 
enzyme E2D 4 BM072375       2.2       2.4       
unknown BM036395       2.2       2.3       
unknown BI867672       2.5             2.5 
unknown BI533153       2.0       3.6       
unknown AI354170       -2.1     -2.0         
unknown BI839240       2.1       2.1       
Glutamate-cysteine ligase, 
modifier subunit BG304082           2.4   2.4       
Tubulin, beta 4 BM186665           -2.8         -2.0 
Complement component 3 AW116558           2.3     2.8     
Myeloperoxidase AF349034           2.5     2.2     
unknown AW019023           2.3 2.7         
Complement component 3 AF047415           2.9     3.1     
unknown BI474299           2.2         2.0 
unknown BE605410           -2.2         -2.0 
complement component 
C3A AF047413           2.4     3.0     
unknown AW154517             2.2 3.9       
Kruppel-like factor 2 (lung) AF392992             -2.3 -2.5       
unknown BF157296             2.5 2.1       
Ornithine decarboxylase 1 AF290981             3.0 3.4       
unknown BI839678             -2.1 -2.3       
Chymotrypsin C 
(Caldecrin) AW174168             -3.2       -2.1 
unknown BI670896               2.8     2.5 
H1 histone family, member 
X AW280290               2.7     2.1 
Green sensitive cone opsin AF109369               -2.0 -2.4     
Gelsolin, AF175294               -2.1 -2.5     
Stathmin-like 4 BG308624               2.2     3.0 
SPANX-N2 protein BI889255               3.5     2.4 
unknown BM183152               -2.4   3.3   
unknown BI706384               -2.6 -6.2     
Tissue inhibitor of 
metalloproteinase 3  BM023829               2.5     2.0 
Guanine nucleotide binding 
protein (G protein), beta BI879650                 -2.1   -2.6 
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polypeptide 3 
unknown BM101640 -2.2                     
unknown BG883709 2.1                     
Alkyl-
dihydroxyacetonephosphate 
synthase precursor BI709370 -2.9                     
 Heat shock protein HSP 
90-alpha AF068773   2.6                   
unknown AI497477   -2.1                   
unknown AF006006   2.5                   
unknown AI658234   -2.5                   
Monoacylglycerol O-
acyltransferase 1 BI892323   -2.3                   
unknown AI641383   2.1                   
unknown AI959120   -2.6                   
unknown AW019145   -2.3                   
Apolipoprotein A-IV AI477980   -2.0                   
unknown BG303673   -2.1                   
Alanine-glyoxylate 
aminotransferase 2-like 1 AW154396   -2.0                   
Dihydrodiol dehydrogenase 
(dimeric) BI708067   2.1                   
unknown BG883651   -2.1                   
unknown BM072262   -2.1                   
Heat shock cognate 70 kDa 
protein BM024785   3.0                   
Keratin 6 AI477659   -2.1                   
unknown BF938011   2.8                   
unknown AW420765   2.1                   
unknown AW232145   2.1                   
Fatty acid binding protein 
2, intestinal AF180921   -2.4                   
Membrane-bound 
aminopeptidase P   BG304004   -2.0                   
unknown AI957765   2.5                   
unknown AW202621   2.1                   
unknown BG799351   -2.1                   
unknown BI880804   2.2                   
Proteasome (prosome, 
macropain) subunit, beta 
type, 8 AF155578   2.1                   
unknown AW184521   -2.0                   
unknown AW019312   -2.2                   
DNA-damage-inducible 
transcript 4 BI843145     -2.8                 
Apolipoprotein B 
(including Ag(x) antigen) AI943057     -2.2                 
Microsomal NAD+-
dependent retinol 
dehydrogenase 4 AW019006     2.2                 
Tumor necrosis factor, 
alpha-induced protein 9 BI878750       2.3               
unknown AI331043       2.2               
Topoisomerase (DNA) II 
alpha  BM156751       -2.2               
unknown AW019526       -2.5               
unknown AI353803       -2.4               
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unknown BF717646       -2.1               
unknown BE605735       2.5               
Cytochrome P450 
monooxygenase CYP2K6 AF283813       3.1               
Guanylate kinase 1 BI670894       -2.1               
 High choriolytic enzyme, AI877922       -2.0               
unknown BI704423       -2.5               
unknown BM186492       2.1               
unknown BF157317       2.0               
Retinoblastoma binding 
protein 4 AW116425       -2.1               
unknown BE606169       5.0               
Claudin 7 AF260240       2.1               
unknown AI353541       2.8               
unknown BG727177       2.2               
Mic2l1 BI888934       -2.1               
unknown AI330404       3.1               
Ubiquitin-conjugating 
enzyme E2T (putative) AW420785       -2.1               
 similar to Serum amyloid 
A protein BI883516       5.5               
unknown BI892060       2.0               
unknown BM072227       -2.0               
unknown BI896258       -2.4               
unknown BI878269       2.2               
unknown BF158097       2.0               
unknown BI843139       2.7               
unknown BI430332       2.1               
Apolipoprotein E precursor 
(Apo-E) AJ236882       2.2               
unknown AI354073       2.2               
unknown AI385015         4.0             
unknown BM103895         2.2             
unknown AI384392         3.1             
unknown AF272963         2.1             
unknown BM070515         2.7             
 Odorant receptor 9.1 AF283560         2.7             
Dynamo protein precursor, X99769         2.3             
unknown BI866476         4.6             
unknown BM185062           -2.5           
unknown AW420476           -2.7           
unknown AI957831           -2.3           
unknown BI886601           -2.1           
unknown AI667275           -2.2           
unknown BG306925           -2.3           
unknown BI979388           -2.4           
unknown AA542597           -2.0           
unknown BI891316           -2.0           
unknown AI722545           -3.1           
unknown AI558658           -3.1           
unknown BI885320           -2.1           
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unknown BI889335           -2.2           
unknown BI350885           -2.3           
unknown BE016427           -3.1           
unknown BI886668           -2.3           
unknown BM182366           -2.2           
unknown AW171394           -2.1           
unknown AI793818           2.9           
unknown AI721719           -2.1           
unknown BI980805           -2.1           
unknown AW420546           2.1           
unknown BI844137           -2.0           
NADH-cytochrome b5 
reductase AI722339           -2.1           
Serine protease-like protein 
precursor,  AW174653           2.0           
unknown AW279682           -2.0           
 Sirtuin 2 (Silent mating 
type information regulation 
2, homolog) 2, BI876457           -2.0           
unknown BG303805           -2.1           
 iodothyronine deiodinase 
type I BF717782           -2.9           
unknown BI886819           -2.2           
unknown BI887093           -2.3           
unknown BI318394           -2.1           
unknown AW343746           -2.2           
unknown BI890893           -2.2           
unknown BI865881           -2.1           
unknown AW466634           -3.0           
unknown AI584430           2.0           
unknown BG302634           3.0           
unknown BG303804           -2.3           
unknown AW058848           -2.1           
Hypoxia up-regulated 1 AW116343           2.2           
Taldo1 protein, c BI886290           2.1           
unknown AI415997           -2.1           
unknown BI889194           -2.6           
unknown AI723212           -2.2           
glutathione peroxidase AW232474           -4.2           
Prostate cancer antigen-1 BI708772           -2.2           
Leucine zipper 
transcription factor-like 1 BI879148           -2.0           
Hypoxia up-regulated 1 BI876732           2.3           
unknown AW174469           -2.2           
Myeloid-restricted 
CCAAT/enhancer-binding 
protein 1, AF306857           2.6           
unknown BI878747           -2.2           
Prostate cancer antigen-1 BI673635           -2.3           
unknown BI892110           2.7           
unknown AW128255           -2.6           
unknown BI887764           -2.0           
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unknown AW059129           -2.1           
phospholipid 
hydroperoxide glutathione 
peroxidase A  BI896246           -2.6           
unknown BI888493           2.0           
unknown BG303490           -2.9           
Proto galectin Gal1-L2, BM155827           2.1           
unknown BG302581           2.9           
unknown BI867917           -2.2           
unknown BM036297           -2.3           
unknown BI982778           -2.6           
unknown AI974189           2.1           
 Tubulin, beta, 2, BI864873           -2.4           
unknown BI705720           -2.5           
Ceruloplasmin, AF336125           2.0           
Cry5 protein  AB042254           2.2           
unknown BI673353           -2.1           
unknown AW077600           2.3           
unknown BI672089           -2.3           
unknown BI880385           -2.1           
 Chaperone protein GP96  AW116284           2.1           
unknown AA495102           2.2           
Cofactor of BRCA1 AI959391           -2.2           
ZEFEPEN ependymin M89643             -3.2         
unknown BI868150             2.2         
UDP glycosyltransferase 2 
family, polypeptide B7 AW127886             2.2         
unknown AI384206             -2.1         
unknown AI958489             -3.8         
unknown AI793508             -2.1         
Myelin protein zero AI667023             -3.0         
unknown BM036460             2.0         
carboxyl ester lipase AF003943             -2.0         
unknown BM005137             -2.2         
ATPase, Na+/K+ 
transporting, alpha 2 (+) 
polypeptide AF286374             -3.8         
Similar to peptidyl-Pro cis 
trans isomerase AW567464             -2.2         
unknown BM186973               -2.1       
unknown AW154454               -2.2       
Cyclin-selective ubiquitin 
carrier protein E2-C BE558133               -2.1       
unknown BM025101               2.1       
unknown AI942960               2.0       
unknown AF237712               -2.6       
unknown AI585113               -3.9       
unknown BI882477               2.5       
unknown BM154668               2.0       
unknown AI522421               2.1       
unknown BM104369               -2.2       
unknown AW018635               -2.1       
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unknown BI888241               2.6       
unknown BI886200               -2.3       
Fatty acid binding protein 
6, ileal (gastrotropin) AF254642               -2.9       
unknown BI882450               2.5       
unknown BI671128               2.1       
Thymidine kinase 1 AW116726               -2.1       
DNA methyltransferase 3 BI886329               -2.2       
Ecrg4-A protein,  BI844226               2.0       
unknown BM095379               -2.5       
unknown BI843105               -2.2       
unknown AW058891               2.1       
unknown AI974197               3.4       
Solute carrier family 15, 
member 4 BI866561               2.2       
Ankyrin repeat domain 11 AW115851               -2.0       
unknown BI866278               2.3       
unknown AW280217               2.4       
unknown BI888424               2.5       
 glutathione peroxidase AW232570               3.1       
unknown AI878420               2.2       
 Proliferating cell nuclear 
antigen (PCNA AF140608               -2.9       
Protein tyrosine 
phosphatase, receptor type, 
N AF190144               2.0       
MKK3 (Mitogen-activated 
protein kinase kinase 3) AB030899               -2.3       
Protein kinase, cAMP-
dependent, regulatory, type 
I, alpha  BE557009               -2.5       
Alpha-2-macroglobulin BI326783               -2.4       
unknown BI705537               -2.5       
Cell division control 
protein 2 BI888928               -2.2       
unknown BM182744               3.4       
F-box protein 2 BI879965               -2.0       
unknown BI878593               -2.8       
Activating transcription 
factor 5 AW420576               2.1       
 Ephx1 protein  BI704181               -2.1       
Heterogeneous nuclear 
ribonucleoprotein L BI889298               -2.0       
unknown BI983342               -2.1       
 flap structure-specific 
endonuclease 1 AI957820               -2.0       
unknown BI475933               2.6       
Blue-sensitive opsin AF109372               -2.6       
unknown AI626605               2.0       
Period homolog 2 
(Drosophila) BG303941               3.5       
unknown AI883944               2.1       
unknown AI584429               -2.2       
unknown BG308412               2.4       
unknown BE016173               2.2       
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Beta ig-h3 BF717383               -2.2       
Connective tissue growth 
factor precursor BE693178               2.5       
unknown BM154097               2.5       
unknown AL719902               -2.1       
unknown BM070610               2.1       
unknown AI588560               -2.2       
unknown BI982101               2.6       
unknown AI877518               -3.4       
Gonadotropin releasing 
hormone precursor, AJ304429               2.0       
unknown BI880600               2.1       
 Ribonucleoside-
diphosphate reductase M1 
chain  U57964               -2.3       
unknown AI641731               2.2       
unknown BI983434               -2.4       
Tribbles homolog 2 
(Drosophila) BI886711               3.6       
unknown AI878005               -2.5       
Response gene to 
complement 32 BI888368               2.9       
unknown BI880133               2.3       
unknown BI883408               2.2       
Succinate-CoA ligase, 
GDP-forming, beta subunit BF717706               -2.2       
unknown AI354010               -2.1       
unknown BE015932               3.1       
F-box protein 8 BG799020               2.1       
unknown BG884516               2.4       
unknown BI983410               2.1       
follistatin-like 1  AI884233               2.4       
Prostaglandin G/H synthase 
2  AW077995               3.2       
unknown AI793707               2.2       
unknown AI544644               2.6       
MutS homolog 6  AF412834               -2.2       
unknown AL591382               3.9       
unknown AI584441               -2.1       
Solute carrier family 43, 
member 2 BI887324               2.1       
Ring finger protein 38 AI666928               2.2       
unknown BG727383               2.4       
Solute carrier family 3 BG985518               2.1       
Component of oligomeric 
golgi complex 2 BG728947               2.3       
Alpha tubulin AI877819               -2.0       
unknown BI326782               -2.2       
unknown AW342722               -2.1       
unknown BI886268               -2.5       
unknown BM082387               2.0       
unknown BE016163               4.4       
MMMNK1 map kinase 
interacting kinase BI705604               3.3       
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unknown AW019245               2.1       
unknown BG727339               2.2       
unknown BG883210               -2.8       
unknown AI721732               2.1       
Sprouty homolog 4 
(Drosophila) AF371368               2.7       
Type II Na/Pi cotransport 
system protein, AF121796               -2.7       
Myeloid cell leukemia 
sequence 1 AF441284               2.2       
 RNA-binding protein AI958253               -2.2       
Ribonucleotide reductase 
M2 polypeptide AI957409               -3.4       
unknown BM071693               2.8       
Jun dimerization protein 2 BI326453               3.5       
unknown AI331606               -2.1       
Protein tyrosine 
phosphatase type IVA, 
member 3 BM095161               2.3       
unknown BG303759               2.1       
unknown BI865702               2.1       
unknown BG985441               -2.2       
Cyclin B2 AB040435               -2.4       
Brain-derived neurotrophic 
factor| U42489               3.0       
unknown BG728644               2.2       
MAM domain containing 2 BI866865               3.4       
unknown BI672160               2.0       
Prestin (motor protein) BG727321               2.0       
 Cytochrome b5 AI558444               2.1       
APEX nuclease 
(multifunctional DNA 
repair enzyme) 1 BI883953               -2.3       
Pim-3 oncogene AF062643               3.9       
unknown AI722353               7.3       
unknown BI983171               2.3       
unknown AI723236               2.7       
unknown BM005448               2.1       
Cytochrome P450 AF248042               -2.6       
Thymidylate synthetase AY005804               -3.3       
Cell death regulator Mcl-
1a, AF302805               3.0       
Solute carrier family 20 
(phosphate transporter), 
member 1 BI890772               2.2       
MCM5 minichromosome 
maintenance deficient 5 AW058902               -2.8       
unknown BI883251               -2.6       
unknown AI105923               2.3       
Replication protein A2, AY007304               -2.5       
Myogenin AF202639               2.2       
Nuclear transcription factor 
Y, beta BM070524               2.5       
 Serine/threonine-protein 
kinase PLK1 AW116681               -2.1       
unknown BM777961               2.1       
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Deoxycytidine kinase AW203020               -2.3       
 Creatine kinase 
mitochondrial isoform 
precursor,  AW116371                 -2.6     
Retina and anterior neural 
fold homeobox AF001908                 -2.3     
unknown BI879707                 -2.6     
Tyrosinase  , AJ250302                 -2.2     
Tyrosinase-related protein 
1 BI882649                 -3.9     
Retinol binding protein 3, 
interstitial X85957                 -2.1     
Retinol binding protein 1, 
cellular AW018731                 -2.0     
unknown BE016208                 -3.0     
Complement component 9 AW019201                 2.3     
unknown BI670844                 -2.2     
unknown BG305908                 -2.5     
Retinal pigment 
epithelium-specific protein 
65kDa BI670861                 -4.2     
Silver homolog (mouse) AW076688                 -3.7     
Silver homolog (mouse) AW232707                 -3.1     
Retinal G protein coupled 
receptor AI497566                 -2.5     
unknown BI883231                 -2.3     
Photoreceptor protein s26 BI670920                 -2.1     
Dopachrome tautomerase AF280090                 -2.4     
unknown BG305033                 -4.0     
Gngt2 protein AY050507                 -2.4     
unknown AI384221                   2.1   
Forkhead box Q1 AW566603                   2.1   
Sulfotransferase AI959735                   2.8   
unknown BM101698                   2.2   
Cytochrome c oxidase 
subunit IV isoform 2  BI672330                   2.3   
unknown AW280011                     2.1 
Stathmin-like 4 BI430135                     2.1 
unknown BI888755                     -2.1 
unknown AI959644                     -2.2 
Mitogen-activated protein 
kinase phosphatase x  BI888527                     2.3 
unknown BI474304                     2.1 
unknown BI702683                     2.2 
Lipocalin-type 
prostaglandin D synthase-
like protein, BE017457                     2.4 
unknown BM035924                     2.1 
unknown BI886755                     2.2 
Solute carrier family 6 
(GABA transporter), 
member 1 BF157011                     -3.1 
 Cathepsin D BG303005                     2.1 
Protein kinase (cAMP-
dependent, catalytic) 
inhibitor alpha BI863877                     2.6 
Angiopoietin-like 3 AW421268                     2.0 
 153
unknown AI793607                     2.2 
unknown AW777561                     2.4 
Kruppel-like factor 10 AI641738                     2.2 
LIM and cysteine-rich 
domains protein 1, BG799149                     2.1 
unknown BM037052                     2.2 
unknown BG728726                     2.0 
unknown AI545224                     2.1 
Solute carrier family 6 
(transporter, GABA), 
member 1 BI563084                     -2.1 
unknown BI866300                     2.2 
unknown BI889456                     -2.3 
unknown BI865754                     -2.0 
unknown AL590147                     2.2 
unknown AW280656                     -2.0 
unknown BM156045                     2.2 
ATPase, Na+/K+ 
transporting, alpha 2 (+) 
polypeptide AF308599                     -2.3 
unknown BI673984                     2.3 
Gamma crystallin M3  BM154967                     2.8 
unknown AI617260                     2.7 
unknown BG308220                     -2.0 
unknown BI896367                     2.3 
Nr0b2 protein BI892036                     -2.0 
Neuroglobin, AJ315610                     -2.2 
Histone 3, H2a AI667325                     -2.0 
unknown BI533455                     -2.0 
unknown BM141538                     2.0 
 
 
 
 
 
 
 
 
 
